data_2m1b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 ' CD2' ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 70' ' ' VAL . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' LEU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.466 ' CE1' ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.494 ' O ' HD21 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.529 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.71 0.29 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 70' ' ' VAL . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 38' ' ' LEU . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' NH1' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.441 ' NH1' ' CD1' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.496 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 98' ' ' PHE . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.657 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.455 HG13 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' CG2' HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.405 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 70' ' ' VAL . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 38' ' ' LEU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 96' ' ' TYR . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG13 ' CB ' ' A' ' 91' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' CG ' ' CE1' ' A' ' 73' ' ' HIS . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HD23 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 52' ' ' LYS . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' A' ' 70' ' ' VAL . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.779 0.323 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' CG2' HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.447 ' CE1' ' CG ' ' A' ' 34' ' ' GLU . 1.1 t60 -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD23 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 121.152 0.501 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 81' ' ' LEU . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CG1' ' CD1' ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.529 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 74' ' ' ILE . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 91' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 41' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 21' ' ' VAL . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' A' ' 98' ' ' PHE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.535 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 85' ' ' GLY . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.419 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 91' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.411 ' CG ' HD11 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.705 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.517 HG13 ' HG ' ' A' ' 42' ' ' LEU . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.452 ' CD2' ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.476 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 35' ' ' SER . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 58' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 96.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.732 0.301 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' HG12 ' A' ' 70' ' ' VAL . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 74' ' ' ILE . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CD1' HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.433 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.453 HG22 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG2' ' CE1' ' A' ' 73' ' ' HIS . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.559 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.367 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.434 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 m-70 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 73' ' ' HIS . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' HA ' ' CD1' ' A' ' 58' ' ' ILE . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 38' ' ' LEU . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.4 tp60 -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.664 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.664 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 37' ' ' ILE . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.4 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 74' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.434 ' CG ' ' HB2' ' A' ' 84' ' ' TYR . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 98' ' ' PHE . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 87' ' ' ARG . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.732 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' CD2' HG23 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 5' ' ' GLU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HA ' HD21 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 HD22 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CD2' ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 54' ' ' LEU . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.418 ' CE1' ' HG3' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' NH1' HD22 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.46 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.411 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 HD13 ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' CE1' ' A' ' 98' ' ' PHE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.601 ' O ' HD23 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG13 ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.633 0.254 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 70' ' ' VAL . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' CA ' HD22 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CG2' ' CE1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.479 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.219 0.533 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' ILE . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD2' HG23 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.604 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.41 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG12 ' CB ' ' A' ' 91' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.111 0.481 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' HD11 ' A' ' 37' ' ' ILE . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 34' ' ' GLU . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 98' ' ' PHE . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.588 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' N ' HD22 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.334 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.402 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 88' ' ' ILE . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.582 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 87.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 74' ' ' ILE . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 HD22 ' CA ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.415 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.43 ' CA ' HD22 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 121.096 0.474 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.691 0.281 . . . . 0.0 110.765 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 74' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 88' ' ' ILE . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.474 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 89' ' ' VAL . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.469 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 32' ' ' PRO . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.692 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.49 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 70' ' ' VAL . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 73' ' ' HIS . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.45 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.466 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.537 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.051 0.453 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' CG ' ' HB2' ' A' ' 84' ' ' TYR . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG22 ' CD2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.631 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 21' ' ' VAL . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.421 ' HB2' HD21 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' GLU . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' NZ ' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 39' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 6.7 t60 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.435 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 ' CD1' ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 1.6 t-160 -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 81' ' ' LEU . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.471 ' CE2' ' CG2' ' A' ' 88' ' ' ILE . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' PHE . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 2.5 m120 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.42 HD23 ' CE1' ' A' ' 14' ' ' PHE . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.427 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HA ' HD13 ' A' ' 37' ' ' ILE . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 81' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' N ' ' HB3' ' A' ' 98' ' ' PHE . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.723 ' O ' HD11 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 58' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' CG ' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.845 0.355 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.515 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 96' ' ' TYR . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 95' ' ' GLY . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 94' ' ' VAL . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 88' ' ' ILE . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.498 ' CZ ' ' CD ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE1' HD21 ' A' ' 38' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 39' ' ' LYS . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HA ' ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 HG13 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.515 ' CE1' HD23 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.416 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CZ ' ' CG2' ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG2' ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' HD11 ' A' ' 37' ' ' ILE . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 98' ' ' PHE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD23 ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.685 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.685 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 74' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HA ' HD21 ' A' ' 81' ' ' LEU . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.43 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' CG1' ' CB ' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.505 ' C ' HG11 ' A' ' 16' ' ' VAL . 3.3 mt-10 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.565 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.565 ' CG1' ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 80' ' ' LYS . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 28.0 m-70 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.509 ' O ' HD21 ' A' ' 30' ' ' LEU . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' HD23 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 98' ' ' PHE . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD13 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.671 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.436 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 88' ' ' ILE . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.464 ' CD1' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE1' HD23 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.817 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.541 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.49 HG23 HD13 ' A' ' 58' ' ' ILE . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.713 0.292 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 74' ' ' ILE . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 77' ' ' LEU . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CE1' ' HB3' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 88' ' ' ILE . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG23 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD1' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.817 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.247 0.546 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 28.7 m120 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.433 ' OG ' ' CD2' ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' CE1' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD13 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.476 HG13 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.976 0.417 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.43 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 77' ' ' LEU . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 9' ' ' PHE . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' CE1' ' HG ' ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' CD1' ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 98' ' ' PHE . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.522 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 54' ' ' LEU . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CZ ' ' CE1' ' A' ' 9' ' ' PHE . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 t60 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.48 118.1 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.05 111.81 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.13 156.97 17.53 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.571 2.181 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.07 40.31 3.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' CD2' ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 70' ' ' VAL . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.68 61.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 73' ' ' HIS . . . 55.88 101.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.851 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.62 35.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.175 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.1 p -173.23 40.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.192 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.55 -172.75 3.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 -26.48 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CD2' ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' LEU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.466 ' CE1' ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.03 116.15 9.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -106.42 -79.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.36 -58.07 0.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 -35.46 3.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.544 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.18 85.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -171.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.65 69.94 1.2 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.6 113.41 13.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.2 79.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.96 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -65.46 172.77 3.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -109.29 -20.4 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.14 178.96 9.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.15 95.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.24 88.6 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.17 160.52 32.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 pp -59.56 159.02 8.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.896 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 m -66.51 103.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.93 134.03 47.47 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -52.2 116.11 2.6 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.483 2.122 . . . . 0.0 112.367 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -95.89 -17.68 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.494 ' O ' HD21 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.529 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -69.67 63.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 47.49 93.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.317 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 mm -96.69 30.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.182 0.515 . . . . 0.0 110.968 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -157.97 35.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.35 -163.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.911 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -109.95 -21.63 12.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.4 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 70' ' ' VAL . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 38' ' ' LEU . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' NH1' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.441 ' NH1' ' CD1' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.56 131.71 16.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.65 -31.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.196 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.73 -68.22 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.33 38.18 1.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.707 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.46 70.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.955 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 146.28 55.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 141.89 58.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 162.29 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 138.77 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.0 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -67.56 -31.86 72.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.049 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 113.9 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.2 -16.26 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.5 t -56.57 148.44 19.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.334 . . . . 0.0 111.077 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -62.16 155.99 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.85 126.64 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.0 t -160.2 94.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -54.22 46.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -97.16 101.95 13.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 p -159.22 98.38 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.43 89.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.505 2.136 . . . . 0.0 112.257 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -98.41 32.94 2.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.496 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 98' ' ' PHE . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.657 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.455 HG13 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 56.98 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 49.68 98.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.408 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 tp -94.2 33.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.922 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.11 38.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.045 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.14 -165.38 1.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -110.62 -27.56 8.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' CG2' HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.405 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 70' ' ' VAL . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 38' ' ' LEU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 96' ' ' TYR . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG13 ' CB ' ' A' ' 91' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 91.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -80.54 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -160.54 -69.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.006 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.37 -25.15 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.639 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -175.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.167 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -130.17 -176.38 3.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -150.06 104.45 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -65.3 122.9 18.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 94.33 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -70.04 -25.35 63.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.23 93.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -127.87 1.57 6.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.506 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -160.21 158.86 30.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -65.47 78.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 135.45 57.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -160.06 161.45 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.69 169.86 1.67 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.798 0.333 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.34 105.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.18 128.48 11.88 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 96.2 Cg_endo -84.2 157.61 13.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.554 2.169 . . . . 0.0 112.168 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -53.04 4.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' CG ' ' CE1' ' A' ' 73' ' ' HIS . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HD23 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 4' ' ' PRO . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 52' ' ' LYS . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' A' ' 70' ' ' VAL . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -70.22 61.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.09 96.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.637 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 65' ' ' ILE . 6.6 tp -95.56 30.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.08 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.2 t -157.69 37.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.532 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.39 -165.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.106 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -109.7 -25.22 10.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' CG2' HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.447 ' CE1' ' CG ' ' A' ' 34' ' ' GLU . 1.1 t60 -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD23 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.22 122.65 23.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.46 -80.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.38 -57.89 0.06 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.08 66.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -171.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 156.73 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.26 135.38 17.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.44 92.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.3 140.11 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -74.25 161.73 29.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -109.75 -28.51 8.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.963 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 83.19 3.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -59.69 119.29 7.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -150.15 146.82 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 t -160.12 149.71 17.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.44 -59.36 5.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -101.9 131.87 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.7 t 59.14 90.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.93 -170.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.245 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.14 -75.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.718 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 81' ' ' LEU . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CG1' ' CD1' ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.529 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -55.14 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.7 72.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.527 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.01 106.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t 54.16 69.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.51 -168.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -115.68 -35.57 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 74' ' ' ILE . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 91' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 41' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -61.9 84.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -120.29 -70.73 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.124 0.488 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.19 -59.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.31 30.7 8.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -130.07 100.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 152.29 38.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 117.56 8.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -179.98 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -150.11 79.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -63.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.1 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -58.78 124.42 19.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.49 -18.76 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.383 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -61.98 150.82 36.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.5 172.07 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.13 159.08 44.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.6 127.04 29.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.93 -49.33 68.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.913 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -48.22 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.63 83.93 11.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HB3' ' CE ' ' A' ' 104' ' ' LYS . 52.7 Cg_exo -54.01 126.13 21.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.49 2.126 . . . . 0.0 112.21 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.04 -30.29 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 21' ' ' VAL . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' A' ' 98' ' ' PHE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' NZ ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.44 51.98 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 33' ' ' SER . . . 62.15 37.63 14.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 0.7 OUTLIER 41.92 79.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.399 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 7.7 p 44.0 59.83 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.639 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.42 -170.11 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -62.48 -65.32 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.535 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 85' ' ' GLY . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.419 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 91' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.411 ' CG ' HD11 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.705 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t -39.33 146.68 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.19 65.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.958 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -39.76 -70.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.822 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 43.22 80.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.095 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 0.0 111.221 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' NZ ' ' CD1' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.25 155.51 20.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.866 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -150.3 93.9 2.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 111.368 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.22 135.88 37.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.3 t -150.15 91.96 1.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -68.78 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 166.59 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.73 30.81 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.13 144.82 14.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.002 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -62.22 124.93 22.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 127.9 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -66.06 117.34 8.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.93 150.2 34.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.806 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 1.4 m 59.77 103.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.94 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.13 148.1 65.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 144.6 49.92 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.61 2.206 . . . . 0.0 112.296 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -149.11 40.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 HG13 ' HG ' ' A' ' 42' ' ' LEU . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.452 ' CD2' ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.476 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 35' ' ' SER . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 58' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -71.16 65.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.78 90.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.5 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.267 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -152.11 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.27 67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.983 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 96.0 mtt180 -158.36 55.48 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.995 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' HG12 ' A' ' 70' ' ' VAL . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 74' ' ' ILE . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CD1' HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.433 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.453 HG22 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.85 139.41 47.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.32 -37.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -160.08 -67.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.892 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 75.3 0.43 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.591 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.07 77.28 1.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.834 0.349 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.47 113.21 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -73.99 112.07 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 2' ' ' SER . 0.3 OUTLIER -75.94 61.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 77.32 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -60.19 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.1 -165.22 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -95.85 23.09 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -69.81 115.91 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.13 154.04 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.89 79.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.41 149.26 48.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.33 143.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.5 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 m -65.51 109.19 2.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.12 178.01 4.59 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -124.74 -74.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.587 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG2' ' CE1' ' A' ' 73' ' ' HIS . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.559 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.12 129.48 35.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.25 62.19 2.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.84 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.68 89.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.704 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t 56.09 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 57.11 66.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -160.08 55.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.434 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 m-70 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p -63.72 95.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.404 ' CB ' ' HD3' ' A' ' 87' ' ' ARG . 44.0 t0 -116.22 -80.61 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -160.6 -62.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 36.07 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.19 149.02 43.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.16 141.77 50.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -62.21 167.61 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -53.87 120.8 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -59.8 137.42 58.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -60.5 -55.91 27.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 141.02 56.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -61.54 -27.02 68.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.3 p -71.76 141.18 49.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -160.14 125.19 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 90.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 118.94 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -56.54 149.14 17.91 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.22 82.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.924 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.98 156.41 51.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.16 129.93 12.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.7 2.267 . . . . 0.0 112.245 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.54 -55.28 2.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 73' ' ' HIS . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' HA ' ' CD1' ' A' ' 58' ' ' ILE . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 38' ' ' LEU . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.4 tp60 -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.664 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.664 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 37' ' ' ILE . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 77.82 3.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . 57.35 82.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.201 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 2.0 tt -56.24 116.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 12.9 p 44.38 45.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.51 -175.45 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -82.28 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 74' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' CG ' ' HB2' ' A' ' 84' ' ' TYR . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 98' ' ' PHE . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 87' ' ' ARG . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.6 m -59.82 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -128.79 -80.3 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.058 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -69.88 0.83 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.958 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.14 29.07 2.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.11 154.31 47.6 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 167.37 18.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -47.89 134.41 13.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.281 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.61 134.93 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 144.07 57.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.72 -50.49 70.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.31 156.27 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -149.99 31.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -60.95 142.15 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -160.09 159.75 32.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.958 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.14 103.1 3.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.57 78.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -61.27 141.91 57.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.882 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 m80 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.847 0.356 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -114.22 -56.47 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.2 114.28 28.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -60.94 -177.26 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.449 2.099 . . . . 0.0 112.232 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.8 OUTLIER -136.87 -76.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.732 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' CD2' HG23 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 5' ' ' GLU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HA ' HD21 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD22 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CD2' ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 54' ' ' LEU . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 65.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.98 93.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.49 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 mt -97.69 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.17 0.509 . . . . 0.0 110.783 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -177.03 38.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . . . -169.56 -165.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -117.21 -17.97 10.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.617 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' NH1' HD22 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.46 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.411 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p -43.45 166.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -64.85 -18.57 65.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.563 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -61.85 51.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.58 69.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.532 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.94 -169.98 2.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -57.48 175.92 0.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 95.01 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.958 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.53 100.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 128.2 34.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.08 -73.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.74 148.83 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -121.07 29.6 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -160.16 124.02 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -60.19 92.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 119.29 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -160.11 147.24 16.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.39 112.82 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.929 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -71.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -87.8 148.65 44.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -56.85 -172.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.98 -75.13 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CE2' ' OD2' ' A' ' 101' ' ' ASP . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 HD13 ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' CE1' ' A' ' 98' ' ' PHE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.601 ' O ' HD23 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG13 ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -85.46 48.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 54.49 86.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 tt -91.1 32.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 111.052 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.74 41.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.941 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 59.48 77.8 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 -160.1 55.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 70' ' ' VAL . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' CA ' HD22 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CG2' ' CE1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.479 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -126.23 132.27 51.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -77.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.732 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -109.98 -70.02 0.83 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.05 35.71 2.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.597 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.42 83.0 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 128.71 36.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.62 88.94 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.21 86.96 2.11 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.2 t -66.36 109.02 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -86.99 7.73 26.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.41 132.82 54.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -122.54 -41.27 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t -160.23 159.42 31.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.2 69.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.29 104.16 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.78 124.53 21.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.17 178.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.8 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.775 0.321 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.13 103.52 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.38 110.83 4.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.02 -168.57 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.442 2.095 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -132.9 -58.65 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' ILE . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD2' HG23 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.604 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.03 61.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 66' ' ' VAL . . . 58.73 110.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.864 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.79 28.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.565 0.698 . . . . 0.0 110.198 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.7 t -159.64 164.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.578 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.53 87.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 111.163 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -160.22 55.6 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.41 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG12 ' CB ' ' A' ' 91' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.8 m -57.92 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -75.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -160.25 -67.88 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.7 5.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.31 137.41 57.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 176.06 1.25 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -60.74 138.61 58.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.73 153.08 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.18 148.67 35.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -69.55 -32.52 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.13 149.23 42.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -142.44 -69.36 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.179 0.514 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.28 -174.8 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -159.36 73.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.68 -177.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 t -160.11 -175.65 5.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.74 146.68 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.872 0.368 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m -110.54 -27.4 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.91 95.67 30.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.181 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.97 -172.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.508 2.139 . . . . 0.0 112.138 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.97 -75.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.817 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' HD11 ' A' ' 37' ' ' ILE . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 34' ' ' GLU . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 98' ' ' PHE . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.588 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' N ' HD22 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.26 61.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . 54.44 26.14 6.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' ALA . 5.8 mt 26.36 43.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER 179.99 -165.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' N ' ' CG1' ' A' ' 66' ' ' VAL . . . -76.03 87.63 2.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.359 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -150.0 55.39 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.402 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 88' ' ' ILE . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -100.46 134.64 43.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' HB2' ' CD ' ' A' ' 87' ' ' ARG . 4.8 t70 -140.33 -63.4 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.275 0.56 . . . . 0.0 110.778 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -160.12 -55.81 0.06 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.736 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.92 8.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.605 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.2 98.96 6.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.773 0.32 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 133.35 16.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 162.19 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.34 85.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.21 -74.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.3 91.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -71.27 -18.17 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.17 146.39 28.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 111.002 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -160.14 92.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 pp -59.82 163.86 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.18 115.79 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.12 -67.3 0.4 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.805 0.335 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -174.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.87 75.98 71.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.195 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.65 165.15 16.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.603 2.202 . . . . 0.0 112.229 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -110.44 -76.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.582 ' C ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.26 65.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 52.07 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -94.06 34.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 0.0 110.968 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p -170.21 41.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.353 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 56.2 72.41 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 87.0 mtt180 -159.8 55.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 74' ' ' ILE . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 HD22 ' CA ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.43 ' CA ' HD22 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.79 130.11 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.52 -59.04 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.167 0.508 . . . . 0.0 110.898 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.1 -44.61 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.936 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 47.24 3.44 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -130.1 91.76 3.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.851 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.24 165.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.784 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 101.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 171.91 13.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.989 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.21 135.24 17.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.799 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.24 -44.63 95.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -66.47 157.42 32.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -100.32 30.64 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.2 p -160.05 135.67 8.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.12 75.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.72 80.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.44 152.31 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 154.74 19.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.882 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 60.74 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 t 62.41 97.96 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 23.3 Cg_exo -64.13 -176.48 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.702 2.268 . . . . 0.0 112.14 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.82 -76.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.641 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.584 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt -79.14 55.23 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' CB ' ' CB ' ' A' ' 68' ' ' ARG . . . 50.79 35.96 13.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.727 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER 42.66 47.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.246 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.2 t 59.25 153.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.96 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 75.06 29.72 0.94 Allowed 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.402 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.455 ' CB ' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -161.17 55.92 0.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 74' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 88' ' ' ILE . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' CE1' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 89' ' ' VAL . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m -38.72 137.35 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -22.29 5.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.262 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -39.69 -70.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.475 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 34.88 80.13 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.317 -0.402 . . . . 0.0 113.61 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.37 97.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 0.0 110.99 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 162.44 23.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -64.94 143.12 58.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.36 174.67 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.057 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -64.72 102.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -70.19 -72.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.74 109.27 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.127 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -116.93 -17.2 10.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 p -59.11 105.37 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.764 0.316 . . . . 0.0 111.036 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.28 69.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.93 140.77 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.1 159.65 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.43 103.78 0.44 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.55 132.61 36.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 19.9 Cg_exo -64.5 162.59 30.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.357 2.038 . . . . 0.0 112.737 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.15 -67.89 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 32' ' ' PRO . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.469 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 32' ' ' PRO . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.692 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -82.24 56.53 3.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 33' ' ' SER . . . 62.1 36.12 15.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG21 ' A' ' 65' ' ' ILE . 0.4 OUTLIER 39.74 76.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.506 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t 59.42 77.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.67 -172.39 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -75.05 -65.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.49 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 70' ' ' VAL . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 73' ' ' HIS . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.45 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.537 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 98' ' ' PHE . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.8 t -117.91 130.68 56.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 -73.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.98 -49.45 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.849 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.45 77.81 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -179.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.822 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 21.0 mttt -150.49 172.29 15.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -69.14 150.01 48.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.4 t -59.06 141.49 53.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.27 -46.68 82.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.29 115.33 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.059 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -134.84 -30.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.492 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.0 p -62.51 146.63 51.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 120.48 2.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.13 120.17 7.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.977 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.35 129.82 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -60.28 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -162.29 128.23 3.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.89 96.37 26.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.25 -171.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.539 2.159 . . . . 0.0 112.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.74 -75.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 109.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.57 75.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.598 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.92 97.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.826 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p 43.89 43.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.514 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.74 -168.45 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -44.02 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 81' ' ' LEU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' CG ' ' HB2' ' A' ' 84' ' ' TYR . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG22 ' CD2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.631 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -39.02 141.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -65.24 -17.52 64.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.536 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.08 52.2 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.83 60.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.567 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -179.43 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.783 0.325 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -60.01 150.99 27.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.73 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 110.87 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -59.91 150.55 28.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -60.51 -66.6 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.93 115.09 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -146.41 29.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.44 124.25 20.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -160.13 118.38 2.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.0 -175.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 158.92 31.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.98 -32.77 71.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.938 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.94 85.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.782 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.79 122.3 19.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 42.0 Cg_endo -68.42 109.72 2.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.506 2.137 . . . . 0.0 112.556 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -150.39 38.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 21' ' ' VAL . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.421 ' HB2' HD21 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' GLU . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' NZ ' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 HD11 ' HG3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 39' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 6.7 t60 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.435 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 59.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 49.65 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.293 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 tt -94.08 33.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.225 0.536 . . . . 0.0 111.006 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.9 p -169.5 38.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB1' ' CE1' ' A' ' 73' ' ' HIS . . . -165.82 -176.5 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -107.54 -25.47 11.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 ' CD1' ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 1.6 t-160 -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HA ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 81' ' ' LEU . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.471 ' CE2' ' CG2' ' A' ' 88' ' ' ILE . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p -44.16 170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -57.78 -19.15 26.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.64 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 51.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.89 71.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.349 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -119.83 120.14 35.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.819 0.342 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' NZ ' ' HB2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -57.21 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.261 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -71.0 115.74 10.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.96 104.06 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -94.23 23.2 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.4 137.34 58.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -98.87 29.94 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -160.18 99.77 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.12 131.27 5.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -62.28 130.23 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.1 t -62.64 104.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -51.4 70.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.858 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -71.71 -35.87 70.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 m -119.98 133.52 23.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 16.7 Cg_exo -66.73 153.75 76.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.391 2.061 . . . . 0.0 112.005 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -91.86 -78.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' PHE . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 2.5 m120 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 4' ' ' PRO . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 HD23 ' CE1' ' A' ' 14' ' ' PHE . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.427 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HA ' HD13 ' A' ' 37' ' ' ILE . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 81' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.422 HD13 ' HG3' ' A' ' 4' ' ' PRO . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' N ' ' HB3' ' A' ' 98' ' ' PHE . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.723 ' O ' HD11 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 58' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' CG ' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.29 34.82 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.27 37.06 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.347 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -71.56 71.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.202 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 12.6 p 45.87 38.64 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.409 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -172.7 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.894 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -113.95 -29.18 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.431 ' CE1' HG22 ' A' ' 65' ' ' ILE . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 96' ' ' TYR . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 95' ' ' GLY . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 94' ' ' VAL . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 88' ' ' ILE . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.498 ' CZ ' ' CD ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 t -109.29 93.97 4.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -140.2 -53.35 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.204 0.526 . . . . 0.0 110.95 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.1 -70.13 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.006 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 131.17 -40.05 1.69 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.862 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 138.2 58.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.177 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -171.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.759 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 75.7 8.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.54 132.51 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.2 t -73.23 115.23 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.9 -68.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.235 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.19 152.14 11.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -150.11 -42.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 m -56.49 165.44 1.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.17 127.0 4.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.98 143.92 57.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.51 137.73 58.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -179.19 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.2 m170 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.733 0.301 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -127.96 160.85 30.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.32 117.74 52.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.46 82.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.487 2.124 . . . . 0.0 112.263 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.4 20.29 10.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE1' HD21 ' A' ' 38' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 39' ' ' LYS . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HA ' ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG13 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.31 55.0 3.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.66 34.72 24.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 65' ' ' ILE . 5.4 tp 41.24 81.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.542 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t 47.28 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.21 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.97 -172.1 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -63.95 -65.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' CE1' HD23 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -39.82 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -78.44 -17.16 56.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.486 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.09 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.68 0.792 . . . . 0.0 113.048 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.91 74.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.204 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.12 166.99 14.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.222 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -170.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 120.4 12.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.32 153.09 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -150.18 168.22 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -76.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -173.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.28 -69.54 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 0.0 110.792 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.09 111.34 1.94 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.765 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 70.04 1.43 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 82.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.6 t -57.29 158.75 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.9 mt -60.08 -45.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.896 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -174.37 108.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -116.62 88.27 24.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.09 129.23 23.76 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.62 2.214 . . . . 0.0 112.052 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 -50.32 3.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' HB ' ' CB ' ' A' ' 14' ' ' PHE . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CZ ' ' CG2' ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG2' ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' HD11 ' A' ' 37' ' ' ILE . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 98' ' ' PHE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD23 ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.685 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.685 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -99.83 30.84 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.15 -157.79 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.511 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 39.6 mm 52.46 27.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.8 0.81 . . . . 0.0 109.585 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 14.7 p 176.98 33.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.107 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 66' ' ' VAL . . . 154.42 -173.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 -26.16 9.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 74' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HA ' HD21 ' A' ' 81' ' ' LEU . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' N ' ' CD2' ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' CG1' ' CB ' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -71.02 107.42 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -140.11 -71.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 111.124 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -160.2 -65.11 0.07 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.7 22.66 3.58 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.0 69.68 6.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.01 175.46 8.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.97 144.91 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.042 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.94 117.21 6.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 t -65.17 120.9 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -30.03 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.72 117.7 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.18 -19.19 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.227 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.4 m -58.0 102.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -60.02 135.32 57.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.21 146.37 26.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 113.89 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.63 -43.33 97.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.985 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.8 m170 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.847 0.356 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.93 133.72 44.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.5 t 64.04 136.15 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 13.8 Cg_exo -69.45 58.47 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.571 2.181 . . . . 0.0 112.527 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.505 ' C ' HG11 ' A' ' 16' ' ' VAL . 3.3 mt-10 -82.51 -22.11 35.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.676 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.565 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.565 ' CG1' ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 80' ' ' LYS . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 28.0 m-70 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.509 ' O ' HD21 ' A' ' 30' ' ' LEU . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' HD23 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 98' ' ' PHE . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 4' ' ' PRO . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD13 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.671 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 ' CD1' ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 65' ' ' ILE . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.42 125.06 27.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 48.27 61.44 3.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.421 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -63.41 83.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p 43.83 39.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.24 -173.27 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.066 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -82.74 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 88' ' ' ILE . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.464 ' CD1' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE1' HD23 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 t -67.85 117.16 9.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 50.9 t0 -132.48 -80.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -160.08 -63.22 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.153 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.1 14.17 3.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.042 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.5 84.19 1.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' CB ' ' HG3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -105.11 148.22 27.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 87.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.77 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.23 103.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.46 164.69 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -58.03 10.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.06 109.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.73 -65.82 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.133 0.492 . . . . 0.0 110.948 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -160.06 159.54 32.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.48 88.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -61.78 149.7 39.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.6 t -61.03 112.62 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.97 143.88 54.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.6 m80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.0 p -158.0 106.92 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.94 101.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.98 176.05 4.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.178 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -63.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 34' ' ' GLU . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.817 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.541 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.49 HG23 HD13 ' A' ' 58' ' ' ILE . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -69.45 65.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.07 103.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 31.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.22 0.533 . . . . 0.0 110.954 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.9 p -178.2 38.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.033 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 73' ' ' HIS . . . -155.18 -167.92 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.112 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -114.43 -22.93 9.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 74' ' ' ILE . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 77' ' ' LEU . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CE1' ' HB3' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 88' ' ' ILE . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG23 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD1' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.817 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p -38.71 154.03 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -22.47 58.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.148 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' GLY . 0.9 OUTLIER -39.84 -70.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.471 -179.398 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' ASP . . . 29.88 79.12 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.754 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.57 88.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -56.88 153.77 10.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.05 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -150.2 108.97 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -72.74 132.37 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.62 93.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -36.01 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -58.54 111.82 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.9 -24.09 10.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 m -64.96 167.24 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -160.16 159.07 31.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.3 tp -150.11 104.53 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.73 117.11 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.002 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pp -59.43 125.92 25.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.928 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.26 -31.06 54.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -55.85 117.32 15.12 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' CG ' HG12 ' A' ' 43' ' ' ILE . 51.6 Cg_exo -56.03 -169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.518 2.145 . . . . 0.0 112.478 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.44 -62.89 1.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.769 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 28.7 m120 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.433 ' OG ' ' CD2' ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' CE1' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG12 ' CG ' ' A' ' 4' ' ' PRO . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD13 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.476 HG13 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.23 42.04 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 66' ' ' VAL . . . 65.23 23.18 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.401 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 1.3 tt 33.53 31.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 64' ' ' ALA . 1.8 t -163.55 -164.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.502 ' H ' ' CG1' ' A' ' 66' ' ' VAL . . . -84.42 56.97 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.117 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 -122.59 55.65 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.43 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 77' ' ' LEU . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 9' ' ' PHE . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' CE1' ' HG ' ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -111.89 126.57 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.13 -42.02 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -160.02 -59.62 0.06 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.834 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.01 22.09 3.32 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.024 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.73 77.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.33 . . . . 0.0 110.797 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.08 146.95 40.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.159 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.03 140.79 55.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -60.92 99.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.1 t -64.38 89.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.24 -73.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.56 134.47 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.9 -35.73 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.21 115.69 2.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.978 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 123.84 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.57 96.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.0 t -61.76 125.84 25.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 175.9 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.822 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.339 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 t -98.64 97.34 8.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.14 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.5 97.63 27.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 24.3 Cg_exo -65.86 72.7 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.755 2.304 . . . . 0.0 112.366 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.57 -2.9 58.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 65' ' ' ILE . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' CD1' ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 98' ' ' PHE . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 54' ' ' LEU . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 65' ' ' ILE . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 82.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 51.81 74.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.569 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 33' ' ' SER . 67.1 mt -59.39 92.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.453 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t 56.25 75.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 -169.67 1.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 -101.2 -50.33 3.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CZ ' ' CE1' ' A' ' 9' ' ' PHE . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 m -39.88 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -86.82 -17.01 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.559 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 52.65 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.78 67.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.511 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.01 -176.39 5.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -159.68 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -140.15 100.94 4.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 86.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 t -88.64 75.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.008 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.11 -29.25 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.72 151.95 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -147.05 35.64 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 m -60.27 172.98 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.2 113.16 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.6 128.37 36.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 t -160.13 152.17 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.99 -31.27 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.859 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 7' ' ' ILE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 23' ' ' THR . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.653 ' HB3' HD12 ' A' ' 7' ' ' ILE . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 17' ' ' LEU . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 32' ' ' PRO . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 21' ' ' VAL . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.858 ' HB3' HD13 ' A' ' 19' ' ' LEU . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' HD12 ' A' ' 37' ' ' ILE . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.83 ' O ' HD22 ' A' ' 77' ' ' LEU . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.661 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.597 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.859 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.608 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.923 HD12 HG13 ' A' ' 37' ' ' ILE . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.652 ' CD1' HG21 ' A' ' 37' ' ' ILE . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 34' ' ' GLU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 38' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ARG . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.859 ' CG1' HD21 ' A' ' 48' ' ' LEU . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 48' ' ' LEU . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 16' ' ' VAL . 6.4 mt-10 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 HG13 ' A' ' 16' ' ' VAL . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.695 ' HA ' HG12 ' A' ' 13' ' ' VAL . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 8' ' ' ARG . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.801 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 7' ' ' ILE . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 18' ' ' LYS . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 32' ' ' PRO . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.796 ' HB3' HD13 ' A' ' 19' ' ' LEU . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.45 ' CB ' HD11 ' A' ' 30' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.891 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB2' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HG2' HG12 ' A' ' 16' ' ' VAL . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.828 ' O ' HD22 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.536 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.924 HG13 HG21 ' A' ' 70' ' ' VAL . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.71 0.29 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.41 HD21 HG23 ' A' ' 72' ' ' VAL . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 58' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG23 HD21 ' A' ' 69' ' ' ASN . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.79 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 37' ' ' ILE . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.937 HD21 ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HB3' HD12 ' A' ' 30' ' ' LEU . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 84' ' ' TYR . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.763 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.504 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' ARG . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 96' ' ' TYR . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 94' ' ' VAL . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.711 HG12 HD21 ' A' ' 48' ' ' LEU . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.503 ' HE1' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 41' ' ' LEU . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 13' ' ' VAL . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG12 ' CG ' ' A' ' 39' ' ' LYS . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 13' ' ' VAL . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 23' ' ' THR . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.65 ' CA ' HD21 ' A' ' 19' ' ' LEU . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 37' ' ' ILE . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.756 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.866 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' CG ' HG12 ' A' ' 16' ' ' VAL . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HE ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 40' ' ' ARG . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.918 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.866 HD12 HG13 ' A' ' 37' ' ' ILE . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.786 HG23 HD12 ' A' ' 88' ' ' ILE . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 38' ' ' LEU . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.852 ' HB2' HD21 ' A' ' 81' ' ' LEU . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.786 HD12 HG23 ' A' ' 74' ' ' ILE . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' HB3' HD21 ' A' ' 41' ' ' LEU . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.989 HG23 HD11 ' A' ' 42' ' ' LEU . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.832 ' CD2' HG22 ' A' ' 21' ' ' VAL . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 17' ' ' LEU . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.595 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.832 HG22 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.595 ' OG ' HG22 ' A' ' 20' ' ' THR . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.704 ' CA ' HD21 ' A' ' 19' ' ' LEU . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' HD12 ' A' ' 37' ' ' ILE . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 77' ' ' LEU . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.781 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.989 HD11 HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HE3' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.761 ' O ' HD12 ' A' ' 97' ' ' LEU . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' CD2' HG12 ' A' ' 94' ' ' VAL . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.555 HD21 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' GLU . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.665 ' N ' HD12 ' A' ' 55' ' ' LEU . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 37' ' ' ILE . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.779 0.323 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.75 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.663 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' ARG . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.51 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG12 ' CD2' ' A' ' 48' ' ' LEU . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 47' ' ' GLN . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.411 ' OG ' HG21 ' A' ' 89' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' OE2' HD21 ' A' ' 17' ' ' LEU . 1.4 tt0 . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 121.152 0.501 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 42' ' ' LEU . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.631 ' CD1' HG22 ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 17' ' ' LEU . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD21 ' OE2' ' A' ' 5' ' ' GLU . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 23' ' ' THR . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.872 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 34' ' ' GLU . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HB3' HD13 ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 37' ' ' ILE . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.815 ' O ' HD11 ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.872 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.787 HD13 ' CD1' ' A' ' 81' ' ' LEU . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.094 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HA ' HD13 ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.711 ' N ' HD23 ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 70' ' ' VAL . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HD12 ' A' ' 58' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.51 HD13 ' HE2' ' A' ' 96' ' ' TYR . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 86' ' ' SER . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HB3' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.79 HD23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 81' ' ' LEU . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.888 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.403 ' CB ' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 90' ' ' THR . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 90' ' ' THR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.094 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.51 ' HE2' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 98' ' ' PHE . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.815 HD11 HG12 ' A' ' 16' ' ' VAL . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 22' ' ' GLU . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.617 ' CD2' HD12 ' A' ' 7' ' ' ILE . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 HD11 ' A' ' 7' ' ' ILE . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 32' ' ' PRO . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.639 ' HB3' HG22 ' A' ' 13' ' ' VAL . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.623 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HB3' HD13 ' A' ' 19' ' ' LEU . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.623 ' CB ' HD13 ' A' ' 30' ' ' LEU . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD13 HD12 ' A' ' 74' ' ' ILE . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.631 ' CD2' HG23 ' A' ' 88' ' ' ILE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.73 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.643 HD22 ' C ' ' A' ' 49' ' ' CYS . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HD13 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.841 HD12 HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.762 HG13 HG21 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.864 HG22 HD11 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 74' ' ' ILE . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.864 HD11 HG22 ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 35' ' ' SER . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.902 HD23 ' HA2' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.627 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.902 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 91' ' ' LEU . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.792 HG22 HD11 ' A' ' 48' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.698 ' CD2' HD12 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.567 HD13 ' C ' ' A' ' 97' ' ' LEU . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.73 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.789 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.789 ' CE1' HG22 ' A' ' 7' ' ' ILE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 13' ' ' VAL . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.781 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG13 ' CD1' ' A' ' 7' ' ' ILE . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HG ' HG23 ' A' ' 16' ' ' VAL . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' C ' HD22 ' A' ' 19' ' ' LEU . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.781 HG22 ' CG ' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.705 ' O ' HD22 ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.833 ' O ' HD21 ' A' ' 77' ' ' LEU . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.988 ' HB3' HD21 ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.668 HD22 HD13 ' A' ' 81' ' ' LEU . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.418 HD11 ' CE ' ' A' ' 39' ' ' LYS . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.876 ' HA ' HD21 ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 37' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 96.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.732 0.301 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 70' ' ' VAL . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HD3' HD23 ' A' ' 30' ' ' LEU . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.879 HD23 ' HA2' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.879 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 84' ' ' TYR . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 91' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 48' ' ' LEU . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.486 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.619 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.744 ' CD1' HD13 ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 42' ' ' LEU . 1.4 tt0 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.893 ' HB ' HD11 ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.902 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' HD22 ' A' ' 19' ' ' LEU . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 23' ' ' THR . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 31' ' ' THR . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.899 ' O ' HD21 ' A' ' 77' ' ' LEU . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.737 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.902 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 98' ' ' PHE . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 7' ' ' ILE . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.574 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 49' ' ' CYS . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.602 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.893 ' HB3' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.367 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 55' ' ' LEU . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.4 m170 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.713 ' HB3' HD12 ' A' ' 30' ' ' LEU . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.891 HD22 HD22 ' A' ' 38' ' ' LEU . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.634 ' HB3' HD21 ' A' ' 81' ' ' LEU . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' GLY . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 94' ' ' VAL . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 91' ' ' LEU . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.573 ' HB2' HD12 ' A' ' 41' ' ' LEU . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.801 HG12 HD13 ' A' ' 42' ' ' LEU . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 13' ' ' VAL . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 23' ' ' THR . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 8' ' ' ARG . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CE1' HG22 ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 7' ' ' ILE . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 32' ' ' PRO . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.658 HG22 ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 23' ' ' THR . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.844 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.747 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.844 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 16' ' ' VAL . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.709 HD13 ' HD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 7' ' ' ILE . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.0 OUTLIER -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 HG13 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.909 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.737 HG13 HG21 ' A' ' 70' ' ' VAL . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 72' ' ' VAL . 17.3 mtp180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.737 HG21 HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 68' ' ' ARG . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 37' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD23 ' CA ' ' A' ' 85' ' ' GLY . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.627 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.59 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 87' ' ' ARG . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' A' ' 97' ' ' LEU . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.709 ' HD1' HD13 ' A' ' 41' ' ' LEU . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.456 ' OG ' HG21 ' A' ' 89' ' ' VAL . 7.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HB3' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.732 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.63 ' HG3' HG13 ' A' ' 13' ' ' VAL . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.63 HG13 ' HG3' ' A' ' 8' ' ' ARG . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.756 ' CD2' HG22 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.911 HG13 HD13 ' A' ' 17' ' ' LEU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.911 HD13 HG13 ' A' ' 16' ' ' VAL . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 19' ' ' LEU . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.756 HG22 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.492 ' HA ' HG23 ' A' ' 20' ' ' THR . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.878 ' HB3' HD13 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.93 ' O ' HD11 ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.966 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.767 HD11 HD21 ' A' ' 54' ' ' LEU . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.811 HD23 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.769 HD13 ' H ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.984 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HB2' HD22 ' A' ' 50' ' ' LEU . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 37' ' ' ILE . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.073 HG23 HD13 ' A' ' 88' ' ' ILE . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.858 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.811 ' NH1' HD23 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.073 HD13 HG23 ' A' ' 74' ' ' ILE . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CG1' HD21 ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.926 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.832 HG23 HD11 ' A' ' 42' ' ' LEU . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.576 ' OD1' HG22 ' A' ' 23' ' ' THR . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 7' ' ' ILE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 39' ' ' LYS . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 32' ' ' PRO . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.739 HG22 ' CD2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' OD1' ' A' ' 12' ' ' ASN . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 23' ' ' THR . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HB3' HD13 ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.643 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HG3' HG12 ' A' ' 16' ' ' VAL . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.814 HD13 HD12 ' A' ' 88' ' ' ILE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD11 HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.896 ' O ' HD22 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 41' ' ' LEU . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.893 ' N ' HD23 ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.633 0.254 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.777 HG21 HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 37' ' ' ILE . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 ' CG2' ' A' ' 37' ' ' ILE . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 38' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 81' ' ' LEU . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 48' ' ' LEU . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.662 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.682 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HD22 ' A' ' 41' ' ' LEU . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt-10 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.219 0.533 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.743 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' ' 13' ' ' VAL . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' ' 23' ' ' THR . 38.6 m-80 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 8' ' ' ARG . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 5' ' ' GLU . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.599 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 28' ' ' VAL . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 23' ' ' THR . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.796 ' O ' HD22 ' A' ' 77' ' ' LEU . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.599 ' OG ' HD12 ' A' ' 19' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 58' ' ' ILE . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.992 HD13 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' NZ ' HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.864 ' O ' HD22 ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.864 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.848 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 37' ' ' ILE . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 58' ' ' ILE . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.802 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 38' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 38' ' ' LEU . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.742 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.992 HD12 HD13 ' A' ' 41' ' ' LEU . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 91' ' ' LEU . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 90' ' ' THR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 48' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 99' ' ' SER . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.621 ' N ' HD23 ' A' ' 97' ' ' LEU . 37.8 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.54 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.111 0.481 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.941 ' HG3' HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 8' ' ' ARG . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CE2' HD11 ' A' ' 38' ' ' LEU . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' A' ' 32' ' ' PRO . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.59 ' HG3' HD13 ' A' ' 19' ' ' LEU . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HD21 ' A' ' 77' ' ' LEU . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.578 ' HA ' HD23 ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG13 HD13 ' A' ' 58' ' ' ILE . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CG ' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 54' ' ' LEU . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' HD22 ' A' ' 97' ' ' LEU . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.077 HD21 HG22 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.855 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.56 ' H ' HD23 ' A' ' 50' ' ' LEU . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.933 HD11 HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.938 HD12 HG11 ' A' ' 70' ' ' VAL . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.334 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 72' ' ' VAL . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG23 ' OD1' ' A' ' 69' ' ' ASN . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.592 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.659 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.81 HD22 ' HB2' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.548 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 89' ' ' VAL . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 87' ' ' ARG . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.077 HG22 HD21 ' A' ' 48' ' ' LEU . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.811 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 16' ' ' VAL . 5.6 mt-10 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 13' ' ' VAL . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 17' ' ' LEU . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 32' ' ' PRO . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' HD13 ' A' ' 19' ' ' LEU . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.927 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.628 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.927 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 54' ' ' LEU . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' CG ' HD13 ' A' ' 42' ' ' LEU . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.02 HD21 HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' C ' HD22 ' A' ' 50' ' ' LEU . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.819 ' O ' HD22 ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.887 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.98 HD11 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.572 ' OD1' HG23 ' A' ' 72' ' ' VAL . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 69' ' ' ASN . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 70' ' ' VAL . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.787 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 89' ' ' VAL . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 87' ' ' ARG . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.02 HG12 HD21 ' A' ' 48' ' ' LEU . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.527 ' CE1' HD22 ' A' ' 41' ' ' LEU . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 121.096 0.474 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.588 ' OD1' HG23 ' A' ' 23' ' ' THR . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' A' ' 8' ' ' ARG . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.626 ' CE2' HD21 ' A' ' 30' ' ' LEU . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 32' ' ' PRO . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 19' ' ' LEU . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.744 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.573 ' HG3' HG12 ' A' ' 16' ' ' VAL . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' LYS . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.903 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.912 ' N ' HD23 ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.433 ' HD3' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.691 0.281 . . . . 0.0 110.765 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 58' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 34' ' ' GLU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.854 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.854 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.834 HD12 ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 97' ' ' LEU . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.727 HD12 ' HG ' ' A' ' 42' ' ' LEU . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HE ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.72 ' CD1' HG22 ' A' ' 7' ' ' ILE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 23' ' ' THR . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 HG22 ' HE ' ' A' ' 8' ' ' ARG . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' A' ' 30' ' ' LEU . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 39' ' ' LYS . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 28' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.639 HG22 HD21 ' A' ' 12' ' ' ASN . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 35' ' ' SER . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.617 ' CB ' HD13 ' A' ' 30' ' ' LEU . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 34' ' ' GLU . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.69 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.909 HD22 ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.727 ' HG ' HD12 ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.898 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 70' ' ' VAL . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 58' ' ' ILE . 48.9 pttt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.94 HD12 HD13 ' A' ' 88' ' ' ILE . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 34' ' ' GLU . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.798 HD23 ' HA2' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.798 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 74' ' ' ILE . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 87' ' ' ARG . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 90' ' ' THR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 48' ' ' LEU . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.674 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.909 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.051 0.453 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.821 HD11 HG13 ' A' ' 16' ' ' VAL . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.821 HG13 HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 19' ' ' LEU . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.795 ' O ' HD22 ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.776 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.896 HG21 HD12 ' A' ' 74' ' ' ILE . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.974 HD12 HD12 ' A' ' 88' ' ' ILE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.651 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.838 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.99 ' N ' HD23 ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 72' ' ' VAL . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 69' ' ' ASN . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.896 HD12 HG21 ' A' ' 37' ' ' ILE . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' ' 34' ' ' GLU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.681 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.974 HD12 HD12 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 90' ' ' THR . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 98' ' ' PHE . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.914 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' OD1' HG23 ' A' ' 23' ' ' THR . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.61 ' HZ ' HD21 ' A' ' 30' ' ' LEU . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HD23 ' A' ' 17' ' ' LEU . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 16' ' ' VAL . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 28' ' ' VAL . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.836 HG12 ' HB ' ' A' ' 28' ' ' VAL . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.742 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.742 ' HD2' HG22 ' A' ' 23' ' ' THR . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 20' ' ' THR . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' N ' HG12 ' A' ' 28' ' ' VAL . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.698 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD11 ' A' ' 37' ' ' ILE . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' HB3' HD23 ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.698 ' CB ' HD13 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.04 HD12 HD13 ' A' ' 58' ' ' ILE . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.708 HD23 ' CE ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.708 ' CE ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 57' ' ' GLU . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 39' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.954 ' HA ' HD21 ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 55.2 t-80 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 40' ' ' ARG . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.04 HD13 HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.846 ' CG2' HD12 ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.466 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.785 ' CD1' HD13 ' A' ' 81' ' ' LEU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.968 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ARG . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 48' ' ' LEU . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' CYS . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 42' ' ' LEU . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.654 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 1.5 m-80 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.654 HG22 ' HG3' ' A' ' 8' ' ' ARG . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 21' ' ' VAL . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 17' ' ' LEU . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 16' ' ' VAL . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.697 HD23 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.67 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HD2' HG22 ' A' ' 23' ' ' THR . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.653 ' CA ' HD21 ' A' ' 19' ' ' LEU . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' HD12 ' A' ' 37' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.733 ' O ' HD11 ' A' ' 77' ' ' LEU . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.858 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.884 ' CG1' HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 42' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.798 HD11 HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.726 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.798 ' CD2' HD11 ' A' ' 74' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.884 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.845 0.355 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' NE2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.945 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 99' ' ' SER . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 48' ' ' LEU . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.716 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' HG ' ' A' ' 48' ' ' LEU . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 89' ' ' VAL . 18.4 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 42' ' ' LEU . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.866 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.866 HG12 ' HB3' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 30' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 17' ' ' LEU . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.453 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.601 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' CA ' HD21 ' A' ' 19' ' ' LEU . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.825 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.053 HD11 HD23 ' A' ' 54' ' ' LEU . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.675 HD13 ' OH ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.928 HD11 HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 39' ' ' LYS . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.704 ' CD1' HG12 ' A' ' 94' ' ' VAL . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HA ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.594 ' H ' HD23 ' A' ' 50' ' ' LEU . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.053 HD23 HD11 ' A' ' 37' ' ' ILE . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.629 HG13 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 55' ' ' LEU . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 37' ' ' ILE . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 34' ' ' GLU . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.675 ' OH ' HD13 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.552 HD13 HG21 ' A' ' 74' ' ' ILE . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 97' ' ' LEU . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 48' ' ' LEU . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.544 HD13 ' HG ' ' A' ' 42' ' ' LEU . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 8' ' ' ARG . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HG3' ' A' ' 39' ' ' LYS . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.633 HD22 ' OG ' ' A' ' 35' ' ' SER . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 31' ' ' THR . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 37' ' ' ILE . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.786 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.672 ' HB3' HD13 ' A' ' 30' ' ' LEU . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 88' ' ' ILE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.696 HD13 ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG3' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.881 HD12 HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.558 ' O ' HD21 ' A' ' 54' ' ' LEU . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.939 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 41' ' ' LEU . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 54' ' ' LEU . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 58' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 38' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.744 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' NH2' HD11 ' A' ' 88' ' ' ILE . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 41' ' ' LEU . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 90' ' ' THR . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 96' ' ' TYR . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.884 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.689 ' CD2' HD11 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.881 HD13 HD12 ' A' ' 48' ' ' LEU . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.864 ' HB3' HG12 ' A' ' 16' ' ' VAL . 3.3 mt-10 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.894 ' HB2' HG13 ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HA ' HG12 ' A' ' 13' ' ' VAL . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 8' ' ' ARG . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.58 HD22 ' HB ' ' A' ' 16' ' ' VAL . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 23' ' ' THR . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 20' ' ' THR . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.531 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 39.1 m80 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.871 ' HA ' HD11 ' A' ' 19' ' ' LEU . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.85 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.787 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 54' ' ' LEU . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 40' ' ' ARG . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.858 HD11 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.874 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.081 HD11 HD21 ' A' ' 41' ' ' LEU . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.771 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.771 ' CG2' HD12 ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 74' ' ' ILE . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 71' ' ' ASP . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.587 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.812 HD13 HD22 ' A' ' 38' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.664 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 89' ' ' VAL . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.798 HG22 ' CE1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.406 ' HG1' ' HE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 89' ' ' VAL . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 48' ' ' LEU . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.798 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE1' HD22 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 97' ' ' LEU . 1.4 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 21' ' ' VAL . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.908 ' CE2' HD21 ' A' ' 38' ' ' LEU . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.575 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 32' ' ' PRO . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 27' ' ' SER . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 20' ' ' THR . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.956 ' HB3' HD13 ' A' ' 19' ' ' LEU . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.665 ' HB3' HD23 ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.828 ' HA ' HD23 ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.867 HG13 HD12 ' A' ' 58' ' ' ILE . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.908 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CG ' HG12 ' A' ' 16' ' ' VAL . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.835 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 50' ' ' LEU . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.885 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.004 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 1.004 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.869 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.713 0.292 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB3' HG22 ' A' ' 72' ' ' VAL . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.588 ' CD2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.78 ' O ' HD13 ' A' ' 77' ' ' LEU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB2' HD22 ' A' ' 77' ' ' LEU . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 85' ' ' GLY . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.602 ' H ' HD23 ' A' ' 81' ' ' LEU . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.706 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.937 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 90' ' ' THR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.657 HG23 HD22 ' A' ' 91' ' ' LEU . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.937 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.835 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.247 0.546 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 42' ' ' LEU . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 13' ' ' VAL . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 79.1 m-20 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 8' ' ' ARG . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 13' ' ' VAL . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 32' ' ' PRO . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 84' ' ' TYR . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.873 HD22 ' OG ' ' A' ' 35' ' ' SER . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.713 ' HB3' HD13 ' A' ' 19' ' ' LEU . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.8 ' O ' HD11 ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.873 ' OG ' HD22 ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 81' ' ' LEU . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' CE ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 57' ' ' GLU . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HG2' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.728 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.694 HD22 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.976 0.417 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.49 ' OD1' HG23 ' A' ' 72' ' ' VAL . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.83 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 69' ' ' ASN . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.739 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 71' ' ' ASP . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.638 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 21' ' ' VAL . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.476 HH12 HD11 ' A' ' 38' ' ' LEU . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 HD22 ' A' ' 41' ' ' LEU . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.98 HG22 HD11 ' A' ' 48' ' ' LEU . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.694 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.674 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' HB3' HD23 ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.7 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.082 HD11 HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 13' ' ' VAL . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 8' ' ' ARG . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.84 ' CD2' HG22 ' A' ' 21' ' ' VAL . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.082 HG13 HD11 ' A' ' 7' ' ' ILE . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 16' ' ' VAL . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.84 HG22 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.794 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HA ' HD22 ' A' ' 19' ' ' LEU . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.742 ' O ' HD11 ' A' ' 77' ' ' LEU . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.794 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 58' ' ' ILE . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.74 HD12 ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 54' ' ' LEU . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 45' ' ' LYS . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.753 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.709 HD11 HG13 ' A' ' 37' ' ' ILE . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.419 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.848 HG23 HD13 ' A' ' 88' ' ' ILE . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA2' HD12 ' A' ' 38' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 89' ' ' VAL . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.848 HD13 HG23 ' A' ' 74' ' ' ILE . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' ARG . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 91' ' ' LEU . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 98' ' ' PHE . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 97' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 t60 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.48 118.1 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 3' ' ' VAL . 29.6 m -83.05 111.81 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.13 156.97 17.53 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.571 2.181 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.07 40.31 3.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 7' ' ' ILE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 23' ' ' THR . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.653 ' HB3' HD12 ' A' ' 7' ' ' ILE . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 17' ' ' LEU . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 32' ' ' PRO . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 21' ' ' VAL . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.858 ' HB3' HD13 ' A' ' 19' ' ' LEU . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' HD12 ' A' ' 37' ' ' ILE . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.83 ' O ' HD22 ' A' ' 77' ' ' LEU . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.661 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.597 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.859 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.608 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.923 HD12 HG13 ' A' ' 37' ' ' ILE . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.68 61.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.88 101.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.851 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.62 35.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.175 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.1 p -173.23 40.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.192 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.55 -172.75 3.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 -26.48 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HE1' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.652 ' CD1' HG21 ' A' ' 37' ' ' ILE . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 34' ' ' GLU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 38' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ARG . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.859 ' CG1' HD21 ' A' ' 48' ' ' LEU . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 48' ' ' LEU . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.03 116.15 9.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -106.42 -79.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.36 -58.07 0.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 -35.46 3.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.544 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.18 85.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -171.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.65 69.94 1.2 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.6 113.41 13.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.2 79.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.96 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -65.46 172.77 3.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 111' ' ' THR . 38.5 t70 -109.29 -20.4 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -160.14 178.96 9.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.15 95.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 113' ' ' LEU . 6.1 tt -150.24 88.6 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.17 160.52 32.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.504 ' C ' HD12 ' A' ' 115' ' ' LEU . 4.2 pp -59.56 159.02 8.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.896 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 m -66.51 103.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.93 134.03 47.47 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 58.1 Cg_exo -52.2 116.11 2.6 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.483 2.122 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 16' ' ' VAL . 6.4 mt-10 -95.89 -17.68 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 HG13 ' A' ' 16' ' ' VAL . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.695 ' HA ' HG12 ' A' ' 13' ' ' VAL . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 8' ' ' ARG . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.801 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 7' ' ' ILE . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 18' ' ' LYS . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 32' ' ' PRO . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.773 HG21 HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.796 ' HB3' HD13 ' A' ' 19' ' ' LEU . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' CB ' HD11 ' A' ' 30' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.891 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB2' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HG2' HG12 ' A' ' 16' ' ' VAL . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.828 ' O ' HD22 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.536 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.924 HG13 HG21 ' A' ' 70' ' ' VAL . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -69.67 63.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 47.49 93.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.317 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 65' ' ' ILE . 21.2 mm -96.69 30.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.182 0.515 . . . . 0.0 110.968 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 31' ' ' THR . 23.5 t -157.97 35.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.35 -163.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.911 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -109.95 -21.63 12.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.4 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.41 HD21 HG23 ' A' ' 72' ' ' VAL . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 58' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG23 HD21 ' A' ' 69' ' ' ASN . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.79 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 37' ' ' ILE . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.937 HD21 ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HB3' HD12 ' A' ' 30' ' ' LEU . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 84' ' ' TYR . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.763 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.504 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' ARG . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 96' ' ' TYR . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 94' ' ' VAL . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.711 HG12 HD21 ' A' ' 48' ' ' LEU . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.503 ' HE1' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 41' ' ' LEU . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.56 131.71 16.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.65 -31.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.73 -68.22 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.33 38.18 1.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.707 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.46 70.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.955 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 146.28 55.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 141.89 58.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 162.29 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 138.77 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.0 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -67.56 -31.86 72.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.049 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 113.9 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.2 -16.26 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.5 t -56.57 148.44 19.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.334 . . . . 0.0 111.077 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -62.16 155.99 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -63.85 126.64 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.516 ' N ' HD13 ' A' ' 113' ' ' LEU . 14.0 t -160.2 94.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -54.22 46.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -97.16 101.95 13.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.8 p -159.22 98.38 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.43 89.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.505 2.136 . . . . 0.0 112.257 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -98.41 32.94 2.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 13' ' ' VAL . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG12 ' CG ' ' A' ' 39' ' ' LYS . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 13' ' ' VAL . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 23' ' ' THR . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.65 ' CA ' HD21 ' A' ' 19' ' ' LEU . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 37' ' ' ILE . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.756 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.866 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' CG ' HG12 ' A' ' 16' ' ' VAL . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HE ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 40' ' ' ARG . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.918 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.866 HD12 HG13 ' A' ' 37' ' ' ILE . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 56.98 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 49.68 98.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.408 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.3 tp -94.2 33.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.922 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 66' ' ' VAL . 10.7 p -175.11 38.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.045 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -157.14 -165.38 1.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -110.62 -27.56 8.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.786 HG23 HD12 ' A' ' 88' ' ' ILE . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 38' ' ' LEU . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.852 ' HB2' HD21 ' A' ' 81' ' ' LEU . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.786 HD12 HG23 ' A' ' 74' ' ' ILE . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' HB3' HD21 ' A' ' 41' ' ' LEU . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 91.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -80.54 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -160.54 -69.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.006 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.37 -25.15 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.639 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -175.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.167 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -130.17 -176.38 3.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -150.06 104.45 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -65.3 122.9 18.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 94.33 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -70.04 -25.35 63.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.23 93.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -127.87 1.57 6.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.506 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -160.21 158.86 30.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -65.47 78.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 135.45 57.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -160.06 161.45 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.2 mm? -60.69 169.86 1.67 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.798 0.333 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.418 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 61.34 105.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.18 128.48 11.88 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' CG ' HG11 ' A' ' 16' ' ' VAL . 96.2 Cg_endo -84.2 157.61 13.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.554 2.169 . . . . 0.0 112.168 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -53.04 4.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.989 HG23 HD11 ' A' ' 42' ' ' LEU . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.832 ' CD2' HG22 ' A' ' 21' ' ' VAL . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' CG ' ' A' ' 4' ' ' PRO . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.595 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.832 HG22 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.595 ' OG ' HG22 ' A' ' 20' ' ' THR . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.704 ' CA ' HD21 ' A' ' 19' ' ' LEU . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' HD12 ' A' ' 37' ' ' ILE . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 77' ' ' LEU . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.781 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 4' ' ' PRO . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.989 HD11 HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.418 HD13 ' C ' ' A' ' 2' ' ' SER . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HE3' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.761 ' O ' HD12 ' A' ' 97' ' ' LEU . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' CD2' HG12 ' A' ' 94' ' ' VAL . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.555 HD21 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' GLU . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.665 ' N ' HD12 ' A' ' 55' ' ' LEU . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 37' ' ' ILE . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -70.22 61.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.09 96.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.637 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 65' ' ' ILE . 6.6 tp -95.56 30.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.08 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 66' ' ' VAL . 22.2 t -157.69 37.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.532 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.39 -165.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.106 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -109.7 -25.22 10.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.75 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.663 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' ARG . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.51 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG12 ' CD2' ' A' ' 48' ' ' LEU . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 47' ' ' GLN . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.411 ' OG ' HG21 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -74.22 122.65 23.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 14.7 t70 -129.46 -80.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.38 -57.89 0.06 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.08 66.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -171.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 156.73 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.26 135.38 17.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.44 92.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.3 140.11 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -74.25 161.73 29.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -109.75 -28.51 8.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.963 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 83.19 3.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -59.69 119.29 7.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -150.15 146.82 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 t -160.12 149.71 17.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.44 -59.36 5.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -101.9 131.87 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.7 t 59.14 90.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.93 -170.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.245 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' OE2' HD21 ' A' ' 17' ' ' LEU . 1.4 tt0 -147.14 -75.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.718 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 42' ' ' LEU . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.631 ' CD1' HG22 ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 17' ' ' LEU . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD21 ' OE2' ' A' ' 5' ' ' GLU . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 23' ' ' THR . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.872 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 34' ' ' GLU . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HB3' HD13 ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 37' ' ' ILE . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.815 ' O ' HD11 ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.872 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.787 HD13 ' CD1' ' A' ' 81' ' ' LEU . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.094 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HA ' HD13 ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.711 ' N ' HD23 ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 70' ' ' VAL . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -55.14 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.7 72.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.527 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 65' ' ' ILE . 18.2 tt -57.01 106.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.776 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 66' ' ' VAL . 70.8 t 54.16 69.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.51 -168.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -115.68 -35.57 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HD12 ' A' ' 58' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.51 HD13 ' HE2' ' A' ' 96' ' ' TYR . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 86' ' ' SER . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HB3' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.79 HD23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 81' ' ' LEU . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.888 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.403 ' CB ' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 90' ' ' THR . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 90' ' ' THR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.094 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.51 ' HE2' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 98' ' ' PHE . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -61.9 84.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -120.29 -70.73 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.124 0.488 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.19 -59.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.31 30.7 8.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -130.07 100.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 152.29 38.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 117.56 8.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -179.98 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -150.11 79.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -63.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.1 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -58.78 124.42 19.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.49 -18.76 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.383 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -61.98 150.82 36.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.5 172.07 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.13 159.08 44.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.6 127.04 29.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 115' ' ' LEU . 7.8 mt -65.93 -49.33 68.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.913 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -48.22 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 3' ' ' VAL . 12.7 m -115.63 83.93 11.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.01 126.13 21.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.49 2.126 . . . . 0.0 112.21 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.04 -30.29 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.815 HD11 HG12 ' A' ' 16' ' ' VAL . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 22' ' ' GLU . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.617 ' CD2' HD12 ' A' ' 7' ' ' ILE . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 HD11 ' A' ' 7' ' ' ILE . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 32' ' ' PRO . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' HB3' HG22 ' A' ' 13' ' ' VAL . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.623 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HB3' HD13 ' A' ' 19' ' ' LEU . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.623 ' CB ' HD13 ' A' ' 30' ' ' LEU . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD13 HD12 ' A' ' 74' ' ' ILE . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.631 ' CD2' HG23 ' A' ' 88' ' ' ILE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.73 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.643 HD22 ' C ' ' A' ' 49' ' ' CYS . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HD13 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.841 HD12 HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.762 HG13 HG21 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -89.44 51.98 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB2' ' CB ' ' A' ' 33' ' ' SER . . . 62.15 37.63 14.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 0.7 OUTLIER 41.92 79.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.399 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.7 p 44.0 59.83 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.639 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.42 -170.11 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -62.48 -65.32 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG22 HD11 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 74' ' ' ILE . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.864 HD11 HG22 ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 35' ' ' SER . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.902 HD23 ' HA2' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.627 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.902 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 91' ' ' LEU . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.792 HG22 HD11 ' A' ' 48' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.698 ' CD2' HD12 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.567 HD13 ' C ' ' A' ' 97' ' ' LEU . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.73 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t -39.33 146.68 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.19 65.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.958 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -39.76 -70.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.822 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 43.22 80.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.095 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 0.0 111.221 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' NZ ' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.25 155.51 20.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.866 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 8' ' ' ARG . 1.4 mttt -150.3 93.9 2.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 111.368 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.22 135.88 37.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.3 t -150.15 91.96 1.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -68.78 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 166.59 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.73 30.81 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.13 144.82 14.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.002 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -62.22 124.93 22.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 127.9 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -66.06 117.34 8.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -60.93 150.2 34.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.806 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 1.4 m 59.77 103.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.94 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.13 148.1 65.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 144.6 49.92 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.61 2.206 . . . . 0.0 112.296 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -149.11 40.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.789 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.789 ' CE1' HG22 ' A' ' 7' ' ' ILE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 13' ' ' VAL . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.781 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.583 HG13 ' CD1' ' A' ' 7' ' ' ILE . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HG ' HG23 ' A' ' 16' ' ' VAL . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' C ' HD22 ' A' ' 19' ' ' LEU . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.781 HG22 ' CG ' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.705 ' O ' HD22 ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.833 ' O ' HD21 ' A' ' 77' ' ' LEU . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.988 ' HB3' HD21 ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.668 HD22 HD13 ' A' ' 81' ' ' LEU . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.418 HD11 ' CE ' ' A' ' 39' ' ' LYS . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.876 ' HA ' HD21 ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 37' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -71.16 65.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 68' ' ' ARG . . . 64.78 90.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.5 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.267 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.1 t -152.11 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.27 67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.983 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 96.0 mtt180 -158.36 55.48 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.995 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 70' ' ' VAL . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HD3' HD23 ' A' ' 30' ' ' LEU . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.879 HD23 ' HA2' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.879 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 84' ' ' TYR . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 91' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 48' ' ' LEU . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.486 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.619 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.744 ' CD1' HD13 ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.85 139.41 47.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.32 -37.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -160.08 -67.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.892 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 75.3 0.43 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.591 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.07 77.28 1.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.834 0.349 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.47 113.21 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -73.99 112.07 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' SER . 0.3 OUTLIER -75.94 61.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 77.32 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -60.19 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.1 -165.22 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -95.85 23.09 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -69.81 115.91 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.13 154.04 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.89 79.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.41 149.26 48.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 115' ' ' LEU . 4.0 pp -59.33 143.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.5 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 43' ' ' ILE . 5.3 m -65.51 109.19 2.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 14.4 Cg_exo -69.12 178.01 4.59 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 42' ' ' LEU . 1.4 tt0 -124.74 -74.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.587 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.893 ' HB ' HD11 ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.902 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' HD22 ' A' ' 19' ' ' LEU . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 23' ' ' THR . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 31' ' ' THR . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.899 ' O ' HD21 ' A' ' 77' ' ' LEU . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.737 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.902 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 98' ' ' PHE . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 3' ' ' VAL . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 7' ' ' ILE . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.574 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 49' ' ' CYS . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.602 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.893 ' HB3' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.12 129.48 35.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.25 62.19 2.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.84 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 65' ' ' ILE . 6.5 tp -59.68 89.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.704 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 66' ' ' VAL . 60.7 t 56.09 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.944 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 57.11 66.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -160.08 55.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 55' ' ' LEU . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.4 m170 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.713 ' HB3' HD12 ' A' ' 30' ' ' LEU . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.891 HD22 HD22 ' A' ' 38' ' ' LEU . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.634 ' HB3' HD21 ' A' ' 81' ' ' LEU . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' GLY . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 94' ' ' VAL . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 91' ' ' LEU . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.573 ' HB2' HD12 ' A' ' 41' ' ' LEU . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p -63.72 95.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' CB ' ' HD3' ' A' ' 87' ' ' ARG . 44.0 t0 -116.22 -80.61 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -160.6 -62.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 36.07 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.19 149.02 43.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.16 141.77 50.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -62.21 167.61 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -53.87 120.8 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -59.8 137.42 58.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -60.5 -55.91 27.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.423 ' CD ' ' HG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -59.91 141.02 56.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -61.54 -27.02 68.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.423 ' HG1' ' CD ' ' A' ' 109' ' ' GLN . 28.3 p -71.76 141.18 49.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -160.14 125.19 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 90.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 118.94 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 115' ' ' LEU . 1.6 pp -56.54 149.14 17.91 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.22 82.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.924 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.98 156.41 51.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.721 ' CB ' HG11 ' A' ' 16' ' ' VAL . 2.8 Cg_exo -75.16 129.93 12.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.7 2.267 . . . . 0.0 112.245 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 105' ' ' LYS . 1.2 mm-40 -104.54 -55.28 2.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.801 HG12 HD13 ' A' ' 42' ' ' LEU . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 13' ' ' VAL . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 23' ' ' THR . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 8' ' ' ARG . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CE1' HG22 ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 32' ' ' PRO . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.658 HG22 ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 23' ' ' THR . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.844 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.747 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.844 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 16' ' ' VAL . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.709 HD13 ' HD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 7' ' ' ILE . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 4' ' ' PRO . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.0 OUTLIER -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 HG13 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.909 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.737 HG13 HG21 ' A' ' 70' ' ' VAL . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -76.86 77.82 3.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.797 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 57.35 82.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.201 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.0 tt -56.24 116.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 66' ' ' VAL . 12.9 p 44.38 45.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -130.51 -175.45 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 72' ' ' VAL . 17.3 mtp180 -82.28 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.737 HG21 HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 68' ' ' ARG . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.412 ' CE1' ' HA ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 37' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD23 ' CA ' ' A' ' 85' ' ' GLY . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.627 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.59 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 87' ' ' ARG . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' A' ' 97' ' ' LEU . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.709 ' HD1' HD13 ' A' ' 41' ' ' LEU . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.456 ' OG ' HG21 ' A' ' 89' ' ' VAL . 7.6 m -59.82 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -128.79 -80.3 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.058 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -69.88 0.83 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.958 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.14 29.07 2.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.11 154.31 47.6 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 167.37 18.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 1.2 ptmm? -47.89 134.41 13.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.281 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.61 134.93 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 144.07 57.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.72 -50.49 70.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.31 156.27 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -149.99 31.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -60.95 142.15 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -160.09 159.75 32.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.958 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.14 103.1 3.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.57 78.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -61.27 141.91 57.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.882 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 m80 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.847 0.356 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -114.22 -56.47 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.2 114.28 28.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -60.94 -177.26 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.449 2.099 . . . . 0.0 112.232 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HB3' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -136.87 -76.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.732 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.63 ' HG3' HG13 ' A' ' 13' ' ' VAL . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.63 HG13 ' HG3' ' A' ' 8' ' ' ARG . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.756 ' CD2' HG22 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.911 HG13 HD13 ' A' ' 17' ' ' LEU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.911 HD13 HG13 ' A' ' 16' ' ' VAL . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 19' ' ' LEU . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.756 HG22 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.492 ' HA ' HG23 ' A' ' 20' ' ' THR . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.878 ' HB3' HD13 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.93 ' O ' HD11 ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.966 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.767 HD11 HD21 ' A' ' 54' ' ' LEU . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.811 HD23 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD13 ' H ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.984 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HB2' HD22 ' A' ' 50' ' ' LEU . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 37' ' ' ILE . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 65.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.98 93.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.49 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 65' ' ' ILE . 3.2 mt -97.69 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.17 0.509 . . . . 0.0 110.783 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.8 p -177.03 38.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.56 -165.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.006 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -117.21 -17.97 10.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.617 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.073 HG23 HD13 ' A' ' 88' ' ' ILE . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.858 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.811 ' NH1' HD23 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.073 HD13 HG23 ' A' ' 74' ' ' ILE . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CG1' HD21 ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.926 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p -43.45 166.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -64.85 -18.57 65.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.563 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -61.85 51.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.58 69.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.532 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.94 -169.98 2.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -57.48 175.92 0.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 95.01 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.958 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.53 100.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 128.2 34.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.08 -73.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.74 148.83 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 111' ' ' THR . 10.4 t70 -121.07 29.6 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' ASP . 13.6 p -160.16 124.02 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -60.19 92.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 119.29 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -160.11 147.24 16.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.39 112.82 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.929 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -71.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -87.8 148.65 44.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -56.85 -172.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.98 -75.13 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.832 HG23 HD11 ' A' ' 42' ' ' LEU . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CE2' ' OD2' ' A' ' 101' ' ' ASP . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.576 ' OD1' HG22 ' A' ' 23' ' ' THR . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 7' ' ' ILE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 39' ' ' LYS . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 32' ' ' PRO . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.739 HG22 ' CD2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' OD1' ' A' ' 12' ' ' ASN . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 23' ' ' THR . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HB3' HD13 ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.643 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HG3' HG12 ' A' ' 16' ' ' VAL . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.814 HD13 HD12 ' A' ' 88' ' ' ILE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD11 HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.896 ' O ' HD22 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 41' ' ' LEU . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.893 ' N ' HD23 ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -85.46 48.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 68' ' ' ARG . . . 54.49 86.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 tt -91.1 32.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 111.052 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.582 ' O ' HG22 ' A' ' 66' ' ' VAL . 14.9 p -157.74 41.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.941 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 59.48 77.8 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 10.0 mtt-85 -160.1 55.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.777 HG21 HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 37' ' ' ILE . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 ' CG2' ' A' ' 37' ' ' ILE . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 38' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 81' ' ' LEU . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 48' ' ' LEU . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.662 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.682 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HD22 ' A' ' 41' ' ' LEU . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.23 132.27 51.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -77.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.732 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -109.98 -70.02 0.83 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.05 35.71 2.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.597 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.42 83.0 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 128.71 36.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.62 88.94 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.21 86.96 2.11 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.2 t -66.36 109.02 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -86.99 7.73 26.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.41 132.82 54.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -122.54 -41.27 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.405 HG23 HD23 ' A' ' 113' ' ' LEU . 5.3 t -160.23 159.42 31.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.2 69.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 HG23 ' A' ' 111' ' ' THR . 0.2 OUTLIER -73.29 104.16 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.78 124.53 21.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.17 178.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.8 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.775 0.321 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.13 103.52 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 3' ' ' VAL . 29.7 m -63.38 110.83 4.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.02 -168.57 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.442 2.095 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt-10 -132.9 -58.65 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.605 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.743 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' ' 13' ' ' VAL . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' ' 23' ' ' THR . 38.6 m-80 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 8' ' ' ARG . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 5' ' ' GLU . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.599 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 28' ' ' VAL . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 23' ' ' THR . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.796 ' O ' HD22 ' A' ' 77' ' ' LEU . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.599 ' OG ' HD12 ' A' ' 19' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 58' ' ' ILE . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.992 HD13 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' NZ ' HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.864 ' O ' HD22 ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.864 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.848 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 37' ' ' ILE . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.03 61.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' VAL . . . 58.73 110.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.864 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.79 28.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.565 0.698 . . . . 0.0 110.198 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 67' ' ' ALA . 41.7 t -159.64 164.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.578 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' N ' HG12 ' A' ' 66' ' ' VAL . . . -52.53 87.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 111.163 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -160.22 55.6 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 58' ' ' ILE . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.802 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 38' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 38' ' ' LEU . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.742 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.992 HD12 HD13 ' A' ' 41' ' ' LEU . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 91' ' ' LEU . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 90' ' ' THR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 48' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 99' ' ' SER . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.621 ' N ' HD23 ' A' ' 97' ' ' LEU . 37.8 m -57.92 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -75.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -160.25 -67.88 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.7 5.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.31 137.41 57.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 176.06 1.25 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -60.74 138.61 58.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.73 153.08 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.18 148.67 35.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -69.55 -32.52 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.13 149.23 42.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -142.44 -69.36 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.179 0.514 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.28 -174.8 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -159.36 73.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.68 -177.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 t -160.11 -175.65 5.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -59.74 146.68 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.872 0.368 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m -110.54 -27.4 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 43' ' ' ILE . 2.8 m -111.91 95.67 30.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.181 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.97 -172.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.508 2.139 . . . . 0.0 112.138 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.54 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -143.97 -75.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.817 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.941 ' HG3' HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 8' ' ' ARG . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CE2' HD11 ' A' ' 38' ' ' LEU . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' A' ' 32' ' ' PRO . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.59 ' HG3' HD13 ' A' ' 19' ' ' LEU . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HD21 ' A' ' 77' ' ' LEU . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.578 ' HA ' HD23 ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG13 HD13 ' A' ' 58' ' ' ILE . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CG ' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 54' ' ' LEU . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 3' ' ' VAL . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' HD22 ' A' ' 97' ' ' LEU . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.077 HD21 HG22 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.855 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.56 ' H ' HD23 ' A' ' 50' ' ' LEU . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.933 HD11 HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.938 HD12 HG11 ' A' ' 70' ' ' VAL . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -71.26 61.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . . . 54.44 26.14 6.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 65' ' ' ILE . 5.8 mt 26.36 43.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.665 HG13 ' N ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER 179.99 -165.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' N ' HG13 ' A' ' 66' ' ' VAL . . . -76.03 87.63 2.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.359 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 21.4 mmt180 -150.0 55.39 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 72' ' ' VAL . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG23 ' OD1' ' A' ' 69' ' ' ASN . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.592 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.659 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.81 HD22 ' HB2' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.548 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 89' ' ' VAL . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 87' ' ' ARG . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.077 HG22 HD21 ' A' ' 48' ' ' LEU . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.811 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -100.46 134.64 43.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' HB2' ' CD ' ' A' ' 87' ' ' ARG . 4.8 t70 -140.33 -63.4 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.275 0.56 . . . . 0.0 110.778 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -160.12 -55.81 0.06 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.736 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.92 8.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.605 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.2 98.96 6.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.773 0.32 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 133.35 16.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 162.19 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.34 85.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.21 -74.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.3 91.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -71.27 -18.17 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.17 146.39 28.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 111.002 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -160.14 92.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 pp -59.82 163.86 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.18 115.79 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -60.12 -67.3 0.4 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.805 0.335 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -174.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 3' ' ' VAL . 11.8 m -125.87 75.98 71.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.195 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.65 165.15 16.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.603 2.202 . . . . 0.0 112.229 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 16' ' ' VAL . 5.6 mt-10 -110.44 -76.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 13' ' ' VAL . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 17' ' ' LEU . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 32' ' ' PRO . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' HD13 ' A' ' 19' ' ' LEU . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.927 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.628 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.927 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 54' ' ' LEU . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' CG ' HD13 ' A' ' 42' ' ' LEU . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.02 HD21 HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' C ' HD22 ' A' ' 50' ' ' LEU . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.819 ' O ' HD22 ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.887 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.98 HD11 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.26 65.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 68' ' ' ARG . . . 52.07 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 65' ' ' ILE . 16.2 mt -94.06 34.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 0.0 110.968 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 66' ' ' VAL . 10.7 p -170.21 41.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.353 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 56.2 72.41 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' H ' ' HB1' ' A' ' 64' ' ' ALA . 87.0 mtt180 -159.8 55.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.572 ' OD1' HG23 ' A' ' 72' ' ' VAL . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 69' ' ' ASN . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 70' ' ' VAL . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.787 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 89' ' ' VAL . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 87' ' ' ARG . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.02 HG12 HD21 ' A' ' 48' ' ' LEU . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.527 ' CE1' HD22 ' A' ' 41' ' ' LEU . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.79 130.11 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.52 -59.04 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.167 0.508 . . . . 0.0 110.898 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.1 -44.61 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.936 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 47.24 3.44 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -130.1 91.76 3.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.851 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.24 165.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.784 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 101.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 171.91 13.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.989 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.21 135.24 17.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.799 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.24 -44.63 95.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -66.47 157.42 32.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 111' ' ' THR . 3.6 t70 -100.32 30.64 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 110' ' ' ASP . 17.2 p -160.05 135.67 8.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.12 75.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.72 80.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.44 152.31 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 154.74 19.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.882 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 60.74 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 t 62.41 97.96 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 23.3 Cg_exo -64.13 -176.48 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.702 2.268 . . . . 0.0 112.14 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.82 -76.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.641 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' OD1' HG23 ' A' ' 23' ' ' THR . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' A' ' 8' ' ' ARG . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.626 ' CE2' HD21 ' A' ' 30' ' ' LEU . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 32' ' ' PRO . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 19' ' ' LEU . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.744 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.573 ' HG3' HG12 ' A' ' 16' ' ' VAL . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' LYS . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.903 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.912 ' N ' HD23 ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt -79.14 55.23 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' CB ' ' CB ' ' A' ' 68' ' ' ARG . . . 50.79 35.96 13.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.727 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER 42.66 47.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.246 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.2 t 59.25 153.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.96 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 66' ' ' VAL . . . 75.06 29.72 0.94 Allowed 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.402 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.455 ' CB ' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -161.17 55.92 0.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 58' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 34' ' ' GLU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.854 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.854 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.834 HD12 ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 97' ' ' LEU . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m -38.72 137.35 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -22.29 5.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.262 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -39.69 -70.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.475 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 34.88 80.13 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.317 -0.402 . . . . 0.0 113.61 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.37 97.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 0.0 110.99 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 162.44 23.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -64.94 143.12 58.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.36 174.67 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.057 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -64.72 102.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -70.19 -72.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.74 109.27 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.127 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -116.93 -17.2 10.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 p -59.11 105.37 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.764 0.316 . . . . 0.0 111.036 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.28 69.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.93 140.77 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.1 159.65 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.43 103.78 0.44 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 43' ' ' ILE . 35.4 m -89.55 132.61 36.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.626 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 19.9 Cg_exo -64.5 162.59 30.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.357 2.038 . . . . 0.0 112.737 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.15 -67.89 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.727 HD12 ' HG ' ' A' ' 42' ' ' LEU . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HE ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.72 ' CD1' HG22 ' A' ' 7' ' ' ILE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 23' ' ' THR . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 HG22 ' HE ' ' A' ' 8' ' ' ARG . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' A' ' 30' ' ' LEU . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 39' ' ' LYS . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 28' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.639 HG22 HD21 ' A' ' 12' ' ' ASN . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 35' ' ' SER . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 64' ' ' ALA . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.617 ' CB ' HD13 ' A' ' 30' ' ' LEU . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 34' ' ' GLU . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.69 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.909 HD22 ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.727 ' HG ' HD12 ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.898 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 70' ' ' VAL . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 58' ' ' ILE . 48.9 pttt -82.24 56.53 3.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . . . 62.1 36.12 15.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER 39.74 76.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.506 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 66' ' ' VAL . 77.7 t 59.42 77.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.963 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 64' ' ' ALA . . . -116.67 -172.39 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -75.05 -65.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.94 HD12 HD13 ' A' ' 88' ' ' ILE . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 34' ' ' GLU . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.798 HD23 ' HA2' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.798 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 74' ' ' ILE . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 87' ' ' ARG . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 90' ' ' THR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 48' ' ' LEU . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.674 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.909 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.8 t -117.91 130.68 56.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 -73.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.98 -49.45 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.849 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.45 77.81 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -179.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.822 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 21.0 mttt -150.49 172.29 15.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -69.14 150.01 48.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.4 t -59.06 141.49 53.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.27 -46.68 82.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.29 115.33 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.059 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -134.84 -30.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.492 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.0 p -62.51 146.63 51.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 120.48 2.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.13 120.17 7.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.977 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.35 129.82 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -60.28 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -162.29 128.23 3.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 3' ' ' VAL . 19.5 m -129.89 96.37 26.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 104' ' ' LYS . 32.9 Cg_exo -61.25 -171.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.539 2.159 . . . . 0.0 112.132 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.74 -75.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.821 HD11 HG13 ' A' ' 16' ' ' VAL . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.821 HG13 HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 19' ' ' LEU . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.749 ' HB3' HG21 ' A' ' 65' ' ' ILE . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.795 ' O ' HD22 ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.776 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.896 HG21 HD12 ' A' ' 74' ' ' ILE . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.974 HD12 HD12 ' A' ' 88' ' ' ILE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.651 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.838 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.99 ' N ' HD23 ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -61.0 109.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.57 75.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.598 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 33' ' ' SER . 5.8 tt -70.92 97.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.826 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 66' ' ' VAL . 14.8 p 43.89 43.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.514 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.74 -168.45 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -44.02 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 72' ' ' VAL . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 69' ' ' ASN . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.896 HD12 HG21 ' A' ' 37' ' ' ILE . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' ' 34' ' ' GLU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.681 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.974 HD12 HD12 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 90' ' ' THR . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 98' ' ' PHE . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.914 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -39.02 141.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -65.24 -17.52 64.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.536 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.08 52.2 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.83 60.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.567 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.98 -179.43 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.783 0.325 . . . . 0.0 110.77 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 4' ' ' PRO . 31.4 pttt -60.01 150.99 27.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.73 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 110.87 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -59.91 150.55 28.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -60.51 -66.6 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.93 115.09 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -146.41 29.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.44 124.25 20.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -160.13 118.38 2.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.0 -175.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 158.92 31.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -59.98 -32.77 71.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.938 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.94 85.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.782 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.79 122.3 19.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 42.0 Cg_endo -68.42 109.72 2.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.506 2.137 . . . . 0.0 112.556 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -150.39 38.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' OD1' HG23 ' A' ' 23' ' ' THR . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.61 ' HZ ' HD21 ' A' ' 30' ' ' LEU . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HD23 ' A' ' 17' ' ' LEU . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 16' ' ' VAL . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 28' ' ' VAL . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.836 HG12 ' HB ' ' A' ' 28' ' ' VAL . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.742 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.742 ' HD2' HG22 ' A' ' 23' ' ' THR . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 20' ' ' THR . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' N ' HG12 ' A' ' 28' ' ' VAL . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.698 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD11 ' A' ' 37' ' ' ILE . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' HB3' HD23 ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.698 ' CB ' HD13 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.04 HD12 HD13 ' A' ' 58' ' ' ILE . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.708 HD23 ' CE ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.708 ' CE ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 57' ' ' GLU . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.856 HD13 ' HE2' ' A' ' 104' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.954 ' HA ' HD21 ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 55.2 t-80 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 40' ' ' ARG . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.04 HD13 HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 59.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 49.65 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.293 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 tt -94.08 33.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.225 0.536 . . . . 0.0 111.006 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 66' ' ' VAL . 12.9 p -169.5 38.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.82 -176.5 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -107.54 -25.47 11.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.846 ' CG2' HD12 ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.466 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.785 ' CD1' HD13 ' A' ' 81' ' ' LEU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.968 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ARG . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 48' ' ' LEU . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' CYS . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p -44.16 170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -57.78 -19.15 26.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.64 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 51.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.89 71.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.349 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.583 ' C ' HD12 ' A' ' 7' ' ' ILE . 10.3 t0 -119.83 120.14 35.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.819 0.342 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.856 ' HE2' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -57.21 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.261 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -71.0 115.74 10.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.96 104.06 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -94.23 23.2 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.4 137.34 58.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' THR . 3.2 t0 -98.87 29.94 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 110' ' ' ASP . 1.1 p -160.18 99.77 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.12 131.27 5.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -62.28 130.23 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.1 t -62.64 104.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -59.31 -51.4 70.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.2 mt-10 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -71.71 -35.87 70.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 m -119.98 133.52 23.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HG3' HD11 ' A' ' 43' ' ' ILE . 16.7 Cg_exo -66.73 153.75 76.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.391 2.061 . . . . 0.0 112.005 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 105' ' ' LYS . 2.7 mm-40 -91.86 -78.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 42' ' ' LEU . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.654 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 1.5 m-80 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.654 HG22 ' HG3' ' A' ' 8' ' ' ARG . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 21' ' ' VAL . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 17' ' ' LEU . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 16' ' ' VAL . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.697 HD23 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.67 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HD2' HG22 ' A' ' 23' ' ' THR . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.653 ' CA ' HD21 ' A' ' 19' ' ' LEU . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.907 ' HB3' HD13 ' A' ' 65' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.733 ' O ' HD11 ' A' ' 77' ' ' LEU . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.858 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.884 ' CG1' HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 42' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' CD ' ' HG2' ' A' ' 4' ' ' PRO . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.798 HD11 HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.625 HD11 ' HG3' ' A' ' 4' ' ' PRO . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.726 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.798 ' CD2' HD11 ' A' ' 74' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.884 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.29 34.82 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.27 37.06 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.347 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 33' ' ' SER . 1.0 OUTLIER -71.56 71.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.202 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 66' ' ' VAL . 12.6 p 45.87 38.64 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.409 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -172.7 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.894 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -113.95 -29.18 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.502 ' NE2' HG21 ' A' ' 65' ' ' ILE . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.945 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 99' ' ' SER . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 48' ' ' LEU . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.716 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' HG ' ' A' ' 48' ' ' LEU . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 89' ' ' VAL . 18.4 t -109.29 93.97 4.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -140.2 -53.35 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.204 0.526 . . . . 0.0 110.95 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.1 -70.13 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.006 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 131.17 -40.05 1.69 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.862 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 138.2 58.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.177 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -171.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.759 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' CB ' ' HB2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -81.25 75.7 8.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.54 132.51 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.2 t -73.23 115.23 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.9 -68.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.235 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.19 152.14 11.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -150.11 -42.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 m -56.49 165.44 1.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.17 127.0 4.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.98 143.92 57.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.51 137.73 58.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -179.19 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.2 m170 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.733 0.301 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -127.96 160.85 30.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.32 117.74 52.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.46 82.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.487 2.124 . . . . 0.0 112.263 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.4 20.29 10.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 42' ' ' LEU . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.866 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.866 HG12 ' HB3' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 30' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 17' ' ' LEU . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.453 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.601 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' CA ' HD21 ' A' ' 19' ' ' LEU . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.825 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.053 HD11 HD23 ' A' ' 54' ' ' LEU . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.675 HD13 ' OH ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.928 HD11 HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 39' ' ' LYS . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.704 ' CD1' HG12 ' A' ' 94' ' ' VAL . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HA ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.594 ' H ' HD23 ' A' ' 50' ' ' LEU . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.053 HD23 HD11 ' A' ' 37' ' ' ILE . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.629 HG13 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.31 55.0 3.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . . . 58.66 34.72 24.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 65' ' ' ILE . 5.4 tp 41.24 81.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.542 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t 47.28 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.21 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.97 -172.1 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -63.95 -65.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 55' ' ' LEU . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 37' ' ' ILE . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 34' ' ' GLU . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.675 ' OH ' HD13 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.552 HD13 HG21 ' A' ' 74' ' ' ILE . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 97' ' ' LEU . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 48' ' ' LEU . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -39.82 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -78.44 -17.16 56.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.486 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.09 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.68 0.792 . . . . 0.0 113.048 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.91 74.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.204 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.12 166.99 14.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.222 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -170.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 120.4 12.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.32 153.09 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -150.18 168.22 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -76.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -173.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -146.28 -69.54 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -160.09 111.34 1.94 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.765 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 70.04 1.43 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 82.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.6 t -57.29 158.75 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.9 mt -60.08 -45.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.896 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -174.37 108.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 3' ' ' VAL . 12.3 m -116.62 88.27 24.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.768 ' CB ' HG11 ' A' ' 16' ' ' VAL . 22.4 Cg_exo -64.09 129.23 23.76 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.62 2.214 . . . . 0.0 112.052 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 -50.32 3.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.544 HD13 ' HG ' ' A' ' 42' ' ' LEU . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 8' ' ' ARG . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 4' ' ' PRO . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.633 HD22 ' OG ' ' A' ' 35' ' ' SER . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 31' ' ' THR . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 37' ' ' ILE . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.786 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.672 ' HB3' HD13 ' A' ' 30' ' ' LEU . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 88' ' ' ILE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.696 HD13 ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.712 HD11 ' HG3' ' A' ' 4' ' ' PRO . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG3' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.881 HD12 HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.558 ' O ' HD21 ' A' ' 54' ' ' LEU . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.939 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 41' ' ' LEU . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 54' ' ' LEU . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -99.83 30.84 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 66' ' ' VAL . . . -173.15 -157.79 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 65' ' ' ILE . 39.6 mm 52.46 27.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.8 0.81 . . . . 0.0 109.585 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 64' ' ' ALA . 14.7 p 176.98 33.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.107 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 154.42 -173.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 -26.16 9.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 58' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 38' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.744 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' NH2' HD11 ' A' ' 88' ' ' ILE . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 41' ' ' LEU . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 90' ' ' THR . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 96' ' ' TYR . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.884 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.689 ' CD2' HD11 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.881 HD13 HD12 ' A' ' 48' ' ' LEU . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -71.02 107.42 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -140.11 -71.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 111.124 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -160.2 -65.11 0.07 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.7 22.66 3.58 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.0 69.68 6.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.01 175.46 8.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.97 144.91 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.042 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.94 117.21 6.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 t -65.17 120.9 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -30.03 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.72 117.7 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.18 -19.19 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.227 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.4 m -58.0 102.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -60.02 135.32 57.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.21 146.37 26.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 113.89 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -60.63 -43.33 97.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.985 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.8 m170 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.847 0.356 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.93 133.72 44.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.5 t 64.04 136.15 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 104' ' ' LYS . 13.8 Cg_exo -69.45 58.47 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.571 2.181 . . . . 0.0 112.527 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.864 ' HB3' HG12 ' A' ' 16' ' ' VAL . 3.3 mt-10 -82.51 -22.11 35.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.676 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.894 ' HB2' HG13 ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HA ' HG12 ' A' ' 13' ' ' VAL . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 8' ' ' ARG . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.58 HD22 ' HB ' ' A' ' 16' ' ' VAL . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 23' ' ' THR . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 20' ' ' THR . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.531 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 39.1 m80 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.871 ' HA ' HD11 ' A' ' 19' ' ' LEU . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 65' ' ' ILE . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.85 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.787 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 54' ' ' LEU . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 40' ' ' ARG . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.858 HD11 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.874 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.081 HD11 HD21 ' A' ' 41' ' ' LEU . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.771 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' ILE . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.42 125.06 27.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 48.27 61.44 3.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.421 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -63.41 83.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 66' ' ' VAL . 14.4 p 43.83 39.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.24 -173.27 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.066 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -82.74 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.771 ' CG2' HD12 ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 74' ' ' ILE . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 71' ' ' ASP . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.587 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.812 HD13 HD22 ' A' ' 38' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.664 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 89' ' ' VAL . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.798 HG22 ' CE1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.406 ' HG1' ' HE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 89' ' ' VAL . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 48' ' ' LEU . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.798 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE1' HD22 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 97' ' ' LEU . 1.4 t -67.85 117.16 9.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 50.9 t0 -132.48 -80.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -160.08 -63.22 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.153 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.1 14.17 3.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.042 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.5 84.19 1.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -105.11 148.22 27.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 87.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.77 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.23 103.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.46 164.69 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -58.03 10.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.06 109.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.73 -65.82 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.133 0.492 . . . . 0.0 110.948 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -160.06 159.54 32.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.48 88.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -61.78 149.7 39.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.6 t -61.03 112.62 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.97 143.88 54.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.6 m80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.0 p -158.0 106.92 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.9 p -158.94 101.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.98 176.05 4.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.178 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -63.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.406 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 21' ' ' VAL . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.908 ' CE2' HD21 ' A' ' 38' ' ' LEU . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.575 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 32' ' ' PRO . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 27' ' ' SER . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 20' ' ' THR . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.956 ' HB3' HD13 ' A' ' 19' ' ' LEU . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.665 ' HB3' HD23 ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.828 ' HA ' HD23 ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.867 HG13 HD12 ' A' ' 58' ' ' ILE . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.908 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CG ' HG12 ' A' ' 16' ' ' VAL . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.835 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 50' ' ' LEU . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.885 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.004 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.004 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.869 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -69.45 65.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 57.07 103.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.628 HG22 ' OG ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -91.9 31.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.22 0.533 . . . . 0.0 110.954 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.9 p -178.2 38.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.033 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.615 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -155.18 -167.92 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.112 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -114.43 -22.93 9.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB3' HG22 ' A' ' 72' ' ' VAL . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.78 ' O ' HD13 ' A' ' 77' ' ' LEU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB2' HD22 ' A' ' 77' ' ' LEU . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 85' ' ' GLY . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.602 ' H ' HD23 ' A' ' 81' ' ' LEU . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.706 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.937 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 90' ' ' THR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.657 HG23 HD22 ' A' ' 91' ' ' LEU . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.937 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.835 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p -38.71 154.03 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -22.47 58.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.148 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' GLY . 0.9 OUTLIER -39.84 -70.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.471 -179.398 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' ASP . . . 29.88 79.12 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.754 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.57 88.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -56.88 153.77 10.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.05 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 8' ' ' ARG . 2.5 tmtp? -150.2 108.97 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -72.74 132.37 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.62 93.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -36.01 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -58.54 111.82 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.9 -24.09 10.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 m -64.96 167.24 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -160.16 159.07 31.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.3 tp -150.11 104.53 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.73 117.11 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.002 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.682 HD12 ' O ' ' A' ' 115' ' ' LEU . 2.4 pp -59.43 125.92 25.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.928 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.579 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -77.26 -31.06 54.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 3' ' ' VAL . 10.8 p -55.85 117.32 15.12 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' CG ' HG12 ' A' ' 43' ' ' ILE . 51.6 Cg_exo -56.03 -169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.518 2.145 . . . . 0.0 112.478 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.44 -62.89 1.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.769 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 42' ' ' LEU . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 13' ' ' VAL . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 79.1 m-20 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 8' ' ' ARG . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 13' ' ' VAL . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 4' ' ' PRO . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 32' ' ' PRO . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 84' ' ' TYR . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.873 HD22 ' OG ' ' A' ' 35' ' ' SER . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.713 ' HB3' HD13 ' A' ' 19' ' ' LEU . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.8 ' O ' HD11 ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.873 ' OG ' HD22 ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 81' ' ' LEU . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' CE ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 57' ' ' GLU . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' O ' ' A' ' 2' ' ' SER . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HG2' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.728 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.694 HD22 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.23 42.04 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 66' ' ' VAL . . . 65.23 23.18 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.401 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.3 tt 33.53 31.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 67' ' ' ALA . 1.8 t -163.55 -164.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.827 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -84.42 56.97 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.117 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 -122.59 55.65 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.49 ' OD1' HG23 ' A' ' 72' ' ' VAL . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.83 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 69' ' ' ASN . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.739 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 71' ' ' ASP . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.638 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 21' ' ' VAL . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.476 HH12 HD11 ' A' ' 38' ' ' LEU . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 HD22 ' A' ' 41' ' ' LEU . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.98 HG22 HD11 ' A' ' 48' ' ' LEU . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.694 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.674 ' O ' HD13 ' A' ' 97' ' ' LEU . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' HB3' HD23 ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -111.89 126.57 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.13 -42.02 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -160.02 -59.62 0.06 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.834 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.01 22.09 3.32 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.024 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -67.73 77.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.33 . . . . 0.0 110.797 179.807 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.08 146.95 40.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.159 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.03 140.79 55.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -60.92 99.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.1 t -64.38 89.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.24 -73.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.56 134.47 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.9 -35.73 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.21 115.69 2.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.978 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 123.84 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.57 96.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.0 t -61.76 125.84 25.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 175.9 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.822 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.339 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 t -98.64 97.34 8.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.14 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 3' ' ' VAL . 15.6 m -128.5 97.63 27.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 24.3 Cg_exo -65.86 72.7 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.755 2.304 . . . . 0.0 112.366 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.7 mt-10 -89.57 -2.9 58.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.082 HD11 HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 13' ' ' VAL . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 8' ' ' ARG . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.84 ' CD2' HG22 ' A' ' 21' ' ' VAL . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.082 HG13 HD11 ' A' ' 7' ' ' ILE . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 16' ' ' VAL . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.84 HG22 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HA ' HD22 ' A' ' 19' ' ' LEU . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HB3' ' HB ' ' A' ' 65' ' ' ILE . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.742 ' O ' HD11 ' A' ' 77' ' ' LEU . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.794 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 58' ' ' ILE . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.74 HD12 ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 54' ' ' LEU . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 45' ' ' LYS . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.753 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.709 HD11 HG13 ' A' ' 37' ' ' ILE . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.803 ' HB1' HG13 ' A' ' 65' ' ' ILE . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 82.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 51.81 74.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.569 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.803 HG13 ' HB1' ' A' ' 62' ' ' ALA . 67.1 mt -59.39 92.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.453 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 66' ' ' VAL . 57.5 t 56.25 75.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . . . -166.81 -169.67 1.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 -101.2 -50.33 3.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.848 HG23 HD13 ' A' ' 88' ' ' ILE . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA2' HD12 ' A' ' 38' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 89' ' ' VAL . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.848 HD13 HG23 ' A' ' 74' ' ' ILE . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' ARG . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 91' ' ' LEU . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 98' ' ' PHE . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 97' ' ' LEU . 3.5 m -39.88 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -86.82 -17.01 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.559 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 52.65 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.78 67.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.511 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.01 -176.39 5.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -159.68 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -140.15 100.94 4.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 86.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 t -88.64 75.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.008 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.11 -29.25 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.72 151.95 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -147.05 35.64 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 112' ' ' LYS . 1.1 m -60.27 172.98 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' H ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -160.2 113.16 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.6 128.37 36.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 t -160.13 152.17 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.99 -31.27 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.859 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 7' ' ' ILE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 23' ' ' THR . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.653 ' HB3' HD12 ' A' ' 7' ' ' ILE . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' LEU . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 32' ' ' PRO . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 21' ' ' VAL . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.858 ' HB3' HD13 ' A' ' 19' ' ' LEU . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' HD12 ' A' ' 37' ' ' ILE . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.83 ' O ' HD22 ' A' ' 77' ' ' LEU . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.661 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.597 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.859 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.608 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.923 HD12 HG13 ' A' ' 37' ' ' ILE . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.652 ' CD1' HG21 ' A' ' 37' ' ' ILE . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 34' ' ' GLU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 38' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ARG . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.859 ' CG1' HD21 ' A' ' 48' ' ' LEU . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 48' ' ' LEU . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 16' ' ' VAL . 6.4 mt-10 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 HG13 ' A' ' 16' ' ' VAL . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.695 ' HA ' HG12 ' A' ' 13' ' ' VAL . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 8' ' ' ARG . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.801 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 7' ' ' ILE . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 18' ' ' LYS . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 32' ' ' PRO . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.796 ' HB3' HD13 ' A' ' 19' ' ' LEU . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.45 ' CB ' HD11 ' A' ' 30' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.891 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB2' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HG2' HG12 ' A' ' 16' ' ' VAL . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.828 ' O ' HD22 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.536 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.924 HG13 HG21 ' A' ' 70' ' ' VAL . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.71 0.29 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.41 HD21 HG23 ' A' ' 72' ' ' VAL . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 58' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG23 HD21 ' A' ' 69' ' ' ASN . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.79 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 37' ' ' ILE . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.937 HD21 ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HB3' HD12 ' A' ' 30' ' ' LEU . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 84' ' ' TYR . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.763 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.504 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' ARG . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 96' ' ' TYR . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 94' ' ' VAL . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.711 HG12 HD21 ' A' ' 48' ' ' LEU . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.503 ' HE1' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 41' ' ' LEU . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 13' ' ' VAL . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG12 ' CG ' ' A' ' 39' ' ' LYS . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 13' ' ' VAL . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 23' ' ' THR . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.65 ' CA ' HD21 ' A' ' 19' ' ' LEU . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 37' ' ' ILE . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.756 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.866 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' CG ' HG12 ' A' ' 16' ' ' VAL . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HE ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 40' ' ' ARG . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.918 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.866 HD12 HG13 ' A' ' 37' ' ' ILE . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.786 HG23 HD12 ' A' ' 88' ' ' ILE . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 38' ' ' LEU . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.852 ' HB2' HD21 ' A' ' 81' ' ' LEU . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.786 HD12 HG23 ' A' ' 74' ' ' ILE . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' HB3' HD21 ' A' ' 41' ' ' LEU . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.989 HG23 HD11 ' A' ' 42' ' ' LEU . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.832 ' CD2' HG22 ' A' ' 21' ' ' VAL . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 17' ' ' LEU . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.595 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.832 HG22 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.595 ' OG ' HG22 ' A' ' 20' ' ' THR . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.704 ' CA ' HD21 ' A' ' 19' ' ' LEU . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' HD12 ' A' ' 37' ' ' ILE . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 77' ' ' LEU . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.781 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.989 HD11 HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HE3' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.761 ' O ' HD12 ' A' ' 97' ' ' LEU . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' CD2' HG12 ' A' ' 94' ' ' VAL . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.555 HD21 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' GLU . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.665 ' N ' HD12 ' A' ' 55' ' ' LEU . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 37' ' ' ILE . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.779 0.323 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.447 ' CE1' ' CG ' ' A' ' 34' ' ' GLU . 1.1 t60 -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.75 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.663 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' ARG . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.51 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG12 ' CD2' ' A' ' 48' ' ' LEU . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 47' ' ' GLN . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.411 ' OG ' HG21 ' A' ' 89' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' OE2' HD21 ' A' ' 17' ' ' LEU . 1.4 tt0 . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 121.152 0.501 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 42' ' ' LEU . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.631 ' CD1' HG22 ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 17' ' ' LEU . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD21 ' OE2' ' A' ' 5' ' ' GLU . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 23' ' ' THR . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.872 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 34' ' ' GLU . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HB3' HD13 ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 37' ' ' ILE . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.815 ' O ' HD11 ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.872 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.787 HD13 ' CD1' ' A' ' 81' ' ' LEU . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.094 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HA ' HD13 ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.711 ' N ' HD23 ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 70' ' ' VAL . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.469 HD22 HG23 ' A' ' 72' ' ' VAL . 63.1 t30 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HD12 ' A' ' 58' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 69' ' ' ASN . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.51 HD13 ' HE2' ' A' ' 96' ' ' TYR . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 86' ' ' SER . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HB3' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.79 HD23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 81' ' ' LEU . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.888 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.403 ' CB ' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 90' ' ' THR . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 90' ' ' THR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.094 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.51 ' HE2' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 98' ' ' PHE . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.815 HD11 HG12 ' A' ' 16' ' ' VAL . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 22' ' ' GLU . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.617 ' CD2' HD12 ' A' ' 7' ' ' ILE . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 HD11 ' A' ' 7' ' ' ILE . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 32' ' ' PRO . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.639 ' HB3' HG22 ' A' ' 13' ' ' VAL . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.623 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HB3' HD13 ' A' ' 19' ' ' LEU . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.623 ' CB ' HD13 ' A' ' 30' ' ' LEU . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD13 HD12 ' A' ' 74' ' ' ILE . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.631 ' CD2' HG23 ' A' ' 88' ' ' ILE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.73 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.643 HD22 ' C ' ' A' ' 49' ' ' CYS . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HD13 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.841 HD12 HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.762 HG13 HG21 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.864 HG22 HD11 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 74' ' ' ILE . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.864 HD11 HG22 ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 35' ' ' SER . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.902 HD23 ' HA2' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.627 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.902 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 91' ' ' LEU . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.792 HG22 HD11 ' A' ' 48' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.698 ' CD2' HD12 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.73 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.789 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.789 ' CE1' HG22 ' A' ' 7' ' ' ILE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 13' ' ' VAL . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.781 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG13 ' CD1' ' A' ' 7' ' ' ILE . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HG ' HG23 ' A' ' 16' ' ' VAL . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' C ' HD22 ' A' ' 19' ' ' LEU . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.781 HG22 ' CG ' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.705 ' O ' HD22 ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.833 ' O ' HD21 ' A' ' 77' ' ' LEU . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.988 ' HB3' HD21 ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.668 HD22 HD13 ' A' ' 81' ' ' LEU . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.418 HD11 ' CE ' ' A' ' 39' ' ' LYS . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.876 ' HA ' HD21 ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 37' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 96.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.732 0.301 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 70' ' ' VAL . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HD3' HD23 ' A' ' 30' ' ' LEU . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.879 HD23 ' HA2' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.879 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 84' ' ' TYR . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 91' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 48' ' ' LEU . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.486 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.744 ' CD1' HD13 ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 42' ' ' LEU . 1.4 tt0 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.893 ' HB ' HD11 ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.902 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' HD22 ' A' ' 19' ' ' LEU . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 23' ' ' THR . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 31' ' ' THR . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.899 ' O ' HD21 ' A' ' 77' ' ' LEU . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.737 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.797 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.902 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 98' ' ' PHE . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 7' ' ' ILE . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.574 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 49' ' ' CYS . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.602 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.893 ' HB3' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HD2' ' CE1' ' A' ' 73' ' ' HIS . 6.1 ttm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.367 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 55' ' ' LEU . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.5 m-70 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.713 ' HB3' HD12 ' A' ' 30' ' ' LEU . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.891 HD22 HD22 ' A' ' 38' ' ' LEU . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.634 ' HB3' HD21 ' A' ' 81' ' ' LEU . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' GLY . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 94' ' ' VAL . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 91' ' ' LEU . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 97' ' ' LEU . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.573 ' HB2' HD12 ' A' ' 41' ' ' LEU . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.801 HG12 HD13 ' A' ' 42' ' ' LEU . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 13' ' ' VAL . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 23' ' ' THR . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 8' ' ' ARG . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CE1' HG22 ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 7' ' ' ILE . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 32' ' ' PRO . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.658 HG22 ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 23' ' ' THR . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.844 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.747 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.844 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 16' ' ' VAL . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.709 HD13 ' HD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 7' ' ' ILE . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.4 tp60 -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 HG13 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.909 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.737 HG13 HG21 ' A' ' 70' ' ' VAL . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 72' ' ' VAL . 17.3 mtp180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.737 HG21 HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 68' ' ' ARG . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 37' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD23 ' CA ' ' A' ' 85' ' ' GLY . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.627 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.59 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 87' ' ' ARG . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' A' ' 97' ' ' LEU . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.709 ' HD1' HD13 ' A' ' 41' ' ' LEU . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.456 ' OG ' HG21 ' A' ' 89' ' ' VAL . 7.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HB3' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.732 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.63 ' HG3' HG13 ' A' ' 13' ' ' VAL . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.63 HG13 ' HG3' ' A' ' 8' ' ' ARG . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.756 ' CD2' HG22 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.911 HG13 HD13 ' A' ' 17' ' ' LEU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.911 HD13 HG13 ' A' ' 16' ' ' VAL . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 19' ' ' LEU . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.756 HG22 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.492 ' HA ' HG23 ' A' ' 20' ' ' THR . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.878 ' HB3' HD13 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.93 ' O ' HD11 ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.966 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.767 HD11 HD21 ' A' ' 54' ' ' LEU . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.811 HD23 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.769 HD13 ' H ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.984 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HB2' HD22 ' A' ' 50' ' ' LEU . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 37' ' ' ILE . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.073 HG23 HD13 ' A' ' 88' ' ' ILE . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.858 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.811 ' NH1' HD23 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.073 HD13 HG23 ' A' ' 74' ' ' ILE . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CG1' HD21 ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.926 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.832 HG23 HD11 ' A' ' 42' ' ' LEU . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.576 ' OD1' HG22 ' A' ' 23' ' ' THR . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 7' ' ' ILE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 39' ' ' LYS . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 32' ' ' PRO . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.739 HG22 ' CD2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' OD1' ' A' ' 12' ' ' ASN . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 23' ' ' THR . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HB3' HD13 ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.643 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HG3' HG12 ' A' ' 16' ' ' VAL . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.814 HD13 HD12 ' A' ' 88' ' ' ILE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD11 HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.896 ' O ' HD22 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 41' ' ' LEU . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.893 ' N ' HD23 ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.633 0.254 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.777 HG21 HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 37' ' ' ILE . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 ' CG2' ' A' ' 37' ' ' ILE . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 38' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 81' ' ' LEU . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 48' ' ' LEU . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.662 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HD22 ' A' ' 41' ' ' LEU . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt-10 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.219 0.533 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.743 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' ' 13' ' ' VAL . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.592 ' ND2' HG22 ' A' ' 23' ' ' THR . 15.8 m120 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 8' ' ' ARG . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 5' ' ' GLU . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.599 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.592 HG22 ' ND2' ' A' ' 12' ' ' ASN . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 23' ' ' THR . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.796 ' O ' HD22 ' A' ' 77' ' ' LEU . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.599 ' OG ' HD12 ' A' ' 19' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 58' ' ' ILE . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.992 HD13 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' NZ ' HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.864 ' O ' HD22 ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.848 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 37' ' ' ILE . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 58' ' ' ILE . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.802 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 38' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 38' ' ' LEU . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.742 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.992 HD12 HD13 ' A' ' 41' ' ' LEU . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 91' ' ' LEU . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 90' ' ' THR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 48' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 99' ' ' SER . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.621 ' N ' HD23 ' A' ' 97' ' ' LEU . 37.8 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.54 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.111 0.481 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.941 ' HG3' HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 8' ' ' ARG . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CE2' HD11 ' A' ' 38' ' ' LEU . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' A' ' 32' ' ' PRO . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.59 ' HG3' HD13 ' A' ' 19' ' ' LEU . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HD21 ' A' ' 77' ' ' LEU . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.578 ' HA ' HD23 ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG13 HD13 ' A' ' 58' ' ' ILE . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CG ' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 54' ' ' LEU . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' HD22 ' A' ' 97' ' ' LEU . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.077 HD21 HG22 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.855 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.56 ' H ' HD23 ' A' ' 50' ' ' LEU . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.933 HD11 HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.938 HD12 HG11 ' A' ' 70' ' ' VAL . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.334 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 72' ' ' VAL . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG23 ' OD1' ' A' ' 69' ' ' ASN . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.592 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.659 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.81 HD22 ' HB2' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.548 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 89' ' ' VAL . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 87' ' ' ARG . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.077 HG22 HD21 ' A' ' 48' ' ' LEU . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.811 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 16' ' ' VAL . 5.6 mt-10 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 13' ' ' VAL . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 17' ' ' LEU . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 32' ' ' PRO . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' HD13 ' A' ' 19' ' ' LEU . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.927 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.628 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.927 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 54' ' ' LEU . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' CG ' HD13 ' A' ' 42' ' ' LEU . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.02 HD21 HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' C ' HD22 ' A' ' 50' ' ' LEU . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.819 ' O ' HD22 ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.887 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.98 HD11 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.459 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 87.0 mtt180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.572 ' OD1' HG23 ' A' ' 72' ' ' VAL . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 69' ' ' ASN . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 70' ' ' VAL . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.787 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 89' ' ' VAL . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 87' ' ' ARG . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.02 HG12 HD21 ' A' ' 48' ' ' LEU . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.527 ' CE1' HD22 ' A' ' 41' ' ' LEU . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 121.096 0.474 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.588 ' OD1' HG23 ' A' ' 23' ' ' THR . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' A' ' 8' ' ' ARG . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.626 ' CE2' HD21 ' A' ' 30' ' ' LEU . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 32' ' ' PRO . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 19' ' ' LEU . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.744 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.573 ' HG3' HG12 ' A' ' 16' ' ' VAL . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' LYS . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.903 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.912 ' N ' HD23 ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.433 ' HD3' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.691 0.281 . . . . 0.0 110.765 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 58' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 34' ' ' GLU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.854 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.854 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.834 HD12 ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 97' ' ' LEU . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.727 HD12 ' HG ' ' A' ' 42' ' ' LEU . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HE ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.72 ' CD1' HG22 ' A' ' 7' ' ' ILE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 23' ' ' THR . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 HG22 ' HE ' ' A' ' 8' ' ' ARG . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' A' ' 30' ' ' LEU . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 39' ' ' LYS . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 28' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.639 HG22 HD21 ' A' ' 12' ' ' ASN . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 35' ' ' SER . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.617 ' CB ' HD13 ' A' ' 30' ' ' LEU . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 34' ' ' GLU . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.69 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.909 HD22 ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.727 ' HG ' HD12 ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.898 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 70' ' ' VAL . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 58' ' ' ILE . 48.9 pttt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.94 HD12 HD13 ' A' ' 88' ' ' ILE . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 34' ' ' GLU . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.798 HD23 ' HA2' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.798 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 74' ' ' ILE . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 87' ' ' ARG . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 90' ' ' THR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 48' ' ' LEU . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.909 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.051 0.453 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.821 HD11 HG13 ' A' ' 16' ' ' VAL . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.821 HG13 HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 19' ' ' LEU . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.795 ' O ' HD22 ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.776 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.896 HG21 HD12 ' A' ' 74' ' ' ILE . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.974 HD12 HD12 ' A' ' 88' ' ' ILE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.651 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.838 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.99 ' N ' HD23 ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 72' ' ' VAL . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 69' ' ' ASN . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.896 HD12 HG21 ' A' ' 37' ' ' ILE . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' ' 34' ' ' GLU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.681 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.974 HD12 HD12 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 90' ' ' THR . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 98' ' ' PHE . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.914 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' OD1' HG23 ' A' ' 23' ' ' THR . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.61 ' HZ ' HD21 ' A' ' 30' ' ' LEU . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HD23 ' A' ' 17' ' ' LEU . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 16' ' ' VAL . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 28' ' ' VAL . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.836 HG12 ' HB ' ' A' ' 28' ' ' VAL . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.742 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.742 ' HD2' HG22 ' A' ' 23' ' ' THR . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 20' ' ' THR . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' N ' HG12 ' A' ' 28' ' ' VAL . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.698 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD11 ' A' ' 37' ' ' ILE . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' HB3' HD23 ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.698 ' CB ' HD13 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.04 HD12 HD13 ' A' ' 58' ' ' ILE . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.708 HD23 ' CE ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.708 ' CE ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 57' ' ' GLU . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 39' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.954 ' HA ' HD21 ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 6.7 t60 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 40' ' ' ARG . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.04 HD13 HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.846 ' CG2' HD12 ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 1.6 t-160 -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.785 ' CD1' HD13 ' A' ' 81' ' ' LEU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.968 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ARG . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 48' ' ' LEU . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' CYS . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 42' ' ' LEU . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.654 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.673 HD21 HG23 ' A' ' 23' ' ' THR . 2.5 m120 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.654 HG22 ' HG3' ' A' ' 8' ' ' ARG . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 21' ' ' VAL . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 17' ' ' LEU . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 16' ' ' VAL . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.697 HD23 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.67 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HD2' HG22 ' A' ' 23' ' ' THR . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.653 ' CA ' HD21 ' A' ' 19' ' ' LEU . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' HD12 ' A' ' 37' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.733 ' O ' HD11 ' A' ' 77' ' ' LEU . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.858 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.884 ' CG1' HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 42' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.798 HD11 HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.726 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.798 ' CD2' HD11 ' A' ' 74' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.884 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.845 0.355 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' NE2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.945 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 99' ' ' SER . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 48' ' ' LEU . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.716 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' HG ' ' A' ' 48' ' ' LEU . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 89' ' ' VAL . 18.4 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 42' ' ' LEU . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.866 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.866 HG12 ' HB3' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 30' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 17' ' ' LEU . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.453 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.601 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' CA ' HD21 ' A' ' 19' ' ' LEU . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.825 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.053 HD11 HD23 ' A' ' 54' ' ' LEU . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.675 HD13 ' OH ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.928 HD11 HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 39' ' ' LYS . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.704 ' CD1' HG12 ' A' ' 94' ' ' VAL . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HA ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.594 ' H ' HD23 ' A' ' 50' ' ' LEU . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.053 HD23 HD11 ' A' ' 37' ' ' ILE . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.629 HG13 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 55' ' ' LEU . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 37' ' ' ILE . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 34' ' ' GLU . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.675 ' OH ' HD13 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.552 HD13 HG21 ' A' ' 74' ' ' ILE . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 97' ' ' LEU . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 48' ' ' LEU . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.544 HD13 ' HG ' ' A' ' 42' ' ' LEU . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 8' ' ' ARG . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HG3' ' A' ' 39' ' ' LYS . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.633 HD22 ' OG ' ' A' ' 35' ' ' SER . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 31' ' ' THR . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 37' ' ' ILE . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.786 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.672 ' HB3' HD13 ' A' ' 30' ' ' LEU . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 88' ' ' ILE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.696 HD13 ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG3' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.881 HD12 HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.558 ' O ' HD21 ' A' ' 54' ' ' LEU . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.939 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 41' ' ' LEU . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 54' ' ' LEU . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 58' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 38' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.744 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' NH2' HD11 ' A' ' 88' ' ' ILE . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 41' ' ' LEU . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 90' ' ' THR . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 96' ' ' TYR . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.884 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.689 ' CD2' HD11 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.881 HD13 HD12 ' A' ' 48' ' ' LEU . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.864 ' HB3' HG12 ' A' ' 16' ' ' VAL . 3.3 mt-10 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.894 ' HB2' HG13 ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HA ' HG12 ' A' ' 13' ' ' VAL . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 8' ' ' ARG . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.58 HD22 ' HB ' ' A' ' 16' ' ' VAL . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 23' ' ' THR . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 20' ' ' THR . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 28.0 m-70 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.871 ' HA ' HD11 ' A' ' 19' ' ' LEU . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.85 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.787 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 54' ' ' LEU . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 40' ' ' ARG . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.858 HD11 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.874 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.081 HD11 HD21 ' A' ' 41' ' ' LEU . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.771 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.771 ' CG2' HD12 ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 74' ' ' ILE . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 71' ' ' ASP . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.587 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.812 HD13 HD22 ' A' ' 38' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.664 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 89' ' ' VAL . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.798 HG22 ' CE1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.406 ' HG1' ' HE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 89' ' ' VAL . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 48' ' ' LEU . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.798 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE1' HD22 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 97' ' ' LEU . 1.4 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 21' ' ' VAL . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.908 ' CE2' HD21 ' A' ' 38' ' ' LEU . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.575 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 32' ' ' PRO . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 27' ' ' SER . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 20' ' ' THR . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.956 ' HB3' HD13 ' A' ' 19' ' ' LEU . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.665 ' HB3' HD23 ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.828 ' HA ' HD23 ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.867 HG13 HD12 ' A' ' 58' ' ' ILE . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.908 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CG ' HG12 ' A' ' 16' ' ' VAL . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.835 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 50' ' ' LEU . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.885 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.004 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 1.004 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.869 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.713 0.292 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB3' HG22 ' A' ' 72' ' ' VAL . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.78 HD13 ' O ' ' A' ' 77' ' ' LEU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB2' HD22 ' A' ' 77' ' ' LEU . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 85' ' ' GLY . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.602 ' H ' HD23 ' A' ' 81' ' ' LEU . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.706 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.937 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 90' ' ' THR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.657 HG23 HD22 ' A' ' 91' ' ' LEU . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.937 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.835 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.247 0.546 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 42' ' ' LEU . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 13' ' ' VAL . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 28.7 m120 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 8' ' ' ARG . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 13' ' ' VAL . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 32' ' ' PRO . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 84' ' ' TYR . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.873 HD22 ' OG ' ' A' ' 35' ' ' SER . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.713 ' HB3' HD13 ' A' ' 19' ' ' LEU . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.8 ' O ' HD11 ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.873 ' OG ' HD22 ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 81' ' ' LEU . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' CE ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 57' ' ' GLU . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HG2' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.728 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.694 HD22 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.976 0.417 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.49 ' OD1' HG23 ' A' ' 72' ' ' VAL . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.83 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 69' ' ' ASN . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.739 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 71' ' ' ASP . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.638 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 21' ' ' VAL . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.476 HH12 HD11 ' A' ' 38' ' ' LEU . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 HD22 ' A' ' 41' ' ' LEU . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.98 HG22 HD11 ' A' ' 48' ' ' LEU . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.694 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' HB3' HD23 ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.7 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.082 HD11 HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 13' ' ' VAL . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 8' ' ' ARG . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.84 ' CD2' HG22 ' A' ' 21' ' ' VAL . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.082 HG13 HD11 ' A' ' 7' ' ' ILE . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 16' ' ' VAL . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.84 HG22 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.794 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HA ' HD22 ' A' ' 19' ' ' LEU . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.742 ' O ' HD11 ' A' ' 77' ' ' LEU . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.794 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 58' ' ' ILE . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.74 HD12 ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 54' ' ' LEU . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.753 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.709 HD11 HG13 ' A' ' 37' ' ' ILE . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.419 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.848 HG23 HD13 ' A' ' 88' ' ' ILE . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA2' HD12 ' A' ' 38' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 89' ' ' VAL . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.848 HD13 HG23 ' A' ' 74' ' ' ILE . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' ARG . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 91' ' ' LEU . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 98' ' ' PHE . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 97' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 t60 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.811 0.339 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.48 118.1 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.6 m -83.05 111.81 33.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.13 156.97 17.53 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.571 2.181 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.07 40.31 3.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 110.818 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.41 167.55 9.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 14' ' ' PHE . 10.4 mt -133.24 132.73 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.117 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 90.57 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 7' ' ' ILE . 23.0 p90 -115.37 98.63 6.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.05 -140.78 40.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.148 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -85.46 43.21 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.648 2.232 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 23' ' ' THR . 56.3 m-20 -154.87 122.09 5.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 t -108.63 137.6 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.653 ' HB3' HD12 ' A' ' 7' ' ' ILE . 2.4 t80 -125.36 132.78 52.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 90.4 m-85 -91.02 133.95 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.699 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.1 m -78.37 -13.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.766 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' LEU . 2.6 mm? -120.06 0.87 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 tttp -109.46 -36.55 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.279 . . . . 0.0 111.302 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 32' ' ' PRO . 8.9 mt 70.62 34.48 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.767 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.3 m -146.59 122.81 10.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.807 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -102.95 129.78 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.46 124.78 33.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -106.87 164.94 13.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.73 -40.53 47.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.714 2.276 . . . . 0.0 112.437 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -72.84 -47.05 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.03 -104.13 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.19 169.94 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 21' ' ' VAL . 87.2 t -146.52 119.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -94.95 170.1 9.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.718 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.7 OUTLIER -167.17 170.1 12.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.065 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.69 134.72 86.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.261 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.858 ' HB3' HD13 ' A' ' 19' ' ' LEU . 64.0 Cg_endo -73.73 -16.2 23.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.376 2.051 . . . . 0.0 113.048 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' HD12 ' A' ' 37' ' ' ILE . 50.8 m -81.13 -34.84 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.451 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.83 ' O ' HD22 ' A' ' 77' ' ' LEU . 59.4 mt-10 -86.22 -37.4 18.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.661 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -75.83 -15.46 60.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.904 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.51 -30.42 71.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.329 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.41 -43.02 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.035 0.445 . . . . 0.0 110.514 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -73.58 -18.8 61.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.006 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -77.55 -31.58 53.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.21 -29.53 38.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 98' ' ' PHE . 9.1 mp -79.48 -25.97 41.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.004 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -69.84 -27.62 65.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.935 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.23 -30.08 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.953 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.19 -46.63 6.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.252 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 55.64 91.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.109 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.09 82.52 0.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.585 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.597 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -156.76 168.6 26.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.888 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.859 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -93.22 104.95 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.74 170.04 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.2 mm? -108.04 171.48 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.55 -69.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.608 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -48.7 -45.08 38.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -61.3 -29.88 70.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -61.22 -29.34 69.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.955 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.01 -29.78 67.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.075 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -74.67 -21.72 59.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.314 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.3 -27.9 19.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.077 0.465 . . . . 0.0 110.645 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.923 HD12 HG13 ' A' ' 37' ' ' ILE . 5.1 mm -90.29 -23.22 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.662 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 32.0 tttt -78.99 -34.43 44.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.53 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -12.75 61.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.094 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -133.81 56.22 1.86 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.323 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.27 101.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.259 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.68 61.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.489 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.88 101.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.851 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.62 35.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.175 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 66' ' ' VAL . 9.1 p -173.23 40.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.192 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.55 -172.75 3.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 -26.48 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -153.1 -177.94 6.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 58' ' ' ILE . 9.1 p -90.09 -33.15 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -31.84 73.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.17 -21.51 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.53 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HE1' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -80.9 -27.88 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.652 ' CD1' HG21 ' A' ' 37' ' ' ILE . 5.0 mt -73.18 -26.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.41 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.57 -43.86 68.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 t -70.26 -27.19 64.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 34' ' ' GLU . 55.0 tp -64.68 -34.6 78.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.571 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.5 -22.83 46.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.628 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -78.92 -46.44 18.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 3.7 mttp -83.28 -50.58 8.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD22 HD22 ' A' ' 38' ' ' LEU . 3.7 tp -54.1 -68.36 0.19 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -135.72 10.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.665 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.77 -17.58 64.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 0.0 111.554 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -76.32 -21.46 56.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.023 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -64.96 -35.05 91.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.441 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -15.07 60.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.707 0.289 . . . . 0.0 110.548 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -52.64 -42.01 64.26 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.751 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.8 mp -63.76 104.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ARG . 17.5 t -97.52 125.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 m -102.61 86.19 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.54 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.76 125.45 28.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 69.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.93 -32.42 0.61 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.174 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.859 ' CG1' HD21 ' A' ' 48' ' ' LEU . 3.1 t -95.72 -44.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.759 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.78 -113.6 1.61 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.389 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 51' ' ' ARG . 1.5 m-85 -122.29 109.04 13.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 0.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 48' ' ' LEU . 2.6 tm? -118.0 79.24 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 14.7 p90 -70.04 69.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 110.316 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.03 116.15 9.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.255 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -106.42 -79.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.36 -58.07 0.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 -35.46 3.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.544 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.18 85.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -171.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.65 69.94 1.2 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.6 113.41 13.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.2 79.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.96 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -65.46 172.77 3.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 111' ' ' THR . 38.5 t70 -109.29 -20.4 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -160.14 178.96 9.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.15 95.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 113' ' ' LEU . 6.1 tt -150.24 88.6 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.17 160.52 32.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 115' ' ' LEU . 4.2 pp -59.56 159.02 8.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.896 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 m -66.51 103.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.93 134.03 47.47 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 58.1 Cg_exo -52.2 116.11 2.6 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.483 2.122 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 16' ' ' VAL . 6.4 mt-10 -95.89 -17.68 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.76 166.87 22.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.531 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 HG13 ' A' ' 16' ' ' VAL . 4.2 mp -129.3 158.2 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 0.0 111.307 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.695 ' HA ' HG12 ' A' ' 13' ' ' VAL . 4.4 ttp180 -164.56 109.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -130.68 84.85 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -142.29 27.78 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.322 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.62 -11.56 32.24 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.462 2.108 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -116.74 135.42 53.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 8' ' ' ARG . 27.6 m -122.34 170.01 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.838 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.801 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.17 157.43 45.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.89 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -131.89 112.85 12.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 7' ' ' ILE . 14.0 m -64.64 -14.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.638 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 18' ' ' LYS . 4.6 pp -113.33 -24.23 9.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.418 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -90.93 -35.3 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 111.297 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 32' ' ' PRO . 33.9 mt 62.69 45.06 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.0 110.898 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.1 m -147.89 139.08 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' CE2' ' A' ' 14' ' ' PHE . 15.6 t -96.66 109.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.17 87.9 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 4.1 p -70.0 159.93 82.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 73.7 Cg_endo -76.15 -7.38 18.07 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.64 2.226 . . . . 0.0 112.65 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -108.01 -30.67 8.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.811 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.04 -101.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.17 166.22 34.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.0 104.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -75.74 169.81 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -166.02 170.12 13.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.085 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.773 HG21 HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -74.76 138.55 73.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.334 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.796 ' HB3' HD13 ' A' ' 19' ' ' LEU . 80.4 Cg_endo -78.29 -19.63 11.74 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.379 2.053 . . . . 0.0 112.844 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -78.17 -36.64 47.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -83.21 -40.58 19.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.431 178.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' CB ' HD11 ' A' ' 30' ' ' LEU . 16.7 p -73.34 -13.52 61.12 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.27 -31.82 71.89 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.284 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.891 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -62.8 -43.29 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB2' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -75.42 -17.95 60.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.898 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HG2' HG12 ' A' ' 16' ' ' VAL . 6.3 ttmt -80.12 -31.18 39.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -33.77 43.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.427 . . . . 0.0 110.643 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 98' ' ' PHE . 41.7 mt -77.91 -22.84 49.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.064 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -73.25 -26.73 61.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.204 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.69 -30.19 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -96.84 -36.19 10.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 110.643 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 49.08 85.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.357 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.69 83.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -154.57 156.82 37.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.747 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.35 100.09 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.997 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.3 m -136.21 104.17 5.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -52.98 146.32 11.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.772 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 12.3 ttt180 -58.56 -31.39 67.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.828 ' O ' HD22 ' A' ' 55' ' ' LEU . 47.4 tttt -67.87 -61.38 1.9 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.813 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -54.5 -26.45 31.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.536 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -56.85 -28.68 62.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -58.07 -19.34 31.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.046 179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.83 -19.8 30.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.135 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.07 -25.29 20.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.924 HG13 HG21 ' A' ' 70' ' ' VAL . 5.2 mm -88.45 -25.16 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.02 -27.75 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.04 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.79 39.2 1.07 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -170.08 -46.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.8 98.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -69.67 63.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 47.49 93.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.317 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 65' ' ' ILE . 21.2 mm -96.69 30.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.182 0.515 . . . . 0.0 110.968 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 31' ' ' THR . 23.5 t -157.97 35.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.35 -163.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.911 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -109.95 -21.63 12.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.4 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.41 HD21 HG23 ' A' ' 72' ' ' VAL . 12.9 p-10 -145.52 176.56 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 58' ' ' ILE . 9.2 p -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -66.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG23 HD21 ' A' ' 69' ' ' ASN . 30.4 t -53.12 -25.33 9.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.768 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.79 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -72.26 -25.12 61.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 37' ' ' ILE . 17.3 mm -70.5 -29.69 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.42 -42.42 71.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m -65.82 -24.27 66.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.129 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.937 HD21 ' O ' ' A' ' 34' ' ' GLU . 2.2 mm? -65.79 -34.62 78.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.938 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -56.96 -28.14 61.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -90.27 -51.32 5.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HB3' HD12 ' A' ' 30' ' ' LEU . 6.9 mptt -64.62 -59.25 4.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 84' ' ' TYR . 3.5 tp -60.44 -70.1 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.16 -127.74 7.54 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.93 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.649 0.262 . . . . 0.0 111.657 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.763 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -86.64 -28.6 23.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.666 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.504 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -56.26 -36.17 67.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.803 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -13.97 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -52.45 -41.18 63.06 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.849 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 34.8 mt -60.0 102.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' ARG . 41.5 t -94.95 157.76 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.981 0.419 . . . . 0.0 111.52 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 96' ' ' TYR . 7.0 m -122.74 87.4 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.507 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 94' ' ' VAL . 3.5 mm? -69.87 126.09 28.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 69.85 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.372 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.3 -29.25 1.79 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.711 HG12 HD21 ' A' ' 48' ' ' LEU . 2.6 t -93.5 -47.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.757 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.69 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 133.27 -113.3 1.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.425 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.503 ' HE1' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -123.59 110.01 14.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.838 0.351 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -113.41 87.27 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 41' ' ' LEU . 39.6 p90 -71.04 87.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.56 131.71 16.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.322 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.65 -31.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.73 -68.22 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.33 38.18 1.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.707 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.46 70.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.955 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 146.28 55.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 141.89 58.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 162.29 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 138.77 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.0 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -67.56 -31.86 72.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.049 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 113.9 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.2 -16.26 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.5 t -56.57 148.44 19.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.334 . . . . 0.0 111.077 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -62.16 155.99 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -63.85 126.64 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.516 ' N ' HD13 ' A' ' 113' ' ' LEU . 14.0 t -160.2 94.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -54.22 46.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -97.16 101.95 13.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.8 p -159.22 98.38 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.43 89.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.505 2.136 . . . . 0.0 112.257 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -98.41 32.94 2.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.323 0.582 . . . . 0.0 110.963 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -170.08 146.34 3.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.574 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 mt -129.17 154.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 13' ' ' VAL . 4.1 ttt85 -170.03 86.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 21.5 p90 -104.39 72.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.75 -138.07 13.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.191 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.52 37.06 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.752 2.301 . . . . 0.0 112.698 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.85 84.73 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -70.44 145.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -126.27 124.34 40.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.338 . . . . 0.0 110.797 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -98.63 129.93 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG12 ' CG ' ' A' ' 39' ' ' LYS . 4.9 m -84.66 -14.36 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.578 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.75 -14.71 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.569 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -103.31 -30.57 10.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.657 0.265 . . . . 0.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.41 28.25 11.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -128.88 122.34 30.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 13' ' ' VAL . 8.5 t -89.22 124.16 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -79.65 107.89 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -109.99 145.39 31.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 23' ' ' THR . 50.5 Cg_endo -68.35 -23.87 37.79 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.19 30.44 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.82 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.99 -158.66 22.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -127.52 163.41 24.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.71 109.69 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 168.82 12.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -170.09 170.15 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.134 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 p -81.76 135.97 48.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.371 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.65 ' CA ' HD21 ' A' ' 19' ' ' LEU . 55.9 Cg_endo -71.14 -15.75 31.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.281 1.987 . . . . 0.0 112.869 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 37' ' ' ILE . 18.4 m -79.35 -36.88 38.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.4 mt-10 -86.53 -38.37 17.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.756 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.5 p -75.1 -17.33 60.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.37 -31.05 76.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.681 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.866 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -68.84 -31.46 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.754 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -79.6 -19.55 49.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.339 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' CG ' HG12 ' A' ' 16' ' ' VAL . 2.0 tmpt? -81.7 -35.15 30.13 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HE ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.81 -29.9 40.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.264 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 40' ' ' ARG . 1.6 tp -77.66 -26.4 50.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.218 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -70.58 -26.65 63.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.078 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.02 -29.58 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.178 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -94.57 -49.45 5.65 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 56.62 91.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 76.16 0.85 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -148.97 148.57 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.919 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -85.79 99.94 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.836 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 m -106.77 170.19 8.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.6 mm? -106.79 160.31 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -64.77 -70.28 0.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.454 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.918 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.06 -22.89 17.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.527 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -82.27 -29.93 30.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.087 0.47 . . . . 0.0 110.217 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -67.93 -48.58 65.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.628 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -53.89 -27.23 29.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.749 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.9 -26.59 66.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 41.9 mm-40 -90.19 -19.17 24.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.866 HD12 HG13 ' A' ' 37' ' ' ILE . 1.6 mm -95.01 -21.68 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -77.45 -34.08 54.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.648 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.3 -31.04 70.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.945 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.12 -56.56 3.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.729 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.02 115.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 56.98 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.012 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 49.68 98.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.408 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.3 tp -94.2 33.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.922 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 66' ' ' VAL . 10.7 p -175.11 38.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.045 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -157.14 -165.38 1.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -110.62 -27.56 8.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.309 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -156.23 -173.13 4.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HG13 ' A' ' 58' ' ' ILE . 11.5 p -85.99 -38.74 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 111.206 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -37.41 75.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -75.5 -23.44 16.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.176 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -75.07 -27.72 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.293 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.786 HG23 HD12 ' A' ' 88' ' ' ILE . 31.7 mm -68.02 -33.7 62.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.17 -28.95 61.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.028 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.28 -31.08 58.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.281 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.5 tp -67.29 -30.58 70.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -20.53 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.42 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -78.36 -45.41 22.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -82.61 -51.55 7.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.673 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.025 HD22 HD22 ' A' ' 38' ' ' LEU . 12.5 tp -82.22 -70.12 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.443 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.84 -60.59 3.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.956 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.93 -70.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 111.793 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.852 ' HB2' HD21 ' A' ' 81' ' ' LEU . 41.8 m-85 -83.06 -12.19 57.37 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.387 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.82 -38.56 94.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.002 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -17.86 50.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.747 0.308 . . . . 0.0 110.77 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -32.1 62.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.786 HD12 HG23 ' A' ' 74' ' ' ILE . 11.8 mt -69.66 101.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.856 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.56 131.58 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.393 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 106.39 14.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.563 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -98.53 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.14 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 72.35 10.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.45 -30.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -114.9 -45.18 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 132.06 -145.26 17.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -84.92 125.61 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -131.24 74.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.65 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' HB3' HD21 ' A' ' 41' ' ' LEU . 34.2 p90 -71.19 81.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 91.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -80.54 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -160.54 -69.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.006 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.37 -25.15 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.639 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -175.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.167 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -130.17 -176.38 3.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -150.06 104.45 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -65.3 122.9 18.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 94.33 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -70.04 -25.35 63.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.23 93.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -127.87 1.57 6.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.506 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -160.21 158.86 30.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -65.47 78.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 135.45 57.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -160.06 161.45 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.2 mm? -60.69 169.86 1.67 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.798 0.333 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.418 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 61.34 105.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.18 128.48 11.88 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' CG ' HG11 ' A' ' 16' ' ' VAL . 96.2 Cg_endo -84.2 157.61 13.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.554 2.169 . . . . 0.0 112.168 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -53.04 4.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.121 0.486 . . . . 0.0 111.357 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.17 170.07 7.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.989 HG23 HD11 ' A' ' 42' ' ' LEU . 1.4 mt -129.28 98.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -103.97 98.44 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 15.4 p90 -123.27 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.79 -143.34 29.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 50.21 3.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.787 2.325 . . . . 0.0 112.623 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -161.93 125.18 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 t -112.99 110.23 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.989 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.832 ' CD2' HG22 ' A' ' 21' ' ' VAL . 1.8 t80 -96.61 118.6 33.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -92.34 117.13 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' CG ' ' A' ' 4' ' ' PRO . 4.2 m -65.27 -13.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.803 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.1 mt -112.22 -18.48 12.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.476 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -94.64 -32.41 13.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.646 0.26 . . . . 0.0 111.34 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER 66.88 26.76 9.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.595 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.4 m -136.1 110.68 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.832 HG22 ' CD2' ' A' ' 14' ' ' PHE . 4.7 t -69.97 115.79 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 129.81 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 11.9 p -126.58 154.77 75.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.718 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 55.2 Cg_endo -69.29 -10.4 28.82 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.645 2.23 . . . . 0.0 112.598 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -32.69 6.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.06 -118.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.593 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.595 ' OG ' HG22 ' A' ' 20' ' ' THR . 0.3 OUTLIER -157.29 170.11 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.797 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 t -131.28 137.7 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.258 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -108.3 155.4 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 pp -167.48 170.18 11.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -84.46 136.98 39.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.171 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.704 ' CA ' HD21 ' A' ' 19' ' ' LEU . 52.7 Cg_endo -69.31 -9.85 27.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.323 2.015 . . . . 0.0 112.945 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' HD12 ' A' ' 37' ' ' ILE . 5.8 t -73.18 -50.27 23.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 110.756 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 77' ' ' LEU . 44.5 mt-10 -76.55 -38.23 55.37 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.781 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.6 -9.96 59.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.226 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.45 55.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.348 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -67.86 -48.88 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.255 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 81' ' ' LEU . 2.0 pp -66.2 -22.39 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.904 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 4' ' ' PRO . 13.9 tttt -70.45 -31.72 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.799 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -31.05 31.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 98' ' ' PHE . 14.1 mt -81.4 -20.82 39.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.032 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.989 HD11 HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -76.4 -24.12 54.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.237 179.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.418 HD13 ' C ' ' A' ' 2' ' ' SER . 2.3 mt -68.36 -30.15 46.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -96.29 -49.69 5.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HE3' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 53.38 88.8 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.213 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.46 72.32 1.28 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.761 ' O ' HD12 ' A' ' 97' ' ' LEU . 2.9 mm100 -150.26 170.0 20.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' CD2' HG12 ' A' ' 94' ' ' VAL . 17.3 tp -94.81 122.97 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.6 m -138.65 170.22 16.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.708 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -112.56 144.38 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 13.2 ptt180 -63.62 -29.14 70.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.246 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -88.96 -17.08 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t-160 -91.04 -25.88 19.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.555 HD21 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.46 -36.09 78.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.323 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' GLU . 4.0 pp -59.69 -29.22 67.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.665 ' N ' HD12 ' A' ' 55' ' ' LEU . 13.6 mt-10 -67.74 -22.19 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.342 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.05 -22.19 21.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 37' ' ' ILE . 4.0 mm -90.96 -21.57 6.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.731 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 -30.68 49.31 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.856 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.65 42.41 1.1 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -171.13 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 177.63 100.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -70.22 61.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.11 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.09 96.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.637 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 65' ' ' ILE . 6.6 tp -95.56 30.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.08 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 66' ' ' VAL . 22.2 t -157.69 37.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.532 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.39 -165.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.106 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -109.7 -25.22 10.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -148.17 -175.43 4.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HG13 ' A' ' 58' ' ' ILE . 8.4 p -90.14 -29.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -61.08 -59.08 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.05 -21.44 24.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.326 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.447 ' CE1' ' CG ' ' A' ' 34' ' ' GLU . 1.1 t60 -73.26 -31.66 64.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 9.1 mt -66.2 -27.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.688 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.03 -44.45 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.596 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -63.1 -25.89 68.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -61.34 -37.91 85.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.486 178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -53.46 -24.25 12.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.71 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -79.9 -57.95 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -54.13 13.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.951 HD22 HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -70.19 -69.95 0.32 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.872 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.1 -140.22 12.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.733 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.43 62.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.607 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.75 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.14 -17.59 54.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.8 -39.74 11.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.337 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -12.88 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.306 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.663 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.21 -28.79 2.02 Favored 'General case' 0 C--O 1.23 0.042 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.165 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -51.24 93.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.239 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' ARG . 26.9 t -89.39 117.25 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.388 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 m -91.47 78.61 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.51 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -71.41 129.01 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 90.42 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.664 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.19 -27.5 4.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.193 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG12 ' CD2' ' A' ' 48' ' ' LEU . 1.3 t -102.28 -56.57 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.43 -169.67 22.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -69.97 98.86 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.703 0.287 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 47' ' ' GLN . 1.3 tp -110.83 93.07 4.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 41' ' ' LEU . 8.4 p90 -69.51 69.92 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.121 0.486 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.411 ' OG ' HG21 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -74.22 122.65 23.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.181 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 14.7 t70 -129.46 -80.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.38 -57.89 0.06 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.08 66.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -171.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 156.73 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.26 135.38 17.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.44 92.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.3 140.11 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -74.25 161.73 29.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -109.75 -28.51 8.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.963 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 83.19 3.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -59.69 119.29 7.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -150.15 146.82 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 t -160.12 149.71 17.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.44 -59.36 5.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -101.9 131.87 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.7 t 59.14 90.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.93 -170.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.245 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' OE2' HD21 ' A' ' 17' ' ' LEU . 1.4 tt0 -147.14 -75.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.718 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 167.77 20.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.596 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 42' ' ' LEU . 7.4 tt -120.53 132.85 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -118.43 74.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 33.1 p90 -99.96 99.35 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 -141.42 41.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.18 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.31 16.35 1.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.642 2.228 . . . . 0.0 112.777 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 18.6 m-80 -117.66 117.56 29.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.35 113.37 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.799 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.631 ' CD1' HG22 ' A' ' 21' ' ' VAL . 37.6 t80 -102.41 107.36 18.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -73.73 110.72 8.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG23 ' HG ' ' A' ' 17' ' ' LEU . 3.0 m -60.76 -18.72 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD21 ' OE2' ' A' ' 5' ' ' GLU . 1.1 mt -101.87 -32.69 10.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.736 0.303 . . . . 0.0 111.222 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -84.7 -34.08 23.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 32' ' ' PRO . 4.0 mt 66.27 56.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 m -157.27 106.34 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.749 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 ' CD1' ' A' ' 14' ' ' PHE . 29.6 t -70.65 121.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.17 85.61 6.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.755 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -72.2 158.93 86.7 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 23' ' ' THR . 78.9 Cg_exo -48.24 -48.68 16.1 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.796 2.331 . . . . 0.0 112.429 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.18 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.03 -144.32 4.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.4 161.44 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.63 121.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.872 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.6 pp -170.21 170.21 7.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.169 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 34' ' ' GLU . 13.3 t -84.31 135.95 40.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.939 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HB3' HD13 ' A' ' 19' ' ' LEU . 49.7 Cg_endo -69.09 -17.29 40.66 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.377 2.052 . . . . 0.0 113.464 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 37' ' ' ILE . 3.3 p -75.74 -39.07 57.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.834 0.35 . . . . 0.0 110.565 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.815 ' O ' HD11 ' A' ' 77' ' ' LEU . 55.0 mt-10 -84.69 -41.22 16.48 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.872 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.69 -13.69 61.4 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 177.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.73 -33.19 63.48 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.718 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -69.58 -37.7 75.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.499 . . . . 0.0 110.292 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.787 HD13 ' CD1' ' A' ' 81' ' ' LEU . 1.5 tt -69.41 -22.73 63.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.213 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -72.83 -32.48 65.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.575 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -78.8 -31.02 45.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.586 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' PHE . 7.9 mt -77.16 -26.99 53.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -67.76 -29.14 68.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.921 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.95 -30.5 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.777 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.63 -35.73 11.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.058 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.22 90.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.405 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.11 69.93 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.682 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.84 141.09 40.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.094 HD21 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.88 89.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.5 m -96.97 170.33 9.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.98 127.44 53.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -60.02 -30.87 69.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HA ' HD13 ' A' ' 55' ' ' LEU . 15.6 tttt -84.15 -22.37 31.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -90.65 -20.82 22.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -25.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.01 -11.67 59.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.239 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.711 ' N ' HD23 ' A' ' 55' ' ' LEU . 5.0 mt-10 -88.78 -20.52 24.62 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.034 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -86.91 -36.38 18.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 110.537 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 70' ' ' VAL . 8.8 mt -81.11 -18.79 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.092 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 3.0 ttpp -84.65 -37.39 21.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.453 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.99 -32.75 74.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -89.13 -41.13 12.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -171.04 96.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -55.14 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.345 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.7 72.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.527 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 65' ' ' ILE . 18.2 tt -57.01 106.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.776 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 66' ' ' VAL . 70.8 t 54.16 69.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.51 -168.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -115.68 -35.57 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.469 HD22 HG23 ' A' ' 72' ' ' VAL . 63.1 t30 -160.17 159.52 31.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HD12 ' A' ' 58' ' ' ILE . 7.9 p -89.97 -25.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.348 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -44.74 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 69' ' ' ASN . 25.0 t -68.03 -26.91 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -70.1 -23.97 63.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.898 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.51 HD13 ' HE2' ' A' ' 96' ' ' TYR . 11.7 mt -63.81 -40.0 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.615 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.42 68.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.435 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 t -70.63 -24.18 62.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.998 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -65.08 -40.84 95.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.441 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 86' ' ' SER . 3.9 ttt180 -55.4 -34.06 64.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -90.82 -30.07 17.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.249 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HB3' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -65.74 -63.95 0.97 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.274 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.79 HD23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -96.98 -1.83 44.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.454 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.04 -134.18 12.36 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.812 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.21 52.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 81' ' ' LEU . 5.9 m-85 -81.85 -32.91 30.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.275 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.888 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -76.58 -28.75 58.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.511 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.403 ' CB ' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -68.0 -12.06 60.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.601 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -48.11 -32.83 7.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.075 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 85' ' ' GLY . 2.1 mp -69.23 85.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 90' ' ' THR . 39.8 t -74.78 158.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 111.297 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 90' ' ' THR . 8.0 t -141.52 106.43 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.771 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -117.02 114.39 23.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.899 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.43 76.32 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.86 -30.15 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.392 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.094 HG22 HD21 ' A' ' 48' ' ' LEU . 11.4 p -115.27 -44.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 134.29 -161.3 24.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.535 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.51 ' HE2' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -88.88 125.15 34.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 98' ' ' PHE . 2.2 tm? -118.49 137.16 53.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.781 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.4 t80 -100.68 69.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -61.9 84.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.106 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -120.29 -70.73 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.124 0.488 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.19 -59.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.31 30.7 8.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -130.07 100.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 152.29 38.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 117.56 8.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -179.98 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -150.11 79.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -63.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.1 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -58.78 124.42 19.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.49 -18.76 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.383 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -61.98 150.82 36.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.5 172.07 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.13 159.08 44.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.6 127.04 29.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 115' ' ' LEU . 7.8 mt -65.93 -49.33 68.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.913 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -48.22 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 3' ' ' VAL . 12.7 m -115.63 83.93 11.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.01 126.13 21.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.49 2.126 . . . . 0.0 112.21 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.04 -30.29 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.05 0.452 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -114.54 169.9 8.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.815 HD11 HG12 ' A' ' 16' ' ' VAL . 6.6 mt -130.36 69.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.015 0.436 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.2 mtt180 -99.84 138.18 37.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -153.18 104.98 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.13 -145.66 44.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.414 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.38 45.81 2.02 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -168.73 99.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 22' ' ' GLU . 10.8 m -87.88 162.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.617 ' CD2' HD12 ' A' ' 7' ' ' ILE . 75.1 t80 -152.03 148.83 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.406 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 53.4 m-85 -108.45 165.34 11.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 HD11 ' A' ' 7' ' ' ILE . 2.9 m -98.38 -24.96 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.91 -33.75 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.266 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -78.45 -32.4 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.219 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 32' ' ' PRO . 95.6 mt 60.25 41.37 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.952 0.406 . . . . 0.0 110.576 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.8 m -137.66 130.63 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 14' ' ' PHE . 2.8 t -92.59 124.46 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' HB3' HG22 ' A' ' 13' ' ' VAL . 4.4 tt0 -91.57 131.04 37.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.902 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -130.67 139.17 34.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.5 -22.28 71.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.448 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -31.94 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.38 -128.44 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.7 p -156.26 169.96 23.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.2 t -145.63 123.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.23 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -96.57 170.12 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.623 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.53 166.67 22.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.187 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.03 133.14 69.56 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.122 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HB3' HD13 ' A' ' 19' ' ' LEU . 54.9 Cg_endo -69.82 -14.1 35.44 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.299 2.0 . . . . 0.0 113.156 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 83.2 p -83.46 -39.49 20.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.074 0.464 . . . . 0.0 110.426 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.59 -32.69 19.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.401 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.623 ' CB ' HD13 ' A' ' 30' ' ' LEU . 3.2 p -82.85 -14.67 53.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.6 -30.68 63.84 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.465 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD13 HD12 ' A' ' 74' ' ' ILE . 8.4 tt -72.95 -27.94 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.735 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -73.44 -18.27 61.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.324 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.88 -41.5 52.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -27.63 63.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.631 ' CD2' HG23 ' A' ' 88' ' ' ILE . 5.9 mp -79.85 -20.2 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.448 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -80.34 -23.91 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 39' ' ' LYS . 4.3 mm -77.76 -31.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.653 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.75 -37.34 13.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.162 0.506 . . . . 0.0 110.387 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 42.86 70.84 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.702 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.73 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 96.24 96.97 1.82 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.016 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.19 145.2 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.96 114.84 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.833 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.2 t -131.1 167.25 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.643 HD22 ' C ' ' A' ' 49' ' ' CYS . 2.2 mm? -125.18 170.81 10.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HD13 ' A' ' 55' ' ' LEU . 6.2 ttm180 -60.1 -70.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.69 -30.18 0.89 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.036 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -74.3 -49.44 23.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.8 OUTLIER -64.81 -25.23 67.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.205 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.841 HD12 HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -72.82 -27.16 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.09 -14.54 59.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.993 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.01 -23.05 21.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.249 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.762 HG13 HG21 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -90.66 -24.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.147 0.499 . . . . 0.0 109.893 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -83.64 -25.16 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.86 32.25 1.29 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.826 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -165.39 -60.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.18 92.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -89.44 51.98 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.494 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB2' ' CB ' ' A' ' 33' ' ' SER . . . 62.15 37.63 14.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 0.7 OUTLIER 41.92 79.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.399 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 66' ' ' VAL . 7.7 p 44.0 59.83 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.639 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.42 -170.11 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -62.48 -65.32 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -158.08 162.88 38.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.749 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG22 HD11 ' A' ' 74' ' ' ILE . 9.7 p -86.0 -31.04 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 74' ' ' ILE . 1.2 t0 -51.94 -66.53 0.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.049 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 t -54.23 -26.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -22.3 59.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.156 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.864 HD11 HG22 ' A' ' 70' ' ' VAL . 8.9 mm -69.84 -33.75 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.12 69.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -28.74 62.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.42 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 35' ' ' SER . 67.9 tp -68.55 -33.5 74.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.24 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -17.46 64.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -89.25 -36.68 15.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.344 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 2.6 mmtt -90.03 -50.27 6.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.902 HD23 ' HA2' ' A' ' 85' ' ' GLY . 5.6 tp -62.03 -61.47 2.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.87 -135.98 13.16 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.737 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.04 40.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.627 ' CE1' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -88.96 -22.4 23.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.571 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.902 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -74.58 -31.45 58.68 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -11.01 60.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.646 0.26 . . . . 0.0 110.388 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -50.32 -27.36 6.05 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.256 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -71.81 72.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.89 0.376 . . . . 0.0 110.211 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 91' ' ' LEU . 28.2 t -74.9 89.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.353 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 t -80.32 105.82 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -91.53 137.77 32.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.48 75.71 7.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 155.58 -31.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.792 HG22 HD11 ' A' ' 48' ' ' LEU . 11.6 p -111.35 -28.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 109.54 -157.91 14.83 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.733 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.698 ' CD2' HD12 ' A' ' 54' ' ' LEU . 2.2 m-85 -69.87 129.89 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD13 ' A' ' 97' ' ' LEU . 3.0 tm? -125.07 130.24 51.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.173 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.73 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-30 -96.08 99.25 11.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.903 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 t -39.33 146.68 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.887 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.19 65.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.958 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -39.76 -70.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.822 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 43.22 80.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.095 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 0.0 111.221 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' NZ ' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.25 155.51 20.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.866 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 8' ' ' ARG . 1.4 mttt -150.3 93.9 2.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 111.368 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.22 135.88 37.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.3 t -150.15 91.96 1.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -68.78 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 166.59 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.73 30.81 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.13 144.82 14.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.002 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -62.22 124.93 22.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 127.9 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -66.06 117.34 8.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.635 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -60.93 150.2 34.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.806 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 1.4 m 59.77 103.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.94 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.13 148.1 65.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 144.6 49.92 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.61 2.206 . . . . 0.0 112.296 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -149.11 40.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.491 . . . . 0.0 111.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 p -170.02 141.14 2.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.694 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.789 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.5 mp -95.13 78.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.84 115.03 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.789 ' CE1' HG22 ' A' ' 7' ' ' ILE . 2.7 p90 -148.79 91.54 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.731 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.87 -142.37 23.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.283 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.52 49.32 3.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.615 2.21 . . . . 0.0 112.56 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -170.2 142.99 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 13' ' ' VAL . 11.3 p -142.31 108.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.781 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -80.37 131.82 35.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.865 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -92.74 111.64 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.583 HG13 ' CD1' ' A' ' 7' ' ' ILE . 3.0 m -60.1 -17.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.962 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HG ' HG23 ' A' ' 16' ' ' VAL . 1.2 mt -112.67 -23.66 10.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' C ' HD22 ' A' ' 19' ' ' LEU . 2.2 tttt -96.98 -25.57 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.613 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER 58.65 47.8 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.916 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.18 105.49 2.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.781 HG22 ' CG ' ' A' ' 14' ' ' PHE . 2.1 t -70.01 125.94 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.063 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -71.49 89.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 m -89.31 139.36 28.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.22 -22.69 40.08 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.54 2.16 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.74 -41.83 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.02 -131.22 1.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.6 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -150.0 170.14 19.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.75 104.38 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.33 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.24 144.55 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.581 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -170.17 170.5 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.705 ' O ' HD22 ' A' ' 30' ' ' LEU . 5.6 m -69.67 135.11 88.14 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.401 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.35 -11.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.699 2.266 . . . . 0.0 113.355 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 p -76.39 -29.51 57.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.833 ' O ' HD21 ' A' ' 77' ' ' LEU . 2.1 mp0 -86.08 -45.56 11.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.907 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.988 ' HB3' HD21 ' A' ' 30' ' ' LEU . 2.0 p -78.18 -12.44 59.99 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -25.69 57.88 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.697 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.37 -30.94 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.779 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.668 HD22 HD13 ' A' ' 81' ' ' LEU . 4.0 pp -78.79 -11.34 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -78.25 -34.24 49.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.592 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.63 -31.97 63.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' A' ' 98' ' ' PHE . 49.9 mt -80.07 -18.75 49.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.022 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HG ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -76.91 -27.04 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.276 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.418 HD11 ' CE ' ' A' ' 39' ' ' LYS . 4.2 mm -68.42 -29.64 44.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -32.73 11.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 47.54 84.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.3 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.96 73.62 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.51 161.41 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -93.98 69.94 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.4 m -89.62 92.21 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.791 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -47.01 169.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -63.95 -50.0 70.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.876 ' HA ' HD21 ' A' ' 55' ' ' LEU . 4.5 tttm -64.25 -14.11 53.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.5 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -90.06 -39.6 12.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.288 0.566 . . . . 0.0 110.668 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 37' ' ' ILE . 4.3 tp -73.0 -28.7 62.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.715 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 52' ' ' LYS . 3.0 pp -80.74 -18.3 48.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.54 -20.16 37.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.99 -35.13 20.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -83.61 -24.85 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -71.93 -33.38 68.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.578 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -78.22 -4.84 49.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.4 40.52 2.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.26 81.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.336 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -71.16 65.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 68' ' ' ARG . . . 64.78 90.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.5 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.267 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.1 t -152.11 39.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.27 67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.983 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 96.0 mtt180 -158.36 55.48 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.995 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -41.65 162.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.1 p -55.4 -27.2 20.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.612 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.95 -65.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.498 . . . . 0.0 110.57 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.78 -21.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.582 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.08 -29.4 60.65 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.569 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 70' ' ' VAL . 36.6 mt -69.11 -31.98 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.82 -49.75 28.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -23.85 67.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.565 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -65.64 -36.29 83.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.57 67.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -90.34 -51.88 5.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.427 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HD3' HD23 ' A' ' 30' ' ' LEU . 12.3 mttm -60.83 -61.26 2.71 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.879 HD23 ' HA2' ' A' ' 85' ' ' GLY . 10.0 tp -65.21 -51.78 58.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.021 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.23 -145.44 16.32 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.782 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.55 -21.91 29.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.507 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 4.1 t80 -80.16 -29.43 38.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.206 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.879 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -60.8 -34.8 88.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.409 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -14.5 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 84' ' ' TYR . 21.2 ttt180 -46.81 -29.86 2.17 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.869 0.366 . . . . 0.0 110.789 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 96' ' ' TYR . 4.8 mt -66.02 90.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.432 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 91' ' ' LEU . 50.4 t -86.13 125.71 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.42 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 86.13 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.699 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -78.39 133.54 37.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.028 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -78.34 69.86 4.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.33 -36.93 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.352 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 48' ' ' LEU . 3.5 t -94.7 -47.03 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.838 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.486 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 131.61 -106.94 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -124.75 110.04 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.827 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.0 tm? -107.19 88.66 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.685 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.744 ' CD1' HD13 ' A' ' 41' ' ' LEU . 54.1 t80 -76.28 70.07 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.85 139.41 47.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.089 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.32 -37.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -160.08 -67.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.892 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 75.3 0.43 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.591 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.07 77.28 1.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.834 0.349 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.47 113.21 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -73.99 112.07 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' SER . 0.3 OUTLIER -75.94 61.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 77.32 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -60.19 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.1 -165.22 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -95.85 23.09 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -69.81 115.91 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.13 154.04 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.89 79.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.41 149.26 48.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 115' ' ' LEU . 4.0 pp -59.33 143.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.5 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 43' ' ' ILE . 5.3 m -65.51 109.19 2.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 14.4 Cg_exo -69.12 178.01 4.59 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 42' ' ' LEU . 1.4 tt0 -124.74 -74.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.587 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -87.29 167.71 13.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.893 ' HB ' HD11 ' A' ' 42' ' ' LEU . 1.3 tt -132.28 122.28 47.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.91 69.77 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.381 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 12' ' ' ASN . 41.8 p90 -86.54 110.06 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.33 -147.6 42.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.281 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.41 -5.76 17.67 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.545 2.164 . . . . 0.0 112.643 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 28.4 m-20 -98.03 139.53 33.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.914 0.388 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.14 116.42 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.701 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.902 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 12.8 t80 -95.61 133.56 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.218 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -102.99 101.7 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.62 -16.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.998 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.46 -18.04 12.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' HD22 ' A' ' 19' ' ' LEU . 13.5 tttm -101.18 -28.39 12.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.609 0.242 . . . . 0.0 111.6 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.5 OUTLIER 65.54 50.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.882 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.0 m -154.22 110.76 3.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 14' ' ' PHE . 16.4 t -78.22 115.24 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 144.95 52.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -149.59 139.8 13.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.741 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 23' ' ' THR . 18.5 Cg_endo -58.94 -20.85 55.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.19 -58.76 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.45 129.55 2.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -70.02 158.91 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.29 135.12 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.35 158.64 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -170.05 170.16 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -77.62 144.04 68.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 31' ' ' THR . 69.5 Cg_endo -74.19 -13.32 23.4 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.973 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -77.8 -39.31 44.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.899 ' O ' HD21 ' A' ' 77' ' ' LEU . 5.7 mt-10 -85.27 -37.81 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.737 ' HA ' HD23 ' A' ' 38' ' ' LEU . 1.7 p -77.27 -15.0 59.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.818 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.71 -32.42 64.18 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.542 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.797 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -72.66 -31.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.191 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.902 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -78.52 -21.19 49.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.516 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -37.01 74.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.49 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.53 70.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.373 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 98' ' ' PHE . 4.0 mm? -77.11 -23.26 51.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.83 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -72.74 -24.23 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.156 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 3' ' ' VAL . 21.9 mm -69.16 -27.95 37.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.906 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -102.63 -38.54 7.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.994 0.426 . . . . 0.0 110.957 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 7' ' ' ILE . 2.2 mttt 52.88 88.99 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 71.62 82.17 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.737 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -147.58 149.35 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.419 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.87 70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.0 111.057 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.574 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.3 m -71.86 170.13 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.405 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 49' ' ' CYS . 3.3 mm? -119.96 152.76 36.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.602 ' O ' HD13 ' A' ' 55' ' ' LEU . 63.6 ttt-85 -55.42 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -50.11 -21.66 1.37 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.339 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -82.78 -16.9 46.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.722 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -86.66 -40.79 14.77 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.151 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.893 ' HB3' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -80.34 -10.03 59.75 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.922 178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -86.97 -18.65 30.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.117 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.78 -46.82 13.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.935 0.398 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.21 -17.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.495 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.6 ttmm -73.15 -38.56 66.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.28 -27.68 66.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.043 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -93.62 -69.71 0.74 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.49 95.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.12 129.48 35.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 45.25 62.19 2.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.84 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 65' ' ' ILE . 6.5 tp -59.68 89.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.704 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 66' ' ' VAL . 60.7 t 56.09 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.944 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 57.11 66.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HD2' ' CE1' ' A' ' 73' ' ' HIS . 6.1 ttm-85 -160.08 55.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -47.42 169.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 55' ' ' LEU . 9.5 p -67.82 -24.71 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -59.13 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.062 0.458 . . . . 0.0 110.632 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.37 -21.93 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.28 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.5 m-70 -70.47 -29.07 65.52 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.506 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.8 mm -66.56 -37.29 79.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.931 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.07 60.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.4 p -73.47 -25.2 60.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.888 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -67.91 -31.79 71.82 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -33.62 72.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.39 -44.48 9.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.713 ' HB3' HD12 ' A' ' 30' ' ' LEU . 17.1 mmtt -67.32 -58.59 4.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.317 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.891 HD22 HD22 ' A' ' 38' ' ' LEU . 4.0 tp -77.01 -39.08 51.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.039 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.39 -137.06 13.31 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.881 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.66 -21.76 29.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.859 0.361 . . . . 0.0 111.536 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.634 ' HB3' HD21 ' A' ' 81' ' ' LEU . 3.1 m-85 -85.46 -15.44 42.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -68.84 -33.37 75.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.357 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -17.72 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 0.0 110.537 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -48.5 -30.77 5.53 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.017 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' GLY . 3.2 mt -68.02 93.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -84.18 150.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.865 0.364 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.5 m -122.28 80.72 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 94' ' ' VAL . 1.8 mt -72.35 128.55 35.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -76.02 74.57 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.702 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.76 -27.88 2.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.282 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 91' ' ' LEU . 6.5 t -91.73 -52.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.09 -110.36 0.86 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.473 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 54' ' ' LEU . 6.6 m-85 -127.07 108.29 10.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.885 0.374 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 97' ' ' LEU . 1.7 tm? -107.71 100.12 9.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.324 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.573 ' HB2' HD12 ' A' ' 41' ' ' LEU . 5.1 t80 -69.98 69.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.6 p -63.72 95.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' CB ' ' HD3' ' A' ' 87' ' ' ARG . 44.0 t0 -116.22 -80.61 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -160.6 -62.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 36.07 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.19 149.02 43.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.16 141.77 50.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -62.21 167.61 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -53.87 120.8 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -59.8 137.42 58.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -60.5 -55.91 27.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.423 ' CD ' ' HG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -59.91 141.02 56.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -61.54 -27.02 68.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.423 ' HG1' ' CD ' ' A' ' 109' ' ' GLN . 28.3 p -71.76 141.18 49.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -160.14 125.19 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 90.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 118.94 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.81 ' O ' HD12 ' A' ' 115' ' ' LEU . 1.6 pp -56.54 149.14 17.91 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.22 82.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.924 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.98 156.41 51.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.721 ' CB ' HG11 ' A' ' 16' ' ' VAL . 2.8 Cg_exo -75.16 129.93 12.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.7 2.267 . . . . 0.0 112.245 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 105' ' ' LYS . 1.2 mm-40 -104.54 -55.28 2.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.268 0.556 . . . . 0.0 111.042 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -170.71 157.03 5.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.801 HG12 HD13 ' A' ' 42' ' ' LEU . 3.3 mp -140.45 74.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 13' ' ' VAL . 38.6 ptt85 -95.96 114.7 26.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 37.4 p90 -126.32 107.87 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.77 -142.17 46.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.53 -27.08 39.64 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.485 2.123 . . . . 0.0 112.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 23' ' ' THR . 24.7 m-80 -98.11 149.4 22.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 8' ' ' ARG . 28.5 m -133.9 161.71 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CE1' HG22 ' A' ' 21' ' ' VAL . 1.3 m-85 -133.87 94.03 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 80.7 m-85 -77.13 137.65 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.796 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 m -93.31 16.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.409 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.34 -34.01 3.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -113.17 -23.34 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 32' ' ' PRO . 5.8 mt 61.5 42.7 11.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.6 m -122.75 128.81 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.751 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.658 HG22 ' CE1' ' A' ' 14' ' ' PHE . 6.4 t -87.8 116.06 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.03 76.85 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.52 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -69.89 170.12 10.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 23' ' ' THR . 71.6 Cg_endo -78.08 -27.15 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.35 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.77 -30.17 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.82 -100.18 0.14 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.548 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 p -152.39 170.08 20.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -142.92 94.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.53 110.15 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.844 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.3 OUTLIER -104.02 168.59 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.04 123.98 71.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.98 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.3 Cg_endo -62.63 -13.88 36.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.336 2.024 . . . . 0.0 112.951 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.76 -42.34 21.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.084 0.469 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.747 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.2 mm-40 -87.02 -32.93 19.76 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.844 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.8 -14.73 57.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.75 -34.49 66.45 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.704 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.4 tt -68.75 -30.7 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.247 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.35 -23.65 46.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.47 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 16' ' ' VAL . 5.9 mtpt -71.5 -38.03 71.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -42.48 65.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.709 HD13 ' HD1' ' A' ' 98' ' ' PHE . 8.5 mt -73.5 -20.24 60.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.082 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 7' ' ' ILE . 6.9 mt -73.76 -31.05 63.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.109 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 4' ' ' PRO . 6.0 mm -60.07 -28.3 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.723 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.8 m120 -89.8 -37.94 14.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.12 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.63 79.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.941 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.8 47.02 8.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.903 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 44' ' ' ASN . 1.4 tp60 -127.5 162.57 26.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.593 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 HG13 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.99 107.63 3.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.0 m -121.38 170.33 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.281 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.62 159.43 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtp-105 -64.44 -68.5 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.008 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.909 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.6 mttt -53.39 -24.04 11.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -81.07 -32.61 33.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.266 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -67.97 -45.28 74.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.927 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -61.66 -23.12 65.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.704 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.69 -26.08 60.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.96 -22.9 21.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.268 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.737 HG13 HG21 ' A' ' 70' ' ' VAL . 1.1 mm -86.22 -22.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -68.9 -32.08 71.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.569 178.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -92.92 27.32 2.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.493 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 14.9 t60 -166.78 54.98 0.08 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 75.72 99.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.183 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -76.86 77.82 3.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.797 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 57.35 82.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.201 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.0 tt -56.24 116.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.9 p 44.38 45.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -130.51 -175.45 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 72' ' ' VAL . 17.3 mtp180 -82.28 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.93 -175.01 4.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.757 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.737 HG21 HG13 ' A' ' 58' ' ' ILE . 12.9 p -74.38 -22.98 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.264 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.16 58.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 110.47 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 68' ' ' ARG . 23.9 t -69.93 -25.26 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.374 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.412 ' CE1' ' HA ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -69.06 -26.49 64.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.225 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 37' ' ' ILE . 35.3 mm -65.11 -34.57 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.696 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.41 -32.29 66.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 -32.29 58.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 34' ' ' GLU . 35.4 tp -67.25 -34.92 78.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.539 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -22.3 60.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.384 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -67.25 -49.57 63.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.998 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -45.77 8.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.078 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD23 ' CA ' ' A' ' 85' ' ' GLY . 54.5 tp -63.77 -70.21 0.23 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.68 -139.52 11.84 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.971 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.92 -9.76 58.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.627 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 26.4 m-85 -74.31 -33.86 63.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.59 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -55.38 -29.75 53.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.942 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -68.1 -13.27 62.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.269 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -44.54 -30.46 0.89 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.94 0.4 . . . . 0.0 110.906 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.781 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 87' ' ' ARG . 50.3 t -90.51 121.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.967 0.413 . . . . 0.0 111.451 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -92.61 85.31 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.257 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' A' ' 97' ' ' LEU . 2.4 mt -69.73 117.17 10.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.212 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -69.98 69.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.443 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.44 -29.24 1.19 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.085 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 t -96.96 -43.83 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.74 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.34 -112.77 1.4 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.601 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 108.34 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.746 0.308 . . . . 0.0 110.923 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -112.15 136.54 51.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.709 ' HD1' HD13 ' A' ' 41' ' ' LEU . 28.5 t80 -97.53 69.88 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.452 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.456 ' OG ' HG21 ' A' ' 89' ' ' VAL . 7.6 m -59.82 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.232 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -128.79 -80.3 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.058 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -69.88 0.83 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.958 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.14 29.07 2.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.11 154.31 47.6 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 167.37 18.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 1.2 ptmm? -47.89 134.41 13.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.281 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.61 134.93 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 144.07 57.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.72 -50.49 70.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.31 156.27 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -149.99 31.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -60.95 142.15 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -160.09 159.75 32.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.958 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.14 103.1 3.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.57 78.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -61.27 141.91 57.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.882 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 m80 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.847 0.356 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -114.22 -56.47 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.2 114.28 28.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -60.94 -177.26 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.449 2.099 . . . . 0.0 112.232 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' HB3' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -136.87 -76.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.732 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -69.62 156.1 39.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.683 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' PHE . 1.6 mt -115.44 69.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.993 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.63 ' HG3' HG13 ' A' ' 13' ' ' VAL . 15.4 ttp180 -97.16 103.89 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -132.36 75.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.66 -163.99 12.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.26 -24.62 27.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -92.1 132.61 36.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.14 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.63 HG13 ' HG3' ' A' ' 8' ' ' ARG . 21.2 t -118.97 133.2 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.756 ' CD2' HG22 ' A' ' 21' ' ' VAL . 2.2 t80 -113.27 116.12 29.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -80.36 107.68 13.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.911 HG13 HD13 ' A' ' 17' ' ' LEU . 11.9 p -66.43 -10.78 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.803 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.911 HD13 HG13 ' A' ' 16' ' ' VAL . 1.4 mp -117.93 -9.05 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.388 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 19' ' ' LEU . 5.1 tttp -109.79 -36.86 5.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.641 0.257 . . . . 0.0 111.273 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 74.88 45.63 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -141.43 138.3 32.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.742 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.756 HG22 ' CD2' ' A' ' 14' ' ' PHE . 21.9 t -100.92 111.29 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.62 110.59 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.09 164.75 15.81 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.24 -38.64 51.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.706 2.271 . . . . 0.0 112.438 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -51.3 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.6 -98.27 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -150.22 170.05 19.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.777 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.44 104.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.492 ' HA ' HG23 ' A' ' 20' ' ' THR . 10.5 m170 -74.64 156.38 36.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.613 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -154.68 170.33 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.859 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.46 119.63 71.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.878 ' HB3' HD13 ' A' ' 19' ' ' LEU . 29.4 Cg_endo -62.98 -28.19 74.83 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.387 2.058 . . . . 0.0 112.719 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.9 p -73.96 -31.63 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.93 ' O ' HD11 ' A' ' 77' ' ' LEU . 33.7 mt-10 -83.66 -46.64 12.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.966 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.89 -17.6 64.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.24 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.3 -32.05 78.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.524 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 58' ' ' ILE . 3.5 mp -69.6 -36.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 110.381 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.68 -23.13 61.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.295 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.19 -35.4 61.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.851 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -77.99 -23.04 48.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.62 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.767 HD11 HD21 ' A' ' 54' ' ' LEU . 2.9 mp -82.54 -21.13 35.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.505 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.811 HD23 ' NH1' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -79.48 -23.28 43.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.704 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mm -76.21 -28.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 69.3 m-80 -92.9 -16.81 24.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 36.57 75.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 112.245 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 70.57 96.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.604 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.5 146.07 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -73.23 104.62 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.3 m -150.15 91.32 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD13 ' H ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -49.26 174.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -52.0 -48.28 64.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.141 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.984 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -54.7 -24.02 20.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.479 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HB2' HD22 ' A' ' 50' ' ' LEU . 1.1 t-80 -90.28 -30.73 17.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.545 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.98 -41.59 77.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.751 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -63.21 -19.62 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.183 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.56 -22.37 43.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.175 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 -24.11 21.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 37' ' ' ILE . 5.0 mm -87.73 -23.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -75.07 -30.32 60.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 41.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -172.09 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.698 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -177.76 96.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 65.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.98 93.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.49 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 65' ' ' ILE . 3.2 mt -97.69 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.17 0.509 . . . . 0.0 110.783 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.8 p -177.03 38.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.505 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . . . -169.56 -165.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -117.21 -17.97 10.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.617 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -159.88 -176.49 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 111.14 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.13 -27.12 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.287 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -57.01 -61.67 2.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.99 -19.84 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.471 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -78.67 -29.5 45.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.073 HG23 HD13 ' A' ' 88' ' ' ILE . 7.8 mt -75.14 -34.04 30.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.02 63.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.58 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.1 m -70.07 -27.23 64.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.15 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.53 -35.55 80.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.173 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -26.06 63.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.615 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -90.85 -51.76 5.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.817 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -52.75 8.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.439 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.997 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -65.25 -67.72 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.862 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.0 -133.0 10.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.441 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.46 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.7 OUTLIER -90.05 -40.41 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.84 0.352 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.858 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -56.35 -32.81 60.94 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.848 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 -13.35 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.811 ' NH1' HD23 ' A' ' 42' ' ' LEU . 29.0 ttm180 -46.15 -32.37 2.91 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.073 HD13 HG23 ' A' ' 74' ' ' ILE . 1.3 mt -73.78 102.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.213 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.77 118.15 45.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.837 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -93.79 88.05 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.92 130.14 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.192 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.7 mtt-85 -77.34 69.93 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.36 -42.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.245 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CG1' HD21 ' A' ' 48' ' ' LEU . 1.9 t -84.26 -48.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.737 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.25 -121.02 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.373 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.926 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.43 109.41 13.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.782 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 2.0 tt -110.72 149.44 30.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.429 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -103.13 94.36 5.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.176 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 p -43.45 166.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.299 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -64.85 -18.57 65.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.563 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -61.85 51.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.58 69.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.532 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.94 -169.98 2.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -57.48 175.92 0.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 95.01 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.958 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.53 100.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 128.2 34.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.08 -73.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.74 148.83 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 111' ' ' THR . 10.4 t70 -121.07 29.6 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' ASP . 13.6 p -160.16 124.02 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -60.19 92.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 119.29 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -160.11 147.24 16.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.39 112.82 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.929 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -71.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -87.8 148.65 44.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -56.85 -172.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.98 -75.13 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 110.751 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -74.76 170.04 16.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.832 HG23 HD11 ' A' ' 42' ' ' LEU . 7.9 mt -114.54 84.58 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.96 81.07 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CE2' ' OD2' ' A' ' 101' ' ' ASP . 4.9 t80 -102.97 92.59 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.695 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.29 -139.78 48.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.297 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.13 -22.72 46.8 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.42 2.08 . . . . 0.0 112.325 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.576 ' OD1' HG22 ' A' ' 23' ' ' THR . 49.3 m-20 -94.15 132.24 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.46 126.48 65.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 7' ' ' ILE . 1.2 m-85 -110.13 116.05 30.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -80.76 126.89 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 39' ' ' LYS . 15.5 m -72.8 -8.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.626 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.94 -27.61 9.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -102.92 -28.31 12.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.187 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 32' ' ' PRO . 30.7 mt 62.57 33.28 15.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.821 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.6 m -122.89 127.63 49.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.739 HG22 ' CD2' ' A' ' 14' ' ' PHE . 14.3 t -76.59 115.14 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.46 95.67 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' OD1' ' A' ' 12' ' ' ASN . 16.4 p -105.46 155.85 37.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 61.4 Cg_endo -73.59 -23.75 16.74 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.675 2.25 . . . . 0.0 112.409 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 30.13 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.804 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.62 -130.26 6.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -157.09 153.39 27.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 23' ' ' THR . 21.3 t -118.86 124.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.249 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 168.04 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.74 169.97 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.203 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -87.18 126.54 62.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.141 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HB3' HD13 ' A' ' 19' ' ' LEU . 23.4 Cg_endo -61.4 -15.29 39.84 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.305 2.003 . . . . 0.0 112.859 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.81 -43.58 22.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.486 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.01 -32.07 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.198 178.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.643 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.86 -14.52 58.6 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.0 -35.33 71.63 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.781 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -67.04 -31.09 51.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.097 0.475 . . . . 0.0 110.205 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -78.15 -22.97 47.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.911 178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HG3' HG12 ' A' ' 16' ' ' VAL . 13.5 ttpt -76.72 -38.77 53.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -27.28 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.814 HD13 HD12 ' A' ' 88' ' ' ILE . 22.9 mt -81.53 -23.2 37.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.124 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD11 HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -73.39 -26.18 60.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.986 178.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.1 mm -63.61 -31.73 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.325 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -92.53 -43.77 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 52.48 87.57 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.07 85.65 0.3 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -156.32 169.74 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -101.27 72.46 1.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -105.15 105.49 15.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.9 152.87 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -59.92 -24.36 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.896 ' O ' HD22 ' A' ' 55' ' ' LEU . 7.4 tttt -62.18 -68.55 0.32 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.28 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.3 -26.93 8.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 41' ' ' LEU . 2.2 mt -64.23 -24.52 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.859 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.48 -11.82 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.543 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.893 ' N ' HD23 ' A' ' 55' ' ' LEU . 3.2 mm-40 -90.07 -21.37 22.35 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.766 0.317 . . . . 0.0 111.033 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -90.29 -33.23 16.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.134 0.492 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -83.99 -20.56 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.524 178.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -77.47 -42.45 35.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.504 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.92 -24.25 62.2 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.3 t-80 -110.43 38.33 2.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.809 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 81.88 108.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.885 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -85.46 48.2 1.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.537 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 68' ' ' ARG . . . 54.49 86.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 tt -91.1 32.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 111.052 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 66' ' ' VAL . 14.9 p -157.74 41.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.941 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 59.48 77.8 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 10.0 mtt-85 -160.1 55.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -39.89 150.24 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.777 HG21 HG13 ' A' ' 58' ' ' ILE . 8.0 p -57.79 -26.79 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.798 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -58.91 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.14 0.495 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.39 -21.8 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.546 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -25.33 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.597 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 37' ' ' ILE . 6.8 mm -70.6 -31.37 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.55 -38.6 65.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -28.63 64.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.131 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 ' CG2' ' A' ' 37' ' ' ILE . 33.4 tp -65.2 -36.1 83.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.663 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -58.09 -21.43 46.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.857 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -43.97 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.375 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -51.33 7.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 38' ' ' LEU . 16.4 tp -69.7 -65.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.1 -152.09 18.55 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.762 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.21 -21.46 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 111.421 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 81' ' ' LEU . 19.2 m-85 -65.51 -29.71 70.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' CA ' HD23 ' A' ' 81' ' ' LEU . . . -57.1 -30.48 60.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.299 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -15.68 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.186 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.72 -31.99 3.31 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -72.91 107.24 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.197 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 20.6 t -89.3 109.98 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 1.8 t -95.43 122.69 38.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.69 141.71 51.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.085 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.26 69.99 10.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.544 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.76 -41.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 48' ' ' LEU . 2.2 t -95.72 -40.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.505 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.662 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 122.91 -120.04 4.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -125.08 108.46 11.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.2 tm? -111.47 88.2 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HD22 ' A' ' 41' ' ' LEU . 24.0 p90 -80.88 80.73 7.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.23 132.27 51.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -77.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.732 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -109.98 -70.02 0.83 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.05 35.71 2.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.597 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.42 83.0 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 128.71 36.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.62 88.94 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.21 86.96 2.11 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.2 t -66.36 109.02 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -86.99 7.73 26.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.41 132.82 54.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -122.54 -41.27 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.405 HG23 HD23 ' A' ' 113' ' ' LEU . 5.3 t -160.23 159.42 31.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.2 69.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 HG23 ' A' ' 111' ' ' THR . 0.2 OUTLIER -73.29 104.16 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.78 124.53 21.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.17 178.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.8 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.775 0.321 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.13 103.52 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.7 m -63.38 110.83 4.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.02 -168.57 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.442 2.095 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt-10 -132.9 -58.65 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.605 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -91.02 170.19 10.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.588 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.743 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.9 tp -137.26 84.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.472 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' ' 13' ' ' VAL . 1.9 ttm-85 -77.64 80.59 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.727 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 25.3 p90 -85.68 97.12 9.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 110.575 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.05 -149.92 48.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.28 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.23 -15.62 45.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.592 ' ND2' HG22 ' A' ' 23' ' ' THR . 15.8 m120 -93.41 121.25 34.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.269 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 8' ' ' ARG . 5.4 t -105.64 122.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 21' ' ' VAL . 13.5 t80 -99.87 143.41 30.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -116.82 103.38 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 5' ' ' GLU . 1.5 m -62.49 -15.75 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.26 -28.67 11.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -95.28 -22.13 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.515 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.599 HD12 ' OG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER 61.56 45.76 7.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.841 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 m -154.99 122.89 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -90.47 126.82 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.924 0.392 . . . . 0.0 111.2 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.04 91.39 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.592 HG22 ' ND2' ' A' ' 12' ' ' ASN . 29.1 p -84.36 157.31 62.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.46 -25.91 9.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.726 2.284 . . . . 0.0 112.383 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -103.91 30.65 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 23' ' ' THR . . . 131.09 -135.08 8.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.09 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.852 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -139.31 113.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.26 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -103.03 157.55 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -162.32 170.05 19.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -73.56 140.44 78.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.644 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.07 -18.75 16.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.393 2.062 . . . . 0.0 113.008 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.6 p -76.9 -41.07 45.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.022 0.439 . . . . 0.0 110.439 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.796 ' O ' HD22 ' A' ' 77' ' ' LEU . 16.6 mp0 -81.15 -36.46 30.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.592 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.599 ' OG ' HD12 ' A' ' 19' ' ' LEU . 4.2 p -76.66 -17.61 59.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.92 72.05 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.385 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 58' ' ' ILE . 2.7 mm -67.62 -42.29 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -67.54 -29.11 68.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.725 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -35.32 78.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.426 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -32.92 55.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.498 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.992 HD13 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -78.78 -22.85 45.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.93 178.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -71.58 -28.52 63.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.029 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.28 -30.98 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -92.68 -46.98 7.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.603 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' NZ ' HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER 57.29 91.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.979 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.04 63.75 4.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.08 153.59 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -71.25 103.52 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -117.06 169.68 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -116.61 142.8 46.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.691 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.41 -31.5 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.864 ' O ' HD22 ' A' ' 55' ' ' LEU . 17.5 mttp -85.16 -15.03 45.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -90.82 -26.85 19.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -25.04 63.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.161 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -74.72 -12.01 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.119 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.848 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.3 mt-10 -87.12 -21.43 26.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -31.47 17.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.659 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 37' ' ' ILE . 8.6 mt -86.88 -18.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.895 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -81.36 -37.21 28.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.467 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.28 -33.77 75.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 t-160 -85.73 -55.85 3.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.073 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 166.85 84.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.03 61.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 109.889 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' VAL . . . 58.73 110.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.864 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.79 28.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.565 0.698 . . . . 0.0 110.198 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 67' ' ' ALA . 41.7 t -159.64 164.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.578 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' N ' HG12 ' A' ' 66' ' ' VAL . . . -52.53 87.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 111.163 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -160.22 55.6 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -39.81 146.28 0.11 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.522 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.786 HG21 HD12 ' A' ' 58' ' ' ILE . 11.7 p -54.62 -24.79 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.791 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -60.45 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.66 -21.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -25.67 59.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.802 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.5 mm -74.66 -39.48 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.92 58.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -77.95 -29.2 49.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.124 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 38' ' ' LEU . 30.5 tp -67.84 -31.63 71.6 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.646 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -24.79 59.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.062 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -90.4 -29.2 18.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.186 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -54.59 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.197 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.006 HD22 HD22 ' A' ' 38' ' ' LEU . 13.4 tp -72.32 -29.46 63.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.15 -140.42 16.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.818 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.55 39.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.716 0.293 . . . . 0.0 111.497 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -85.93 -26.3 25.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.449 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.742 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -64.77 -28.87 73.92 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.316 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -73.3 -16.38 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -48.95 -27.49 3.17 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.08 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.992 HD12 HD13 ' A' ' 41' ' ' LEU . 16.5 mm -64.48 83.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 91' ' ' LEU . 21.6 t -69.77 148.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.555 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 90' ' ' THR . 5.1 t -139.11 96.95 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -106.53 122.71 46.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.037 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -73.87 79.31 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.792 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.8 -26.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.403 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 48' ' ' LEU . 10.5 p -116.09 -39.87 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.087 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.02 179.96 16.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 1.5 m-85 -69.97 130.07 41.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 0.0 110.814 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 99' ' ' SER . 8.9 tt -131.89 139.23 48.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' ARG . 45.9 t80 -100.14 69.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.621 ' N ' HD23 ' A' ' 97' ' ' LEU . 37.8 m -57.92 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.194 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -75.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -160.25 -67.88 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.7 5.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.31 137.41 57.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 176.06 1.25 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -60.74 138.61 58.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.73 153.08 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.18 148.67 35.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -69.55 -32.52 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.13 149.23 42.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -142.44 -69.36 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.179 0.514 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.28 -174.8 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -159.36 73.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.68 -177.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 t -160.11 -175.65 5.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -59.74 146.68 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.872 0.368 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m -110.54 -27.4 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 43' ' ' ILE . 2.8 m -111.91 95.67 30.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.181 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.97 -172.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.508 2.139 . . . . 0.0 112.138 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.54 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -143.97 -75.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.817 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 161.7 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -150.47 128.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.941 ' HG3' HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -114.92 88.71 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.023 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 12' ' ' ASN . 31.5 p90 -90.65 114.97 27.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.665 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.33 -142.36 48.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.38 -3.72 14.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 112.655 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 8.1 m-20 -98.5 153.78 18.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.905 0.384 . . . . 0.0 111.161 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 8' ' ' ARG . 41.6 t -135.09 123.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CE2' HD11 ' A' ' 38' ' ' LEU . 23.2 t80 -103.23 100.03 9.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.02 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -83.01 114.55 21.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.3 m -75.31 -5.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.544 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.32 -28.74 9.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.765 0.316 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.62 -28.29 10.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' A' ' 32' ' ' PRO . 15.5 mt 62.27 45.64 6.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -130.12 115.27 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.31 107.5 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.53 98.04 4.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 169.81 18.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.94 -1.26 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.698 2.265 . . . . 0.0 112.604 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -140.85 30.4 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.78 -133.84 6.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -141.7 163.65 32.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.8 105.76 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 169.82 12.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.624 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -165.9 167.0 17.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 0.0 111.219 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.48 112.57 45.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.421 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.59 ' HG3' HD13 ' A' ' 19' ' ' LEU . 71.1 Cg_exo -47.38 -25.09 4.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.603 2.202 . . . . 0.0 112.968 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -71.82 -40.14 69.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.032 0.444 . . . . 0.0 110.524 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HD21 ' A' ' 77' ' ' LEU . 1.4 mt-10 -79.72 -41.3 27.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.578 ' HA ' HD23 ' A' ' 38' ' ' LEU . 9.3 p -75.64 -9.84 58.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.249 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.67 54.22 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.693 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG13 HD13 ' A' ' 58' ' ' ILE . 3.2 mp -67.36 -40.21 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.555 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.8 pp -75.67 -18.08 59.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.418 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CG ' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -82.9 -28.46 29.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.76 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -33.75 34.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.529 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 54' ' ' LEU . 89.2 mt -77.22 -25.45 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.896 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -69.58 -26.55 64.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.803 178.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 3' ' ' VAL . 25.0 mm -60.5 -34.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -94.14 -34.81 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.41 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.96 83.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.42 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.67 69.48 1.32 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.527 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' HD22 ' A' ' 97' ' ' LEU . 56.9 mm-40 -147.5 168.34 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.077 HD21 HG22 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -98.05 103.7 15.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.9 m -132.33 82.38 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.13 145.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.475 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -54.86 -27.03 39.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.365 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.855 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.426 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.56 ' H ' HD23 ' A' ' 50' ' ' LEU . 41.3 t-80 -59.73 -20.68 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.134 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.933 HD11 HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -71.82 -24.49 61.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.321 179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.86 -10.84 59.65 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.382 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -90.3 -20.63 22.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -89.89 -27.33 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.938 HD12 HG11 ' A' ' 70' ' ' VAL . 3.5 mt -94.52 -16.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 2.9 ttmm -92.95 -29.36 15.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.069 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -69.14 -32.37 71.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.185 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.7 t-160 -85.17 -60.59 1.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 176.76 86.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -71.26 61.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 110.179 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . . . 54.44 26.14 6.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 65' ' ' ILE . 5.8 mt 26.36 43.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.665 HG13 ' N ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER 179.99 -165.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' N ' HG13 ' A' ' 66' ' ' VAL . . . -76.03 87.63 2.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.359 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 21.4 mmt180 -150.0 55.39 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.52 ' OD1' HG23 ' A' ' 72' ' ' VAL . 7.2 p30 -41.42 145.5 0.26 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.477 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.33 -34.85 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -45.6 -67.52 0.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG23 ' OD1' ' A' ' 69' ' ' ASN . 36.8 t -59.69 -24.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.592 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -72.88 -27.14 61.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.788 178.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 70' ' ' VAL . 16.3 mm -61.36 -34.57 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.33 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.6 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.816 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -68.89 -26.12 64.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.959 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.659 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -67.49 -29.05 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.232 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -62.86 -28.85 70.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.22 -48.24 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.3 -62.51 1.81 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.611 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.81 HD22 ' HB2' ' A' ' 38' ' ' LEU . 4.2 tp -60.53 -69.07 0.24 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.22 -129.15 7.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.631 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.53 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.31 . . . . 0.0 111.426 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -89.46 -28.41 19.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.499 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.548 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -52.13 -35.57 42.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.063 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.4 t -71.35 -15.18 62.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.69 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 89' ' ' VAL . 17.8 ttp-105 -54.68 -46.7 74.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.878 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG22 ' CE2' ' A' ' 96' ' ' TYR . 15.1 mt -55.47 91.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 87' ' ' ARG . 15.9 t -90.8 158.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 111.435 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 24.0 m -137.61 133.71 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -131.16 143.69 50.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -88.88 79.7 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -38.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.077 HG22 HD21 ' A' ' 48' ' ' LEU . 14.4 p -110.01 -32.81 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.32 -162.42 13.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.953 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 2.8 m-85 -69.65 131.33 44.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.38 . . . . 0.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.1 tm? -139.0 83.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.811 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -69.89 80.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -100.46 134.64 43.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.326 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' HB2' ' CD ' ' A' ' 87' ' ' ARG . 4.8 t70 -140.33 -63.4 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.275 0.56 . . . . 0.0 110.778 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -160.12 -55.81 0.06 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.736 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.92 8.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.605 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.2 98.96 6.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.773 0.32 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 133.35 16.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 162.19 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.34 85.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.21 -74.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.3 91.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -71.27 -18.17 62.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.17 146.39 28.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 111.002 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -160.14 92.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 pp -59.82 163.86 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.18 115.79 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -60.12 -67.3 0.4 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.805 0.335 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -174.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 3' ' ' VAL . 11.8 m -125.87 75.98 71.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.195 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.65 165.15 16.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.603 2.202 . . . . 0.0 112.229 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 16' ' ' VAL . 5.6 mt-10 -110.44 -76.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -79.2 164.42 24.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.694 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.6 tp -136.9 110.23 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.92 0.39 . . . . 0.0 111.311 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.5 82.15 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.81 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' CE1' ' CB ' ' A' ' 12' ' ' ASN . 22.6 p90 -92.6 109.32 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.56 -141.97 41.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.9 -7.8 21.77 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.504 2.136 . . . . 0.0 112.547 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 2.4 m-80 -109.45 156.35 20.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 13' ' ' VAL . 9.6 p -151.04 125.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -94.44 111.09 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -78.15 107.75 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.46 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 17' ' ' LEU . 2.2 m -61.16 -17.32 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.931 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.8 mm? -111.61 -19.4 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.92 -31.51 10.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 111.518 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 32' ' ' PRO . 22.2 mt 65.02 28.58 12.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -127.12 120.29 28.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.655 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.11 108.79 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.85 111.51 11.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.35 166.08 13.28 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 -8.24 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.752 2.301 . . . . 0.0 112.562 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -127.02 29.93 5.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.344 . . . . 0.0 110.882 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 -134.87 7.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.564 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.1 p -145.29 169.73 17.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -145.5 136.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.41 170.07 8.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.8 OUTLIER -165.59 164.48 19.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.085 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.34 124.43 90.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.344 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' HD13 ' A' ' 19' ' ' LEU . 52.8 Cg_endo -69.23 -21.11 36.44 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.275 1.984 . . . . 0.0 112.87 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 p -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.927 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -82.07 -39.08 23.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.212 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.628 ' HB2' HD11 ' A' ' 30' ' ' LEU . 1.2 p -71.33 -16.35 62.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.56 -33.14 80.39 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.733 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.927 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.6 -29.8 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -76.15 -20.02 57.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.148 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -75.88 -36.19 59.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.817 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -37.54 68.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 54' ' ' LEU . 15.3 mt -75.37 -18.65 59.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.05 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -75.26 -30.2 60.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.22 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.29 -29.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.43 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -95.61 -42.53 8.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' CG ' HD13 ' A' ' 42' ' ' LEU . 1.1 mtpm? 49.55 85.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.304 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.97 65.78 2.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.729 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.81 151.04 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.313 . . . . 0.0 110.779 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.02 HD21 HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -69.9 121.55 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' C ' HD22 ' A' ' 50' ' ' LEU . 20.9 m -146.51 170.17 17.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.667 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.5 mm? -110.42 145.04 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.68 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.842 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.819 ' O ' HD22 ' A' ' 55' ' ' LEU . 5.2 tptm -87.44 -15.76 36.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.63 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -90.68 -25.02 20.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -70.61 -25.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.246 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.62 -14.12 61.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.748 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.887 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -78.52 -25.96 45.71 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.949 0.404 . . . . 0.0 110.484 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -43.78 78.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.98 HD11 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -77.22 -23.23 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.7 tttt -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.43 40.58 1.05 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.104 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -166.16 -51.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.355 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.78 89.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.26 65.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.752 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 68' ' ' ARG . . . 52.07 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 65' ' ' ILE . 16.2 mt -94.06 34.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 0.0 110.968 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 66' ' ' VAL . 10.7 p -170.21 41.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.353 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 56.2 72.41 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' H ' ' HB1' ' A' ' 64' ' ' ALA . 87.0 mtt180 -159.8 55.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.572 ' OD1' HG23 ' A' ' 72' ' ' VAL . 16.3 p30 -39.73 160.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.683 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 58' ' ' ILE . 15.0 p -48.84 -24.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.35 -39.65 28.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.997 0.427 . . . . 0.0 110.704 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 69' ' ' ASN . 43.1 t -75.46 -18.32 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.327 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -79.02 -27.53 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.645 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 70' ' ' VAL . 30.0 mm -74.49 -28.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.65 -36.06 51.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -78.06 -28.34 48.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.926 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.787 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -67.29 -35.66 79.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -48.81 -31.76 7.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.084 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -90.73 -25.14 20.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.557 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -85.47 -58.12 2.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.152 0.501 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -89.2 -28.06 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.559 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.25 -152.54 17.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.86 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -17.96 59.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.719 0.295 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 73.5 m-85 -55.28 -35.42 65.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.348 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -61.47 -37.48 94.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.114 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -65.37 -14.05 59.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.321 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 89' ' ' VAL . 20.8 ttm180 -44.98 -29.89 0.92 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.73 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 87' ' ' ARG . 22.6 t -91.28 135.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 m -100.09 89.86 4.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -70.0 135.02 48.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.843 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.76 87.82 3.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.26 -24.7 6.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.02 HG12 HD21 ' A' ' 48' ' ' LEU . 2.7 t -93.72 -62.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.92 -117.2 0.95 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.335 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -112.33 105.32 13.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.925 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 97' ' ' LEU . 3.0 tm? -105.33 79.58 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.527 ' CE1' HD22 ' A' ' 41' ' ' LEU . 34.6 p90 -69.74 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.981 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.79 130.11 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.52 -59.04 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.167 0.508 . . . . 0.0 110.898 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.1 -44.61 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.936 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 47.24 3.44 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.589 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -130.1 91.76 3.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.851 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.24 165.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.784 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 101.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.17 171.91 13.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.989 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.21 135.24 17.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.799 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.24 -44.63 95.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -66.47 157.42 32.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 111' ' ' THR . 3.6 t70 -100.32 30.64 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 110' ' ' ASP . 17.2 p -160.05 135.67 8.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.12 75.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.72 80.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.44 152.31 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 154.74 19.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.882 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 60.74 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 t 62.41 97.96 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 23.3 Cg_exo -64.13 -176.48 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.702 2.268 . . . . 0.0 112.14 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.82 -76.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.641 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -69.87 156.88 38.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.552 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -134.62 78.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.5 mtp180 -86.85 86.73 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -97.21 75.44 2.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.39 -145.07 20.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.92 -9.19 25.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.498 2.132 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' OD1' HG23 ' A' ' 23' ' ' THR . 2.6 m-80 -99.4 109.95 22.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.898 0.38 . . . . 0.0 111.088 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' A' ' 8' ' ' ARG . 20.8 t -91.24 140.38 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.779 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.626 ' CE2' HD21 ' A' ' 30' ' ' LEU . 4.3 t80 -130.4 139.42 50.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.49 117.65 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -63.71 -16.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.642 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.94 -26.05 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.643 0.258 . . . . 0.0 111.271 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -95.66 -41.12 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 32' ' ' PRO . 2.6 mt 69.35 56.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.6 m -138.51 123.84 19.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 14' ' ' PHE . 5.0 t -99.29 96.91 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.5 103.92 5.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.11 170.04 11.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.848 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.49 -22.54 10.68 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.717 2.278 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.99 -30.45 14.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.01 -108.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.52 167.74 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.12 134.01 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.46 170.01 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -163.04 154.24 17.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -70.21 136.3 86.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.132 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 19' ' ' LEU . 43.6 Cg_endo -67.77 -14.14 40.78 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.18 1.92 . . . . 0.0 112.821 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -85.54 -36.01 20.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 0.0 110.421 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.9 pt-20 -89.65 -32.32 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.45 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.744 ' HB2' HD22 ' A' ' 30' ' ' LEU . 1.4 p -82.7 -13.37 56.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.15 -31.38 64.03 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 58' ' ' ILE . 3.5 mp -62.1 -35.04 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.056 0.455 . . . . 0.0 110.272 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -66.9 -24.29 66.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.281 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.573 ' HG3' HG12 ' A' ' 16' ' ' VAL . 1.8 ttmt -72.6 -28.46 62.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -81.08 -22.26 39.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 6.7 mt -87.55 -19.9 27.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 110.316 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -25.12 38.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' LYS . 1.1 pt -73.43 -28.16 24.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -101.88 -36.82 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 110.308 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 50.88 86.86 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.802 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 73.37 98.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.124 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -170.3 156.57 5.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.72 0.295 . . . . 0.0 110.517 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -75.7 83.93 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -116.37 93.82 4.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.44 169.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.011 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -82.71 -28.55 30.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.903 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.48 -67.83 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.163 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -52.26 -26.68 12.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -25.19 67.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.849 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -72.65 -12.28 60.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.676 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.912 ' N ' HD23 ' A' ' 55' ' ' LEU . 14.0 mt-10 -90.25 -21.18 22.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.716 0.293 . . . . 0.0 111.353 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -90.42 -28.13 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 HG21 ' A' ' 70' ' ' VAL . 7.8 mt -95.49 -9.33 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.197 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 4.7 ttpt -98.71 -26.94 14.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.703 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -88.01 39.98 0.92 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 109.722 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 12.1 t60 -165.86 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.527 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 171.56 87.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 59' ' ' LYS . 18.4 ttpt -79.14 55.23 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' CB ' ' CB ' ' A' ' 68' ' ' ARG . . . 50.79 35.96 13.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.944 0.402 . . . . 0.0 110.727 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER 42.66 47.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.246 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.2 t 59.25 153.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.96 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 66' ' ' VAL . . . 75.06 29.72 0.94 Allowed 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.402 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.455 ' CB ' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -161.17 55.92 0.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -39.49 138.58 0.67 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.474 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 58' ' ' ILE . 14.5 p -51.87 -35.69 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.679 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.58 -65.21 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -56.32 -23.42 16.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.543 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.95 -26.3 60.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.589 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 70' ' ' VAL . 12.0 mm -70.91 -31.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.801 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.71 61.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.54 -28.95 59.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.225 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 34' ' ' GLU . 62.6 tp -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.982 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.11 -19.01 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.9 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -84.55 -38.91 19.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.015 0.436 . . . . 0.0 111.343 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 37.1 mmtt -90.12 -49.25 6.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.854 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.7 tp -56.27 -70.27 0.12 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.227 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.77 -136.06 11.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.86 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.42 61.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 9' ' ' PHE . 9.4 m-85 -84.76 -29.77 25.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.301 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.854 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -59.46 -30.44 68.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.408 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -12.52 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.136 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -48.79 -28.04 3.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.834 HD12 ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -82.3 94.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 39.8 t -81.76 117.13 27.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.567 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.2 m -94.64 96.6 9.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.739 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -90.28 121.08 31.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.027 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 69.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 -34.43 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.2 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.71 -39.69 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.646 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 125.85 -114.8 2.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.592 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -114.38 115.75 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 97' ' ' LEU . 2.8 tm? -108.88 119.1 38.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.334 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 8.2 m-30 -85.14 100.05 11.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.3 m -38.72 137.35 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.849 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -22.29 5.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.262 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -39.69 -70.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.475 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 34.88 80.13 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 116.317 -0.402 . . . . 0.0 113.61 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.37 97.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 0.0 110.99 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 162.44 23.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -64.94 143.12 58.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.36 174.67 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.057 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -64.72 102.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -70.19 -72.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.74 109.27 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.127 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -116.93 -17.2 10.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 p -59.11 105.37 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.764 0.316 . . . . 0.0 111.036 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.28 69.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.93 140.77 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.1 159.65 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.43 103.78 0.44 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 43' ' ' ILE . 35.4 m -89.55 132.61 36.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.626 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' HG2' ' HG3' ' A' ' 45' ' ' LYS . 19.9 Cg_exo -64.5 162.59 30.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.357 2.038 . . . . 0.0 112.737 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.15 -67.89 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -78.87 170.08 17.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.17 179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.727 HD12 ' HG ' ' A' ' 42' ' ' LEU . 19.7 mm -119.44 74.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.063 0.459 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HE ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.57 93.94 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.074 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.72 ' CD1' HG22 ' A' ' 7' ' ' ILE . 25.0 p90 -122.74 96.22 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.07 -151.95 46.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.536 2.157 . . . . 0.0 112.423 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 23' ' ' THR . 4.3 m-20 -90.18 139.23 30.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.105 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 HG22 ' HE ' ' A' ' 8' ' ' ARG . 23.2 t -126.43 123.57 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.357 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' A' ' 30' ' ' LEU . 40.8 t80 -126.43 141.28 51.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.917 0.389 . . . . 0.0 111.07 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.08 141.66 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.947 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 39' ' ' LYS . 9.6 m -79.6 -6.15 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -115.16 -41.8 3.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -79.05 -25.47 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . 1.3 mm? 59.76 44.61 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -136.84 118.41 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 28' ' ' VAL . 7.4 p -104.22 114.72 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.41 120.6 21.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.639 HG22 HD21 ' A' ' 12' ' ' ASN . 3.3 p -100.13 165.39 14.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 77.4 Cg_exo -49.6 -40.13 46.2 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.655 2.237 . . . . 0.0 112.47 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -74.27 -57.97 3.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 -107.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -141.8 169.49 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 21' ' ' VAL . 50.1 t -137.63 138.76 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -114.96 132.31 56.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -135.9 161.91 34.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 131.07 80.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.459 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 35' ' ' SER . 23.4 Cg_endo -61.5 -15.71 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.411 2.074 . . . . 0.0 112.873 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 64' ' ' ALA . 13.1 m -74.27 -58.61 3.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.5 pt-20 -73.87 -26.11 60.39 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.617 ' CB ' HD13 ' A' ' 30' ' ' LEU . 34.5 p -88.6 -9.85 50.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.32 -28.24 53.35 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.598 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 34' ' ' GLU . 8.9 tt -69.75 -35.92 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.69 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.5 pp -73.15 -25.34 60.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.232 0.539 . . . . 0.0 109.733 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.26 -32.98 69.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.516 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -74.26 -39.25 63.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.747 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.909 HD22 ' CD1' ' A' ' 98' ' ' PHE . 38.6 mt -72.81 -20.93 61.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.482 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.727 ' HG ' HD12 ' A' ' 7' ' ' ILE . 1.8 mm? -76.4 -27.57 56.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.413 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' LYS . 25.6 mm -67.95 -30.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.397 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 14.0 m120 -95.29 -44.21 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 56.6 90.68 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.289 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.85 97.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.666 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.8 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.732 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.898 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -83.99 96.03 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.064 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.8 m -134.43 98.42 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -53.47 157.51 2.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.093 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -53.22 -43.21 67.07 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.11 0.481 . . . . 0.0 110.434 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.03 -20.41 52.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.641 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -89.59 -33.03 16.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.942 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.23 -36.06 69.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.209 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -69.39 -33.95 73.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.8 -28.0 69.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.081 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 40' ' ' ARG . 21.8 pt-20 -90.59 -10.91 41.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 70' ' ' VAL . 17.7 mt -104.39 -18.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 9.3 tttt -86.79 -26.92 23.88 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.761 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.4 36.51 0.84 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.541 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.32 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.47 95.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 58' ' ' ILE . 48.9 pttt -82.24 56.53 3.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.567 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . . . 62.1 36.12 15.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER 39.74 76.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.506 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 66' ' ' VAL . 77.7 t 59.42 77.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.963 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 64' ' ' ALA . . . -116.67 -172.39 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -75.05 -65.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -160.98 -179.49 7.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.583 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.26 -28.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.484 178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.827 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.91 -26.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -66.66 -30.25 70.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.94 HD12 HD13 ' A' ' 88' ' ' ILE . 43.1 mm -59.14 -34.39 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.611 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.85 71.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -71.22 -21.45 62.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.479 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 34' ' ' GLU . 3.5 mm? -70.66 -33.66 71.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.146 0.498 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -61.12 -27.72 68.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.688 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -47.59 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.689 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 30' ' ' LEU . 8.6 mmpt? -76.33 -52.89 9.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.8 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.798 HD23 ' HA2' ' A' ' 85' ' ' GLY . 9.7 tp -81.4 -43.18 19.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.85 -147.09 17.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.775 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.93 29.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 111.54 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.17 -29.5 43.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.504 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.798 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -61.99 -34.85 90.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.265 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -14.24 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.633 -0.284 . . . . 0.0 110.358 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.7 ttm105 -46.42 -30.15 2.03 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.961 0.41 . . . . 0.0 110.731 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 74' ' ' ILE . 12.8 mt -63.54 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 87' ' ' ARG . 19.3 t -82.01 161.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 90' ' ' THR . 10.2 t -146.0 91.69 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -81.54 136.23 35.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -81.98 76.53 8.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.753 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.74 -35.88 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.002 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 48' ' ' LEU . 8.7 p -109.11 -43.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.608 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 126.69 -156.15 19.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.86 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 1.9 m-85 -74.3 127.8 33.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.309 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.8 tm? -131.23 87.55 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.909 ' CD1' HD22 ' A' ' 41' ' ' LEU . 33.2 p90 -73.03 85.82 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.8 t -117.91 130.68 56.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.707 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 -73.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.98 -49.45 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.849 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.45 77.81 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -179.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.822 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 21.0 mttt -150.49 172.29 15.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -69.14 150.01 48.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.4 t -59.06 141.49 53.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.27 -46.68 82.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.29 115.33 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.059 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -134.84 -30.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.492 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.0 p -62.51 146.63 51.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 120.48 2.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.13 120.17 7.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.977 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.35 129.82 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -60.28 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -162.29 128.23 3.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.597 ' O ' HG23 ' A' ' 3' ' ' VAL . 19.5 m -129.89 96.37 26.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.034 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 104' ' ' LYS . 32.9 Cg_exo -61.25 -171.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.539 2.159 . . . . 0.0 112.132 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.74 -75.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.84 169.99 11.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.564 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.821 HD11 HG13 ' A' ' 16' ' ' VAL . 4.4 mp -121.77 71.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 111.32 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -76.34 69.79 2.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.231 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' CE2' ' NH1' ' A' ' 87' ' ' ARG . 2.9 t80 -91.09 98.95 12.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.599 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.01 -145.57 29.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.258 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.26 -11.57 32.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.358 2.039 . . . . 0.0 112.368 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.03 128.72 43.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.5 t -109.73 123.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -120.07 143.15 48.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.419 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 49.6 m-85 -116.38 123.15 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.821 HG13 HD11 ' A' ' 7' ' ' ILE . 3.1 m -58.65 -19.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.993 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -112.05 -27.43 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 13.0 tttt -85.13 -36.22 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 mt 63.4 30.07 15.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -121.81 129.22 52.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 14' ' ' PHE . 2.1 t -90.51 106.58 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.15 80.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -69.9 169.45 12.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 86.4 Cg_endo -78.82 -1.2 11.39 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.256 . . . . 0.0 112.708 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -120.7 -45.5 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.853 0.358 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.32 -110.71 0.49 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.41 170.05 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 t -142.35 137.48 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -108.83 169.91 8.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.785 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -170.09 169.79 7.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.109 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' SER . 1.5 p -74.15 133.32 78.4 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 19' ' ' LEU . 58.1 Cg_endo -71.22 -16.52 31.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.456 2.104 . . . . 0.0 113.309 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.749 ' HB3' HG21 ' A' ' 65' ' ' ILE . 35.1 p -76.39 -42.47 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.48 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.795 ' O ' HD22 ' A' ' 77' ' ' LEU . 3.9 mt-10 -82.36 -37.34 25.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.44 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.776 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -76.66 -18.39 58.6 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -29.61 74.57 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.896 HG21 HD12 ' A' ' 74' ' ' ILE . 3.5 mm -65.67 -44.96 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.246 0.546 . . . . 0.0 109.698 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -65.55 -23.54 66.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.232 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.5 tttm -71.82 -31.86 66.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -77.73 -33.68 52.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.974 HD12 HD12 ' A' ' 88' ' ' ILE . 12.2 mt -78.8 -21.39 47.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.181 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.93 -23.03 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.3 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 39' ' ' LYS . 6.9 mm -70.4 -31.07 45.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.636 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.47 -33.22 10.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 50.39 86.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.17 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 76.08 95.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.661 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -167.33 145.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.77 96.8 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -133.33 99.96 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.651 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -52.87 142.93 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.987 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -58.93 -31.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.838 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.838 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -63.23 -65.65 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.11 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.44 -27.55 37.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.46 -24.15 67.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -67.97 -14.89 63.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.25 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.99 ' N ' HD23 ' A' ' 55' ' ' LEU . 11.1 mt-10 -84.94 -22.06 29.37 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.638 0.256 . . . . 0.0 111.517 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.02 -19.03 24.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.31 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 70' ' ' VAL . 3.8 mt -97.49 -18.39 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -83.1 -27.5 30.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.567 178.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 34.48 0.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.957 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -166.16 -41.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.93 68.09 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -61.0 109.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.227 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 46.57 75.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.598 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 33' ' ' SER . 5.8 tt -70.92 97.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.826 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 66' ' ' VAL . 14.8 p 43.89 43.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.514 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.74 -168.45 2.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -44.02 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 72' ' ' VAL . 64.8 m-80 -157.48 169.43 24.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 58' ' ' ILE . 4.8 p -84.94 -24.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.252 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -33.86 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.718 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 69' ' ' ASN . 29.8 t -72.87 -26.03 22.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.523 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -22.23 58.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.49 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.896 HD12 HG21 ' A' ' 37' ' ' ILE . 4.9 mm -73.13 -35.14 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.98 67.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.637 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.1 m -66.35 -25.47 66.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' ' 34' ' ' GLU . 46.1 tp -64.88 -36.07 83.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.719 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -56.65 -22.8 37.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.68 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -81.03 -57.3 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.121 0.486 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -53.23 15.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.144 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' HA2' ' A' ' 85' ' ' GLY . 8.1 tp -51.65 -70.48 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.519 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.96 -120.18 4.16 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.086 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.94 -9.81 59.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 7.9 m-85 -89.28 -26.62 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.681 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -54.13 -25.05 30.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.532 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -79.36 -16.8 55.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.605 0.24 . . . . 0.0 110.794 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -53.6 -23.92 12.36 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 111.005 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.974 HD12 HD12 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -84.84 92.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.339 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 90' ' ' THR . 21.9 t -78.69 157.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.047 0.451 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 89' ' ' VAL . 3.8 t -141.33 84.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.201 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.0 136.17 33.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.401 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -79.33 69.9 5.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.367 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.25 -47.08 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -91.73 -36.57 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.184 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 114.73 -122.39 5.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.519 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -109.64 117.86 35.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.822 0.344 . . . . 0.0 110.61 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 98' ' ' PHE . 1.6 tm? -122.68 132.13 54.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.914 ' CZ ' HD22 ' A' ' 41' ' ' LEU . 1.6 m-85 -85.74 97.14 9.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.367 0.603 . . . . 0.0 109.528 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -39.02 141.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.611 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -65.24 -17.52 64.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.536 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.08 52.2 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.83 60.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.567 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.98 -179.43 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.783 0.325 . . . . 0.0 110.77 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 4' ' ' PRO . 31.4 pttt -60.01 150.99 27.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.73 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 110.87 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -59.91 150.55 28.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -60.51 -66.6 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.93 115.09 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -146.41 29.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.44 124.25 20.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -160.13 118.38 2.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.0 -175.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 158.92 31.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -59.98 -32.77 71.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.938 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.94 85.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.782 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.79 122.3 19.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 42.0 Cg_endo -68.42 109.72 2.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.506 2.137 . . . . 0.0 112.556 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -150.39 38.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 111.312 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 20.0 p -170.17 121.98 0.66 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.689 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -103.56 88.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.322 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 69.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.251 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 42.0 p90 -86.57 112.33 21.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.739 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.12 -149.22 47.16 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.299 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.57 -8.78 24.41 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 112.599 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' OD1' HG23 ' A' ' 23' ' ' THR . 5.5 m-80 -100.85 169.59 8.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.91 0.386 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.6 p -167.74 129.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.589 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.61 ' HZ ' HD21 ' A' ' 30' ' ' LEU . 1.8 t80 -118.15 119.31 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.061 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 79.4 m-85 -78.93 118.08 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.504 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HD23 ' A' ' 17' ' ' LEU . 2.7 m -67.55 -10.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.691 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 16' ' ' VAL . 4.3 mm? -116.74 -18.4 10.26 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.9 tttt -91.39 -31.52 16.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.618 0.247 . . . . 0.0 111.402 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 32' ' ' PRO . 11.2 mt 69.0 45.86 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 28' ' ' VAL . 87.0 m -164.15 121.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.836 HG12 ' HB ' ' A' ' 28' ' ' VAL . 9.6 p -86.35 123.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.38 89.09 3.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.742 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -93.35 146.06 31.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.742 ' HD2' HG22 ' A' ' 23' ' ' THR . 61.1 Cg_endo -72.47 -8.87 23.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.571 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.83 29.81 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.92 131.53 4.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.582 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -72.49 170.26 14.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 20' ' ' THR . 47.2 t -124.3 158.36 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' N ' HG12 ' A' ' 28' ' ' VAL . 82.5 t60 -137.22 156.3 48.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.698 HD13 ' CB ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -170.1 164.69 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -72.6 140.1 81.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.192 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 19' ' ' LEU . 51.3 Cg_endo -69.52 -17.45 38.67 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.37 2.047 . . . . 0.0 113.534 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD11 ' A' ' 37' ' ' ILE . 41.2 t -81.34 -36.29 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.877 0.37 . . . . 0.0 110.731 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' HB3' HD23 ' A' ' 77' ' ' LEU . 3.1 mm-40 -90.09 -34.05 16.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.698 ' CB ' HD13 ' A' ' 30' ' ' LEU . 5.7 p -76.87 -18.38 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.57 73.36 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.45 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.04 HD12 HD13 ' A' ' 58' ' ' ILE . 1.3 mm -67.87 -41.79 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.172 0.511 . . . . 0.0 110.067 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.708 HD23 ' CE ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.3 -19.04 65.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.827 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.708 ' CE ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.29 -51.22 15.9 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.599 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 57' ' ' GLU . 1.7 mtm-85 -66.95 -21.37 65.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -83.61 -22.54 32.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.849 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -80.31 -27.34 38.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.856 HD13 ' HE2' ' A' ' 104' ' ' LYS . 13.4 mm -74.74 -22.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.797 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -99.44 -27.69 13.61 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.924 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.48 69.98 0.14 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.68 94.53 1.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.514 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.24 170.02 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -98.47 100.0 11.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 97.0 m -152.13 74.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -40.94 165.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.125 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.954 ' HA ' HD21 ' A' ' 55' ' ' LEU . 8.4 tttt -56.04 -22.05 25.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.649 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 6.7 t60 -89.7 -32.92 16.8 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 0.0 110.067 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -70.7 -35.56 72.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.095 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -72.62 -16.5 61.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.942 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.52 -18.93 30.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.091 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 40' ' ' ARG . 4.9 mm-40 -90.27 -23.2 21.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.04 HD13 HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.55 -17.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -78.75 -28.98 44.93 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.566 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.51 34.87 1.03 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.302 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -163.27 -45.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.503 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.92 106.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.759 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 59.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 49.65 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.293 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 tt -94.08 33.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.225 0.536 . . . . 0.0 111.006 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.9 p -169.5 38.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.495 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . . . -165.82 -176.5 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -107.54 -25.47 11.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.7 167.26 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.846 ' CG2' HD12 ' A' ' 58' ' ' ILE . 7.5 p -90.02 -44.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.363 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -59.14 -51.78 68.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.919 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.21 -24.41 35.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 67' ' ' ALA . 1.6 t-160 -72.45 -31.33 65.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.232 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 70' ' ' VAL . 27.2 mm -63.47 -27.29 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.347 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.7 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.153 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -33.92 73.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.785 ' CD1' HD13 ' A' ' 81' ' ' LEU . 2.6 tm? -69.72 -24.01 63.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.434 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -62.32 -29.7 70.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.473 179.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -90.15 -16.22 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -58.52 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.18 0.514 . . . . 0.0 111.462 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -63.25 -21.12 66.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.929 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.968 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 108.84 -128.6 9.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.848 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.96 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.756 0.312 . . . . 0.0 111.598 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -60.01 -24.1 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -57.15 -34.58 67.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.521 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 t -71.53 -20.26 62.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.286 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.9 ttp180 -49.39 -28.75 5.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 96' ' ' TYR . 11.7 mm -66.73 76.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.161 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ARG . 30.9 t -76.66 117.43 21.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.801 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.4 m -95.6 81.2 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.294 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.94 140.93 53.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.213 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 81.38 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.48 -26.58 4.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.191 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 48' ' ' LEU . 2.9 t -91.84 -45.01 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.829 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.81 -116.28 3.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' CYS . 2.8 m-85 -121.43 109.45 14.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.78 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.97 137.55 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -94.62 88.92 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.226 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.3 p -44.16 170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.431 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -57.78 -19.15 26.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.64 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 51.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.89 71.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.349 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.583 ' C ' HD12 ' A' ' 7' ' ' ILE . 10.3 t0 -119.83 120.14 35.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.819 0.342 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.856 ' HE2' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -57.21 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.261 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -71.0 115.74 10.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.96 104.06 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -94.23 23.2 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.4 137.34 58.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' THR . 3.2 t0 -98.87 29.94 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 110' ' ' ASP . 1.1 p -160.18 99.77 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.12 131.27 5.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -62.28 130.23 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.1 t -62.64 104.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -59.31 -51.4 70.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.2 mt-10 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -71.71 -35.87 70.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 m -119.98 133.52 23.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HG3' HD11 ' A' ' 43' ' ' ILE . 16.7 Cg_exo -66.73 153.75 76.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.391 2.061 . . . . 0.0 112.005 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 105' ' ' LYS . 2.7 mm-40 -91.86 -78.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.186 0.517 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.8 154.32 4.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.309 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 42' ' ' LEU . 9.2 tt -128.18 131.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 0.0 111.217 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.654 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -123.82 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.897 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 12' ' ' ASN . 14.6 p90 -93.65 69.99 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.88 -147.79 20.6 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.43 -12.33 34.45 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.64 2.227 . . . . 0.0 112.532 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.673 HD21 HG23 ' A' ' 23' ' ' THR . 2.5 m120 -101.12 104.29 15.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.857 0.36 . . . . 0.0 111.494 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.654 HG22 ' HG3' ' A' ' 8' ' ' ARG . 13.6 t -94.5 146.6 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.204 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 21' ' ' VAL . 57.0 t80 -135.81 109.46 8.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.285 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -81.21 111.65 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 17' ' ' LEU . 3.9 m -56.4 -21.14 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.917 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 16' ' ' VAL . 3.9 mm? -91.89 -25.32 18.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.636 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -99.04 -26.77 14.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.65 0.262 . . . . 0.0 111.459 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.697 HD23 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 62.37 35.81 14.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.688 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 88.9 m -129.66 113.0 14.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.67 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.8 t -85.71 111.71 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.93 140.67 53.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.799 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -129.78 151.72 78.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HD2' HG22 ' A' ' 23' ' ' THR . 82.4 Cg_exo -45.62 -36.08 13.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.871 2.38 . . . . 0.0 112.516 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.08 -53.93 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.06 -124.15 1.32 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.34 163.01 30.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 28.1 t -128.0 104.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -77.61 134.96 38.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 35' ' ' SER . 1.9 pp -134.12 170.0 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.11 138.74 34.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.471 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.653 ' CA ' HD21 ' A' ' 19' ' ' LEU . 39.7 Cg_endo -67.12 -21.0 49.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.336 2.024 . . . . 0.0 112.541 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.907 ' HB3' HD13 ' A' ' 65' ' ' ILE . 84.7 p -77.16 -37.15 54.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.367 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.733 ' O ' HD11 ' A' ' 77' ' ' LEU . 7.4 mt-10 -82.01 -39.66 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.576 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.858 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.4 p -77.8 -9.94 59.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.066 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.36 -31.51 51.1 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.884 ' CG1' HD12 ' A' ' 58' ' ' ILE . 3.0 mp -68.51 -47.28 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.111 0.481 . . . . 0.0 110.153 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 42' ' ' LEU . 3.5 pp -70.25 -19.19 63.15 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.783 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' CD ' ' HG2' ' A' ' 4' ' ' PRO . 13.2 ttmt -75.16 -38.95 60.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.641 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -67.42 -35.74 79.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.637 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -79.89 -17.3 53.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.891 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.798 HD11 HD12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -78.32 -28.09 47.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.222 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.625 HD11 ' HG3' ' A' ' 4' ' ' PRO . 3.6 mm -65.17 -31.87 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.881 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 10.4 m-80 -90.75 -39.44 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.1 89.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.811 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 80.23 50.01 5.64 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.301 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 14.6 mm100 -126.24 153.12 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.708 0.29 . . . . 0.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -69.83 116.5 10.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.919 0.39 . . . . 0.0 110.799 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 75.8 m -130.02 75.17 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -43.86 166.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.574 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -46.49 -64.23 0.81 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.726 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -52.52 -16.81 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.792 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -90.13 -12.96 36.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.793 0.33 . . . . 0.0 110.389 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.798 ' CD2' HD11 ' A' ' 74' ' ' ILE . 2.2 tp -90.48 -32.21 16.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.4 -9.76 55.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.974 178.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -87.6 -27.2 22.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.597 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 58' ' ' ILE . 6.4 pt-20 -79.96 -25.25 40.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.621 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.884 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.32 -23.35 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 8.9 tttm -73.94 -28.47 61.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.151 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.39 31.1 1.36 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.224 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -163.33 -53.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.689 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.297 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.29 34.82 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.27 37.06 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.347 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 33' ' ' SER . 1.0 OUTLIER -71.56 71.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.202 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.6 p 45.87 38.64 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.409 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -172.7 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.894 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -113.95 -29.18 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.14 177.87 10.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 55' ' ' LEU . 12.0 p -90.18 -25.6 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.861 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.18 -66.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.079 0.466 . . . . 0.0 110.653 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.25 -23.44 16.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.591 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.502 ' NE2' HG21 ' A' ' 65' ' ' ILE . 2.8 t60 -72.22 -28.29 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.207 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 71' ' ' ASP . 10.7 mt -64.3 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -54.23 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.795 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -60.45 -23.03 64.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.38 -41.3 98.79 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.824 178.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 4.5 mtt180 -55.04 -23.69 21.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.94 -22.23 25.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.804 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -55.26 3.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.356 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -83.6 -19.59 35.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.244 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.945 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 101.87 -126.48 8.9 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.1 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.15 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.753 0.311 . . . . 0.0 111.826 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -54.61 -24.39 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 88' ' ' ILE . . . -63.37 -25.89 68.96 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -21.66 45.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.633 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -47.55 -32.22 5.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.557 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.0 mt -60.8 87.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.631 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 99' ' ' SER . 20.5 t -74.04 141.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.438 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.7 104.35 10.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.58 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -93.46 140.78 29.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 69.86 8.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.66 -35.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 48' ' ' LEU . 7.7 p -114.91 -36.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.77 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.6 -145.9 18.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.856 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.716 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 m-85 -70.01 130.4 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 110.755 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' HG ' ' A' ' 48' ' ' LEU . 3.4 tm? -130.4 135.02 47.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 111.429 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -92.33 95.18 9.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.749 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 89' ' ' VAL . 18.4 t -109.29 93.97 4.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -140.2 -53.35 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.204 0.526 . . . . 0.0 110.95 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.1 -70.13 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.006 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 131.17 -40.05 1.69 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.862 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 138.2 58.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.177 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -171.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.759 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' CB ' ' HB2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -81.25 75.7 8.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.54 132.51 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.2 t -73.23 115.23 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.9 -68.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.235 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.19 152.14 11.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -150.11 -42.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 m -56.49 165.44 1.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.17 127.0 4.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.98 143.92 57.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.51 137.73 58.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -179.19 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.2 m170 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.733 0.301 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -127.96 160.85 30.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.32 117.74 52.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.46 82.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.487 2.124 . . . . 0.0 112.263 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.4 20.29 10.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 111.251 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -170.13 163.69 9.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 42' ' ' LEU . 7.8 tp -154.12 74.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.866 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -77.27 104.79 7.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -105.78 98.18 7.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.28 -149.43 45.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.303 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.97 -14.89 46.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.78 112.02 24.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.866 HG12 ' HB3' ' A' ' 8' ' ' ARG . 34.6 m -98.22 153.97 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.755 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 30' ' ' LEU . 5.5 t80 -131.85 120.57 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.183 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 97.4 m-85 -96.61 105.41 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 17' ' ' LEU . 5.4 m -55.7 -21.31 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' HG23 ' A' ' 16' ' ' VAL . 3.7 mm? -101.74 -14.47 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 14.3 tttt -101.87 -35.25 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.73 0.3 . . . . 0.0 111.38 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.453 HD21 ' CA ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER 65.87 29.27 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.755 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.6 m -135.93 103.49 5.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.1 t -72.99 119.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.009 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.7 88.74 2.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.88 166.33 36.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.16 -0.91 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 0.0 112.783 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.43 30.9 5.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.3 -110.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.02 170.11 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.91 114.17 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -91.35 166.64 12.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.592 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.601 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -169.6 170.11 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 132.86 62.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' CA ' HD21 ' A' ' 19' ' ' LEU . 53.9 Cg_endo -69.67 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.324 2.016 . . . . 0.0 112.935 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.1 p -79.58 -48.41 13.86 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.87 -32.18 35.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.588 178.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.825 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 p -84.41 -12.61 54.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.38 -30.81 57.99 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.053 HD11 HD23 ' A' ' 54' ' ' LEU . 13.9 tt -61.97 -29.35 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -73.93 -14.59 61.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HG3' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -80.1 -34.26 38.07 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.331 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.09 34.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.717 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.675 HD13 ' OH ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -82.77 -23.07 34.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.335 179.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.928 HD11 HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -76.96 -25.21 52.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.258 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 39' ' ' LYS . 1.7 mt -67.53 -34.57 69.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.96 0.409 . . . . 0.0 110.004 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -92.84 -45.08 8.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.77 93.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.957 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 75.91 94.48 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.578 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -164.84 144.78 7.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.727 0.298 . . . . 0.0 110.601 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.704 ' CD1' HG12 ' A' ' 94' ' ' VAL . 26.8 tp -69.98 116.85 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -164.06 93.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -42.04 161.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.38 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 55' ' ' LEU . 36.0 ptt85 -54.54 -23.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.743 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HA ' HD22 ' A' ' 55' ' ' LEU . 9.2 mttm -67.65 -51.86 44.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.301 0.572 . . . . 0.0 110.494 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.594 ' H ' HD23 ' A' ' 50' ' ' LEU . 3.8 t-80 -52.04 -30.06 23.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.407 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.053 HD23 HD11 ' A' ' 37' ' ' ILE . 4.3 mp -61.9 -25.96 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.121 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -61.5 -32.99 73.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.035 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.33 -13.68 60.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.021 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.05 -32.94 16.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.949 0.404 . . . . 0.0 110.821 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.629 HG13 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -86.41 -26.96 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -79.87 -25.3 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.32 31.11 2.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.706 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -166.09 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 95.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.31 55.0 3.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . . . 58.66 34.72 24.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 65' ' ' ILE . 5.4 tp 41.24 81.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.542 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t 47.28 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.21 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.97 -172.1 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -63.95 -65.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.19 0.519 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -156.96 166.69 32.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.749 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 55' ' ' LEU . 12.1 p -89.99 -28.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -33.47 75.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.7 t -80.92 -24.9 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.458 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.84 -28.34 40.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.252 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 37' ' ' ILE . 55.2 mt -72.16 -26.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.208 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.09 -42.05 80.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.635 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -29.97 67.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.798 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 34' ' ' GLU . 12.4 tp -65.58 -30.08 70.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.725 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -61.46 -26.39 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.598 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -72.77 -56.03 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.003 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.98 -53.19 11.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.805 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.68 -70.0 0.28 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.97 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.84 -52.72 4.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.37 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -69.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.338 0.589 . . . . 0.0 111.304 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.675 ' OH ' HD13 ' A' ' 41' ' ' LEU . 77.4 t80 -52.12 -37.64 54.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.81 18.8 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.932 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.1 -20.53 23.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.879 0.371 . . . . 0.0 110.304 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -57.03 -30.8 64.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.552 HD13 HG21 ' A' ' 74' ' ' ILE . 1.1 pt -69.94 89.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 97' ' ' LEU . 21.6 t -76.05 104.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -83.62 79.56 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -70.26 115.97 10.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.62 79.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.72 -30.89 1.8 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.421 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 48' ' ' LEU . 2.0 t -98.9 -58.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.924 0.392 . . . . 0.0 110.961 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.8 -117.39 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -126.06 106.91 9.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.849 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -104.44 146.44 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.95 90.11 4.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.999 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -39.82 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.777 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -78.44 -17.16 56.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.486 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.09 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.68 0.792 . . . . 0.0 113.048 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.91 74.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.204 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.12 166.99 14.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.222 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -170.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 120.4 12.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.32 153.09 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -150.18 168.22 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -76.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -173.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -146.28 -69.54 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -160.09 111.34 1.94 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.765 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 70.04 1.43 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 82.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.6 t -57.29 158.75 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.9 mt -60.08 -45.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.896 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -174.37 108.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 3' ' ' VAL . 12.3 m -116.62 88.27 24.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.768 ' CB ' HG11 ' A' ' 16' ' ' VAL . 22.4 Cg_exo -64.09 129.23 23.76 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.62 2.214 . . . . 0.0 112.052 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 -50.32 3.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.107 0.48 . . . . 0.0 111.152 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.2 162.93 8.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.544 HD13 ' HG ' ' A' ' 42' ' ' LEU . 30.1 mt -136.89 70.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -85.47 114.73 22.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.718 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 8.8 t80 -132.03 103.47 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.72 -151.81 36.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.41 -20.92 34.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.585 2.19 . . . . 0.0 112.449 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -95.27 144.04 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.959 0.409 . . . . 0.0 111.248 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 8' ' ' ARG . 18.4 t -129.21 141.59 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 21' ' ' VAL . 4.1 m-85 -126.78 118.71 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.24 120.14 35.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 4' ' ' PRO . 4.4 m -65.47 -15.5 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -104.0 -43.55 5.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -82.81 -35.23 26.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.134 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.633 HD22 ' OG ' ' A' ' 35' ' ' SER . 11.9 mt 64.15 42.36 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 m -121.44 144.48 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.828 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' CZ ' ' A' ' 14' ' ' PHE . 15.0 t -103.38 113.28 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.122 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.13 76.9 5.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 p -77.51 126.17 85.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -43.75 -30.92 3.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.747 2.298 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.63 -42.32 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.38 -115.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.59 149.72 24.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -130.39 137.89 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.235 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -104.93 170.05 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -165.86 160.63 17.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.187 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -75.04 140.2 73.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.344 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 31' ' ' THR . 42.2 Cg_endo -68.01 -26.2 37.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.322 2.015 . . . . 0.0 112.737 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 37' ' ' ILE . 9.2 t -78.25 -32.69 49.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.271 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.786 ' O ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt-10 -86.31 -39.29 16.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.414 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.672 ' HB3' HD13 ' A' ' 30' ' ' LEU . 4.2 p -75.15 -16.56 60.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.974 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.44 -33.65 72.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.587 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 58' ' ' ILE . 3.1 mp -63.28 -43.24 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.195 0.521 . . . . 0.0 109.969 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -71.3 -22.29 61.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -75.07 -38.62 61.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.251 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.69 -22.98 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.827 179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 88' ' ' ILE . 2.1 tp -84.7 -23.31 29.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.136 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.696 HD13 ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.94 -27.08 61.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.979 178.832 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.712 HD11 ' HG3' ' A' ' 4' ' ' PRO . 9.3 mm -61.83 -33.1 56.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.036 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -85.49 -56.29 3.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.346 0.594 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG3' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 49.6 86.33 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.488 179.362 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.42 45.22 4.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -129.6 134.41 47.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.7 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.881 HD12 HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -69.85 88.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.558 ' O ' HD21 ' A' ' 54' ' ' LEU . 1.8 m -114.49 95.93 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.738 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -42.64 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.542 -179.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -52.55 -44.69 66.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.688 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.939 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -60.45 -19.36 56.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.957 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -84.39 -34.63 23.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.37 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 41' ' ' LEU . 7.0 mt -67.27 -40.72 86.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.923 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -67.95 -13.41 62.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.805 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.49 -24.09 29.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.444 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 54' ' ' LEU . 4.7 pt-20 -86.19 -24.68 26.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.871 HD12 HG13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -89.15 -25.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 8.3 ttpt -67.72 -32.28 72.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.27 40.12 1.06 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -169.0 -60.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.023 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 58' ' ' ILE . . . -174.81 83.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -99.83 30.84 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 0.0 110.641 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 66' ' ' VAL . . . -173.15 -157.79 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 65' ' ' ILE . 39.6 mm 52.46 27.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.8 0.81 . . . . 0.0 109.585 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 64' ' ' ALA . 14.7 p 176.98 33.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.107 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 154.42 -173.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 -26.16 9.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.12 -179.33 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.609 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 58' ' ' ILE . 5.3 p -90.1 -37.25 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.325 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -70.13 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -56.77 -23.68 18.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -74.43 -31.74 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.099 179.151 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 70' ' ' VAL . 63.7 mt -63.02 -29.62 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.89 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.61 -58.57 4.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.8 p -60.62 -26.49 67.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 178.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -63.18 -31.46 72.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.488 178.437 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -60.09 -24.13 64.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.471 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -50.77 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -54.24 15.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.274 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -50.74 -23.93 3.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.266 -178.778 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 81' ' ' LEU . . . 105.57 -124.48 7.91 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.108 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.84 22.03 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 38' ' ' LEU . 62.5 m-85 -57.1 -21.04 29.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.967 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.744 ' H ' HD21 ' A' ' 81' ' ' LEU . . . -48.96 -27.76 6.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.422 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -24.53 24.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.514 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' NH2' HD11 ' A' ' 88' ' ' ILE . 17.6 ttp85 -59.78 -31.98 70.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.93 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 41' ' ' LEU . 7.1 mm -70.56 96.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 90' ' ' THR . 21.1 t -88.01 153.94 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.311 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 96' ' ' TYR . 2.2 m -143.06 116.51 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.678 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.884 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.86 125.38 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 -179.689 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -76.13 69.83 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.079 0.466 . . . . 0.0 110.357 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.66 -39.0 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.073 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 91' ' ' LEU . 15.0 p -102.11 -31.15 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.705 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 108.34 -178.24 21.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.689 ' CD2' HD11 ' A' ' 54' ' ' LEU . 1.2 m-85 -69.86 130.08 41.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.881 HD13 HD12 ' A' ' 48' ' ' LEU . 3.5 tp -137.13 139.85 41.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.08 79.49 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.906 0.384 . . . . 0.0 110.614 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -71.02 107.42 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -140.11 -71.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 111.124 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -160.2 -65.11 0.07 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.7 22.66 3.58 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.0 69.68 6.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.01 175.46 8.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.97 144.91 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.042 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.94 117.21 6.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 t -65.17 120.9 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -30.03 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.72 117.7 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.18 -19.19 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.227 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.4 m -58.0 102.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -60.02 135.32 57.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.21 146.37 26.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 113.89 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -60.63 -43.33 97.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.985 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.8 m170 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.847 0.356 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.93 133.72 44.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.5 t 64.04 136.15 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 104' ' ' LYS . 13.8 Cg_exo -69.45 58.47 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.571 2.181 . . . . 0.0 112.527 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.864 ' HB3' HG12 ' A' ' 16' ' ' VAL . 3.3 mt-10 -82.51 -22.11 35.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.676 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.894 ' HB2' HG13 ' A' ' 16' ' ' VAL . 40.8 t -160.38 122.43 3.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -170.22 158.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.012 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HA ' HG12 ' A' ' 13' ' ' VAL . 7.2 mtm180 -92.8 118.35 31.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -106.86 91.24 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.012 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.13 -119.55 12.12 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.7 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.9 -45.31 2.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.452 2.101 . . . . 0.0 112.298 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.66 165.93 13.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 8' ' ' ARG . 29.0 m -155.58 132.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.387 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -98.19 146.38 25.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.393 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 18' ' ' LYS . 18.7 m-85 -115.75 133.25 56.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.249 0.547 . . . . 0.0 111.771 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER -45.18 -63.46 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.862 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.58 HD22 ' HB ' ' A' ' 16' ' ' VAL . 3.5 mm? -120.05 -14.92 8.82 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 26.0 tttt -56.41 -41.89 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.4 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 64.31 54.36 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.0 110.546 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.15 110.88 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.758 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 28.7 t -90.04 111.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 132.96 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -131.52 149.08 72.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.45 -18.04 51.35 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.89 -29.52 20.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 23' ' ' THR . . . 177.26 -97.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.31 170.19 14.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.682 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 20' ' ' THR . 22.0 t -130.22 145.74 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.731 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 20' ' ' THR . 28.0 m-70 -144.94 126.64 15.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -163.95 170.81 16.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.471 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -69.4 138.18 88.96 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.094 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.871 ' HA ' HD11 ' A' ' 19' ' ' LEU . 11.5 Cg_endo -56.3 -14.34 12.03 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.001 2.467 . . . . 0.0 113.432 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 65' ' ' ILE . 4.8 t -71.36 -32.38 68.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.796 0.331 . . . . 0.0 111.375 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 mp0 -81.8 -48.08 12.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.09 0.471 . . . . 0.0 109.919 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.85 ' HB3' HD21 ' A' ' 30' ' ' LEU . 3.1 p -73.98 -9.66 58.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.19 -30.93 44.25 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.08 179.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.14 -35.12 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 120.939 0.399 . . . . 0.0 110.464 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 81' ' ' LEU . 4.1 pp -75.28 -20.91 58.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.826 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.59 -34.87 72.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.385 179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.787 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.71 -32.84 72.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.245 179.412 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 54' ' ' LEU . 26.4 mt -80.56 -22.47 40.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.42 -31.12 65.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.879 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 40' ' ' ARG . 17.7 mt -63.61 -25.61 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.563 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.01 -52.08 3.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.1 0.476 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.78 88.75 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.05 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.54 53.0 2.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.583 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -137.23 170.02 16.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.35 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.858 HD11 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -97.5 121.17 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.8 m -149.58 92.61 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.829 HD12 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -48.56 165.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -49.49 74.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.874 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -58.79 -20.95 54.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.89 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -83.46 -36.49 24.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.081 HD11 HD21 ' A' ' 41' ' ' LEU . 1.1 mm? -69.65 -43.11 73.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.181 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -67.17 -26.17 66.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.223 179.157 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -26.74 64.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.971 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -86.7 -28.9 22.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.77 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.771 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -89.41 -22.35 6.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.668 178.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 18.8 mtpt -78.68 -30.32 46.07 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.791 178.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.15 40.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.918 178.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -174.17 -38.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.555 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' ILE . . . -167.68 75.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -73.42 125.06 27.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 48.27 61.44 3.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.421 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -63.41 83.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 66' ' ' VAL . 14.4 p 43.83 39.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.24 -173.27 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.066 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -82.74 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 0.0 111.049 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -147.18 169.75 18.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.771 ' CG2' HD12 ' A' ' 58' ' ' ILE . 8.8 p -84.21 -22.1 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.399 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 74' ' ' ILE . 2.1 m-20 -75.23 -43.1 53.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.067 0.461 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.26 -24.06 31.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.574 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.598 ' HE1' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -71.53 -28.47 63.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.233 179.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 71' ' ' ASP . 24.8 mt -64.78 -29.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.421 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.52 -52.42 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.805 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 p -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.823 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.05 -38.88 92.68 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.444 178.637 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.14 -26.16 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.749 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -77.05 -58.67 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.587 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -69.09 -55.94 9.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.719 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.812 HD13 HD22 ' A' ' 38' ' ' LEU . 10.0 tp -54.84 -52.1 63.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.872 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.55 -143.18 17.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.84 63.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.279 . . . . 0.0 111.429 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 21.6 m-85 -76.23 -23.01 54.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.664 ' HA2' HD23 ' A' ' 81' ' ' LEU . . . -62.1 -33.16 84.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.356 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -12.29 59.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 89' ' ' VAL . 1.5 tpm_? -53.12 -34.04 54.97 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.057 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.798 HG22 ' CE1' ' A' ' 96' ' ' TYR . 3.1 mm -56.23 89.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.253 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' ARG . 38.1 t -79.98 115.16 21.93 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.863 0.364 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.406 ' HG1' ' HE1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -91.52 88.31 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.504 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 89' ' ' VAL . 12.5 mt -83.69 118.41 23.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.278 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -70.35 69.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.15 -36.5 0.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.769 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 48' ' ' LEU . 3.0 t -94.72 -37.16 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.039 0.447 . . . . 0.0 110.358 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.829 ' HA3' HD12 ' A' ' 50' ' ' LEU . . . 118.72 -119.65 4.41 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.367 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.798 ' CE1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -122.36 109.2 14.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 0.0 110.666 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -119.6 91.04 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE1' HD22 ' A' ' 41' ' ' LEU . 12.7 p90 -69.78 72.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.172 0.511 . . . . 0.0 110.152 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 97' ' ' LEU . 1.4 t -67.85 117.16 9.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.366 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 50.9 t0 -132.48 -80.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -160.08 -63.22 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.153 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.1 14.17 3.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.042 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.5 84.19 1.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -105.11 148.22 27.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 87.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.77 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.23 103.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.46 164.69 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -58.03 10.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.06 109.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.73 -65.82 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.133 0.492 . . . . 0.0 110.948 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 m -160.06 159.54 32.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.48 88.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -61.78 149.7 39.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.6 t -61.03 112.62 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.97 143.88 54.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.6 m80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.0 p -158.0 106.92 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.9 p -158.94 101.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.98 176.05 4.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.178 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -63.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -69.95 167.03 18.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.73 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.989 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.406 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 5.5 ttt-85 -154.46 100.41 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . 8.5 p90 -125.71 70.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -157.76 24.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.411 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.93 -22.56 30.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.192 . . . . 0.0 112.45 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.79 151.87 21.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.899 0.381 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 21' ' ' VAL . 16.1 t -133.5 160.69 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.908 ' CE2' HD21 ' A' ' 38' ' ' LEU . 1.4 t80 -143.32 128.95 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.354 . . . . 0.0 110.983 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 63.5 m-85 -109.98 109.32 19.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.828 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.575 HG12 ' CG ' ' A' ' 39' ' ' LYS . 2.7 m -55.11 -22.94 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.662 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.67 -45.35 5.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -67.3 -38.88 85.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 32' ' ' PRO . 27.0 mt 63.91 39.14 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 27' ' ' SER . 4.9 m -143.36 111.53 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 14' ' ' PHE . 21.6 t -69.96 122.14 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.15 96.96 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -88.21 165.59 28.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.38 -36.57 48.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.691 2.261 . . . . 0.0 112.497 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -50.22 47.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.54 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 20' ' ' THR . 4.9 m -159.92 169.97 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.823 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 23' ' ' THR . 21.2 t -142.73 123.45 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.223 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -83.83 153.11 24.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -161.01 170.0 21.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.9 128.47 91.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.956 ' HB3' HD13 ' A' ' 19' ' ' LEU . 73.0 Cg_endo -74.45 -23.74 14.78 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.384 2.056 . . . . 0.0 112.662 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -73.81 -34.67 64.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.665 ' HB3' HD23 ' A' ' 77' ' ' LEU . 10.9 mt-10 -79.31 -47.65 15.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.828 ' HA ' HD23 ' A' ' 38' ' ' LEU . 13.8 p -62.96 -17.82 62.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.494 178.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.15 77.66 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.506 -0.855 . . . . 0.0 111.445 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.867 HG13 HD12 ' A' ' 58' ' ' ILE . 2.7 mp -64.64 -43.18 96.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.908 HD21 ' CE2' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -70.51 -26.19 63.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.806 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CG ' HG12 ' A' ' 16' ' ' VAL . 3.2 tmtt? -72.94 -30.66 64.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.31 179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -74.01 -41.36 61.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.66 -21.47 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -74.7 -23.82 58.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.628 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.69 -28.91 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.3 -44.97 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? 47.71 85.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.835 ' HA2' ' O ' ' A' ' 98' ' ' PHE . . . 79.8 84.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.738 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 152.53 4.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.32 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD21 ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -69.83 111.13 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.899 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.8 m -137.1 94.48 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.012 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 50' ' ' LEU . 1.5 mm? -49.97 175.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -90.06 -31.58 17.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 -179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.885 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.95 -64.99 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.132 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -53.24 -25.13 13.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.371 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.6 -27.91 68.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.004 HD23 ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -64.22 -15.12 59.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.483 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.004 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -87.9 -19.6 27.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.596 0.236 . . . . 0.0 111.273 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -90.31 -28.05 19.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.379 . . . . 0.0 111.019 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.869 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 mm -90.9 -21.99 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.861 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -84.38 -24.88 29.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.13 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.44 36.91 0.99 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.446 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.0 t-80 -167.32 -47.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.403 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' HIS . . . 175.19 91.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -69.45 65.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 67' ' ' ALA . . . 57.07 103.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.628 HG22 ' OG ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -91.9 31.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.22 0.533 . . . . 0.0 110.954 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.9 p -178.2 38.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.033 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.615 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . . . -155.18 -167.92 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.112 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -114.43 -22.93 9.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB3' HG22 ' A' ' 72' ' ' VAL . 3.3 t-20 -155.82 178.28 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.929 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 58' ' ' ILE . 12.4 p -90.02 -33.88 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -64.17 -33.23 75.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -79.83 -34.2 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.233 179.4 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.81 -26.01 56.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.122 179.054 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -72.6 -36.47 53.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.38 0.609 . . . . 0.0 109.928 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.3 90.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.451 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 p -76.16 -34.31 59.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.196 0.522 . . . . 0.0 109.602 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.78 HD13 ' O ' ' A' ' 77' ' ' LEU . 3.5 tm? -69.18 -27.27 65.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.292 178.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HA ' ' HA3' ' A' ' 85' ' ' GLY . 2.1 mtp85 -58.86 -28.59 66.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.65 -19.4 27.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB2' HD22 ' A' ' 77' ' ' LEU . 2.9 mttt -78.22 -63.15 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 85' ' ' GLY . 1.1 pt? -64.34 -30.86 71.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.646 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.602 ' H ' HD23 ' A' ' 81' ' ' LEU . . . 111.54 -149.22 18.03 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.973 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.14 -21.9 64.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.787 0.327 . . . . 0.0 111.659 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.36 -28.54 66.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.245 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.706 ' CA ' HD21 ' A' ' 81' ' ' LEU . . . -64.2 -47.99 79.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -14.96 35.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.605 0.241 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 98' ' ' PHE . 1.7 ttm180 -50.99 -23.21 2.74 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.937 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -67.8 87.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.541 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -69.79 109.94 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.612 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 90' ' ' THR . 8.2 t -92.02 79.81 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.539 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -69.9 134.97 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.987 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 72.04 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.721 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.71 -30.36 1.68 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.367 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.657 HG23 HD22 ' A' ' 91' ' ' LEU . 2.9 t -91.89 -42.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.53 -117.2 3.12 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.276 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.937 ' CD1' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -123.27 109.44 13.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -114.75 147.66 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.344 0.592 . . . . 0.0 111.708 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.835 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 10.9 t80 -96.84 103.01 14.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.706 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.0 p -38.71 154.03 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.272 0.558 . . . . 0.0 112.119 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -22.47 58.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.148 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' GLY . 0.9 OUTLIER -39.84 -70.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.471 -179.398 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' ASP . . . 29.88 79.12 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.754 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.57 88.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -56.88 153.77 10.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.05 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 8' ' ' ARG . 2.5 tmtp? -150.2 108.97 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.009 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -72.74 132.37 43.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.62 93.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -36.01 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -58.54 111.82 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.9 -24.09 10.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 m -64.96 167.24 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -160.16 159.07 31.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.3 tp -150.11 104.53 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.73 117.11 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.002 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.682 ' O ' HD12 ' A' ' 115' ' ' LEU . 2.4 pp -59.43 125.92 25.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.928 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.579 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -77.26 -31.06 54.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 3' ' ' VAL . 10.8 p -55.85 117.32 15.12 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' CG ' HG12 ' A' ' 43' ' ' ILE . 51.6 Cg_exo -56.03 -169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.518 2.145 . . . . 0.0 112.478 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.44 -62.89 1.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.769 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -170.15 149.46 3.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 42' ' ' LEU . 1.2 pp -146.22 129.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 13' ' ' VAL . 10.3 ptm180 -128.08 125.46 39.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -107.21 69.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.539 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.32 -133.11 11.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.208 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.35 4.0 7.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.754 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 28.7 m120 -122.62 103.99 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 8' ' ' ARG . 21.6 t -82.43 158.01 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 13' ' ' VAL . 64.2 t80 -136.32 100.08 4.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 0.0 111.084 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' LYS . 65.7 m-85 -78.78 109.6 13.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 4' ' ' PRO . 2.6 m -58.05 -19.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.63 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.61 -28.96 11.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 111.341 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -86.96 -29.83 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.206 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 32' ' ' PRO . 20.6 mt 60.31 32.05 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.4 m -130.65 125.74 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 84' ' ' TYR . 1.8 t -81.31 112.57 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.986 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.04 103.43 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -98.18 169.64 8.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.77 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 83.1 Cg_endo -79.29 -26.86 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.734 2.289 . . . . 0.0 112.408 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -85.36 -30.7 23.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.78 -98.48 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.2 m -155.76 170.06 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.54 133.05 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.209 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.36 170.09 8.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.873 HD22 ' OG ' ' A' ' 35' ' ' SER . 1.7 pp -169.5 170.03 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' GLU . 2.2 t -83.15 118.52 71.91 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.713 ' HB3' HD13 ' A' ' 19' ' ' LEU . 31.2 Cg_endo -64.07 -9.86 20.99 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.381 2.054 . . . . 0.0 113.45 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.69 -37.67 24.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.884 0.373 . . . . 0.0 110.656 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.8 ' O ' HD11 ' A' ' 77' ' ' LEU . 4.6 mp0 -90.36 -37.15 14.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.873 ' OG ' HD22 ' A' ' 30' ' ' LEU . 58.5 m -79.63 -9.96 59.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.813 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.05 -37.06 33.71 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.411 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -64.94 -30.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 109.664 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 81' ' ' LEU . 3.4 tt -74.62 -21.03 59.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.763 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' CE ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -72.19 -37.73 69.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 57' ' ' GLU . 1.3 ttt85 -74.7 -29.82 61.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 98' ' ' PHE . 10.2 mp -80.15 -22.74 41.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.764 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -73.01 -27.44 61.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.13 179.079 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' O ' ' A' ' 2' ' ' SER . 1.2 mt -64.1 -33.31 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.84 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.5 -44.35 9.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.436 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HG2' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 53.13 89.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.333 179.554 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.43 67.29 1.67 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.551 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -137.27 148.56 46.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD11 HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -74.0 99.86 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.71 169.97 8.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -115.62 157.62 23.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.79 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.9 mtt180 -59.3 -59.84 4.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.087 0.47 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.728 ' HA ' HD21 ' A' ' 55' ' ' LEU . 11.7 mttp -56.2 -14.99 3.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.388 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -12.4 38.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.759 0.314 . . . . 0.0 110.303 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.694 HD22 ' CZ ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -89.45 -37.96 14.41 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.33 -10.0 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.928 178.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.7 -19.69 24.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 178.903 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HG3' HD13 ' A' ' 58' ' ' ILE . 4.7 pt-20 -84.15 -37.91 21.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -83.92 -19.36 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.7 -33.38 41.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.885 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.89 -8.78 57.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.723 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -119.69 -57.81 1.94 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.49 120.36 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.412 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.23 42.04 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.348 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 66' ' ' VAL . . . 65.23 23.18 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.401 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.3 tt 33.53 31.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 67' ' ' ALA . 1.8 t -163.55 -164.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.827 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -84.42 56.97 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.117 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 1.8 mmt85 -122.59 55.65 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.49 ' OD1' HG23 ' A' ' 72' ' ' VAL . 18.6 p30 -39.89 156.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HB ' HG13 ' A' ' 58' ' ' ILE . 7.3 p -51.47 -29.28 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.71 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.83 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -59.14 -65.62 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.707 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 69' ' ' ASN . 22.1 t -57.87 -22.25 18.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.739 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -73.03 -33.08 65.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 71' ' ' ASP . 6.5 mt -65.02 -38.68 83.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.22 -28.78 61.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.511 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -71.97 -23.9 61.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.037 178.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -64.46 -37.72 88.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.212 0.53 . . . . 0.0 110.189 179.25 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -22.13 64.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.0 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -90.45 -53.33 4.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 111.862 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -79.74 -51.15 9.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.311 -179.319 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.638 HD23 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.19 -63.47 1.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.703 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.58 -143.34 17.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.405 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -13.49 62.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.693 0.282 . . . . 0.0 111.398 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 21' ' ' VAL . 2.2 m-85 -84.33 -41.88 16.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.394 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.85 -31.94 61.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -67.35 -13.19 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.706 0.289 . . . . 0.0 110.568 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.476 HH12 HD11 ' A' ' 38' ' ' LEU . 16.4 ttm105 -45.7 -31.95 2.2 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.92 0.391 . . . . 0.0 110.689 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 HD22 ' A' ' 41' ' ' LEU . 6.5 mt -68.75 106.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.25 145.2 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.966 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.4 m -126.01 126.86 44.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.59 156.16 24.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 71.91 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.1 0.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.611 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.98 HG22 HD11 ' A' ' 48' ' ' LEU . 10.6 p -115.12 -35.99 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.58 -160.68 13.16 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.778 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.694 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 3.9 m-85 -69.89 130.74 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 97' ' ' LEU . 2.5 tm? -138.0 78.74 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' HB3' HD23 ' A' ' 41' ' ' LEU . 16.9 p90 -69.88 86.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -111.89 126.57 55.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.13 -42.02 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -160.02 -59.62 0.06 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.834 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.01 22.09 3.32 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.024 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -67.73 77.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.33 . . . . 0.0 110.797 179.807 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.08 146.95 40.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.159 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.03 140.79 55.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -60.92 99.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.1 t -64.38 89.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.24 -73.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.56 134.47 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.9 -35.73 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.21 115.69 2.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.978 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 123.84 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.57 96.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.0 t -61.76 125.84 25.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 175.9 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.822 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.339 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 t -98.64 97.34 8.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.14 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.6 m -128.5 97.63 27.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 24.3 Cg_exo -65.86 72.7 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.755 2.304 . . . . 0.0 112.366 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.7 mt-10 -89.57 -2.9 58.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.85 147.78 32.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.781 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.082 HD11 HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -128.63 73.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 111.183 -179.583 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 13' ' ' VAL . 1.3 ttm180 -91.84 91.86 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.646 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -101.54 69.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.693 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.05 -142.96 16.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.027 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.95 -7.49 21.25 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.424 2.083 . . . . 0.0 112.459 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.98 108.23 19.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 8' ' ' ARG . 22.8 t -95.22 125.22 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.84 ' CD2' HG22 ' A' ' 21' ' ' VAL . 9.0 t80 -116.52 147.69 41.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 13.6 m-85 -118.0 127.08 53.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.082 HG13 HD11 ' A' ' 7' ' ' ILE . 2.1 m -69.89 -19.57 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 16' ' ' VAL . 4.4 mm? -103.9 -55.85 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.9 mttm -63.59 -39.59 94.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.983 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER 69.77 46.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.5 m -135.44 119.56 17.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.84 HG22 ' CD2' ' A' ' 14' ' ' PHE . 2.5 t -89.0 101.44 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.082 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -70.66 130.15 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -125.2 152.1 70.41 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.51 -44.34 17.06 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.311 . . . . 0.0 112.39 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -53.03 17.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.96 -113.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.699 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -146.31 164.54 32.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 4.1 t -126.11 95.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -76.75 131.76 38.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD13 ' HB3' ' A' ' 35' ' ' SER . 0.4 OUTLIER -135.95 164.74 27.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.348 -179.34 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -70.21 112.14 11.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HA ' HD22 ' A' ' 19' ' ' LEU . 50.8 Cg_exo -51.33 -19.76 7.14 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 113.196 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HB3' ' HB ' ' A' ' 65' ' ' ILE . 91.1 p -77.61 -38.15 48.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.595 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.742 ' O ' HD11 ' A' ' 77' ' ' LEU . 82.8 mt-10 -84.83 -38.11 19.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.282 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.794 ' HB3' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -80.87 -12.39 59.43 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.077 177.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.88 -33.5 37.01 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.627 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 58' ' ' ILE . 11.7 tt -66.78 -32.12 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.19 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.74 HD12 ' HA2' ' A' ' 85' ' ' GLY . 4.9 tt -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.395 178.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -66.92 -44.23 81.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.738 179.737 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -71.71 -17.37 62.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.299 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 54' ' ' LEU . 4.4 mp -87.84 -23.12 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.404 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HG ' HG12 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -81.5 -21.35 38.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 179.489 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 39' ' ' LYS . 50.7 mt -77.43 -25.7 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 0.0 110.145 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.12 -44.29 6.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.359 0.6 . . . . 0.0 110.098 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 6.2 mtmp? 55.05 92.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.696 179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 98' ' ' PHE . . . 67.07 93.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.885 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -153.85 145.44 23.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 110.557 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -76.8 82.3 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.753 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.0 m -105.99 170.56 7.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.462 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -116.88 -179.79 3.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.647 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.92 69.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.64 -11.69 54.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -89.2 -44.44 10.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -66.92 -26.35 66.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 52' ' ' LYS . 2.1 pp -87.98 -13.29 42.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.178 178.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -90.51 -27.39 19.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 179.42 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 47.1 mt-10 -90.16 -16.37 29.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.186 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.709 HD11 HG13 ' A' ' 37' ' ' ILE . 35.6 mt -98.12 -21.22 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -77.91 -27.34 49.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.054 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.04 36.55 0.92 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.005 0.431 . . . . 0.0 109.945 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -169.87 -40.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.547 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.803 ' HB1' HG13 ' A' ' 65' ' ' ILE . . . -160.16 81.81 0.7 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 82.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 51.81 74.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.569 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.803 HG13 ' HB1' ' A' ' 62' ' ' ALA . 67.1 mt -59.39 92.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.453 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 66' ' ' VAL . 57.5 t 56.25 75.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . . . -166.81 -169.67 1.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtt85 -101.2 -50.33 3.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 111.023 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -160.01 -168.31 2.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.282 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -90.29 -30.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 110.983 179.686 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -53.55 -68.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.734 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.55 -22.44 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -75.3 -32.43 60.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.63 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.848 HG23 HD13 ' A' ' 88' ' ' ILE . 5.9 mt -69.04 -33.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.31 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.86 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -68.53 -27.83 66.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.384 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -64.18 -35.13 79.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.504 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -62.7 -21.04 65.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.37 -53.96 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -76.37 -51.06 12.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.177 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -75.01 -70.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.98 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.43 -131.25 9.74 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.587 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.68 61.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.687 0.279 . . . . 0.0 111.543 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.4 m-85 -89.94 -49.15 6.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.339 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA2' HD12 ' A' ' 38' ' ' LEU . . . -63.91 -26.85 70.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.667 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 t -65.81 -10.3 36.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.527 0.203 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 89' ' ' VAL . 24.3 ttm105 -45.6 -33.56 2.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.979 0.418 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.848 HD13 HG23 ' A' ' 74' ' ' ILE . 2.5 mt -64.61 83.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' ARG . 39.6 t -86.41 132.6 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 m -104.72 85.1 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -69.85 119.54 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.243 -179.339 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.68 72.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.36 -26.52 1.38 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.88 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 91' ' ' LEU . 6.2 t -97.47 -56.64 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.392 . . . . 0.0 110.517 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.56 -110.41 0.64 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.662 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.45 107.54 10.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.782 0.325 . . . . 0.0 110.777 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 98' ' ' PHE . 7.6 tt -107.86 154.35 21.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -116.56 90.16 3.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.721 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 97' ' ' LEU . 3.5 m -39.88 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.719 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' O ' ' N ' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -86.82 -17.01 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.559 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 52.65 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 100' ' ' ASP . . . 140.78 67.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.511 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.01 -176.39 5.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -159.68 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -140.15 100.94 4.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 86.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 t -88.64 75.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.008 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.11 -29.25 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.72 151.95 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -147.05 35.64 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 112' ' ' LYS . 1.1 m -60.27 172.98 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' H ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -160.2 113.16 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.6 128.37 36.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 t -160.13 152.17 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.99 -31.27 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.859 -179.943 . . . . . . . . 0 0 . 1 stop_ save_